data_2k1z_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1z _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 16' ' ' VAL . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.455 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CG2' HG11 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 68' ' ' ILE . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 83' ' ' ALA . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 75' ' ' LEU . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.504 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 91' ' ' MET . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.433 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.0 t-20 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.565 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.565 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.433 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CE2' HD13 ' A' ' 68' ' ' ILE . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.469 ' HB ' HD12 ' A' ' 26' ' ' LEU . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.462 HG11 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.462 ' CG2' HG11 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 27' ' ' GLY . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.498 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 3.4 p30 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' CB ' HD12 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 11' ' ' PHE . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 101' ' ' ILE . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.423 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.419 ' CE ' HD13 ' A' ' 101' ' ' ILE . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.405 ' C ' ' HG2' ' A' ' 94' ' ' GLU . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 3.0 t-20 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.613 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.613 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.535 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.438 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 22.6 ptt180 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.51 0.672 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 16' ' ' VAL . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.481 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 ' N ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' CD1' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.422 ' CD1' ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.454 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.485 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.468 HG22 HD12 ' A' ' 68' ' ' ILE . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB1' ' CD1' ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.403 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 91' ' ' MET . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.9 t-20 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.428 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.706 0.288 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.401 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' A' ' 16' ' ' VAL . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 50' ' ' ILE . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB1' HG22 ' A' ' 49' ' ' ILE . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CB ' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.4 ' NE2' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.4 ' CD1' ' NE2' ' A' ' 66' ' ' GLN . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' MET . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.4 t-20 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.629 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.629 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.415 HG23 ' CE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 13' ' ' THR . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 50' ' ' ILE . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.465 ' HB ' HG21 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' NZ ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.465 HG21 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.4 p30 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 49' ' ' ILE . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.45 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.551 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 11' ' ' PHE . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.441 ' CG1' ' CG2' ' A' ' 86' ' ' THR . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 83' ' ' ALA . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 91' ' ' MET . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.456 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.7 t-20 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.529 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.83 0.347 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.457 HG13 HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.427 HG22 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' N ' ' A' ' 50' ' ' ILE . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 68' ' ' ILE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.5 HD23 ' HE2' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.3 p30 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.506 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.575 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.474 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.832 0.349 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.44 ' CZ ' ' CB ' ' A' ' 12' ' ' LEU . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.485 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.488 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.427 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' HG11 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.8 OUTLIER -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 33.8 m-20 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 101' ' ' ILE . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.427 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.443 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 91' ' ' MET . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.4 t-20 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HG3' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.418 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.518 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.434 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.922 0.392 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 102' ' ' GLN . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 16' ' ' VAL . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.557 ' HA ' HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.656 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 86' ' ' THR . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.503 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.3 t-20 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.469 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 25.3 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.797 0.332 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD2' HD13 ' A' ' 68' ' ' ILE . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.528 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' HB ' ' A' ' 50' ' ' ILE . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.413 ' CD1' ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.464 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 11' ' ' PHE . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' CE ' ' A' ' 84' ' ' MET . 4.6 m120 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.403 ' CE ' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' MET . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.425 ' CE ' ' CD2' ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.484 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.405 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 49' ' ' ILE . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.411 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' HD21 ' A' ' 61' ' ' LEU . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.411 HD13 ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.473 HD22 ' HE2' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.415 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.4 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 98' ' ' ARG . 2.1 t-20 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 96' ' ' ASN . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.488 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.801 0.334 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 68' ' ' ILE . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.503 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.438 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.64 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 11' ' ' PHE . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.424 ' CD2' ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' MET . 14.5 m-20 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.433 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.507 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' MET . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.452 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.5 t-20 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.422 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.514 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 14' ' ' PHE . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 54' ' ' ALA . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.448 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' C ' ' CD ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.471 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HA ' ' CG1' ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' GLY . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.2 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HE2' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.46 ' HB3' HD11 ' A' ' 61' ' ' LEU . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.469 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 82' ' ' GLU . 3.0 pm0 -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.475 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.3 t-20 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.502 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.422 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.411 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CE2' HD12 ' A' ' 68' ' ' ILE . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.506 ' HA ' HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 11' ' ' PHE . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 18.9 m-80 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.481 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB3' ' CE ' ' A' ' 91' ' ' MET . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.402 ' CE ' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.527 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.4 t-20 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.65 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.65 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.806 0.336 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.496 HD12 ' HB ' ' A' ' 16' ' ' VAL . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.512 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.401 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' ARG . 41.5 m-80 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 83' ' ' ALA . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 86' ' ' THR . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 91' ' ' MET . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.476 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.2 t-20 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.487 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.418 ' CE2' HG22 ' A' ' 68' ' ' ILE . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.504 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.523 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.411 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.472 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.471 HG21 HG11 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.626 HD11 ' N ' ' A' ' 50' ' ' ILE . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.418 HG22 ' CE2' ' A' ' 11' ' ' PHE . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.418 ' ND2' ' HA3' ' A' ' 95' ' ' GLY . 70.0 m-80 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 3.0 p30 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.507 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.523 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.577 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.577 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.504 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.488 HG23 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 54' ' ' ALA . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 26' ' ' LEU . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 18' ' ' LEU . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.476 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.478 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.426 ' CB ' HD22 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG2' ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . 0.463 ' ND2' ' HA3' ' A' ' 95' ' ' GLY . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.476 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.437 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.561 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 91' ' ' MET . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.496 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.544 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' ASN . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.477 HG21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 HG12 ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HG11 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.603 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.427 ' CB ' HD21 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.407 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 91' ' ' MET . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.491 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 98' ' ' ARG . 3.4 t-20 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.264 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.446 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.459 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 50' ' ' ILE . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.433 ' HB3' HG23 ' A' ' 49' ' ' ILE . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 86' ' ' THR . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HA ' ' CE ' ' A' ' 78' ' ' LYS . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.477 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 91' ' ' MET . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.567 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.462 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.3 t-20 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.493 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 49' ' ' ILE . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.457 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.7 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CB ' HD22 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' CB ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.468 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 91' ' ' MET . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.481 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 3.5 t-20 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.428 ' CG2' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.755 0.312 . . . . 0.0 110.831 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 39' ' ' HIS . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG12 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.601 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.452 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 68' ' ' ILE . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ALA . . . . . 0.451 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' MET . . . . . 0.413 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 91' ' ' MET . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' MET . . . . . 0.439 ' CE ' HD11 ' A' ' 101' ' ' ILE . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.438 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.2 t-20 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' MET . . . . . 0.502 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.678 ' HB ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -123.28 139.41 54.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.424 ' CA ' HD13 ' A' ' 109' ' ' ILE . 63.1 mtm-85 -129.08 162.12 28.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.824 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.435 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.504 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.511 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.502 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.504 HD13 ' HB ' ' A' ' 16' ' ' VAL . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.455 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.464 HG11 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.431 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.464 ' CG2' HG11 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.456 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.474 HD12 HG21 ' A' ' 68' ' ' ILE . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 83' ' ' ALA . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.504 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.418 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.445 ' HA ' HD23 ' A' ' 75' ' ' LEU . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.418 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.579 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.504 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.409 ' O ' ' CG ' ' A' ' 91' ' ' MET . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.565 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.579 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.409 ' CG ' ' O ' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.433 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.502 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.0 t-20 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.565 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.565 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.511 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.433 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.4 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 -120.69 137.02 54.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 166.13 24.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.678 HD12 ' HB ' ' A' ' 8' ' ' THR . 3.7 mp -133.6 156.61 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 73.0 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.944 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.425 ' HA ' HG13 ' A' ' 109' ' ' ILE . 8.8 p -154.25 54.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.7 108.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.422 ' CE2' HD13 ' A' ' 68' ' ' ILE . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.426 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.469 ' HB ' HD12 ' A' ' 26' ' ' LEU . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.556 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.556 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.5 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.462 HG11 ' CG2' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.454 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.462 ' CG2' HG11 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.5 ' HB ' ' CA ' ' A' ' 27' ' ' GLY . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.498 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 3.4 p30 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.407 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.42 ' CB ' HG13 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.448 ' HA ' HD11 ' A' ' 61' ' ' LEU . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' CB ' HD12 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.476 HD23 ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.411 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.437 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.422 HD13 ' CE2' ' A' ' 11' ' ' PHE . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 101' ' ' ILE . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.409 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.423 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.423 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.447 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.419 ' CE ' HD13 ' A' ' 101' ' ' ILE . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.405 ' C ' ' HG2' ' A' ' 94' ' ' GLU . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' O ' ' HE2' ' A' ' 97' ' ' LYS . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.499 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 3.0 t-20 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.613 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.613 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.535 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 15.2 ttm180 -147.12 143.63 28.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 mtm-85 -74.87 -176.02 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.775 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG13 ' HA ' ' A' ' 8' ' ' THR . 2.1 mt -137.28 159.4 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 26.9 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' O ' ' HB ' ' A' ' 109' ' ' ILE . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 9' ' ' ARG . 37.0 p -164.19 138.37 5.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.766 0.317 . . . . 0.0 110.873 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.499 ' O ' ' O ' ' A' ' 8' ' ' THR . 22.6 ptt180 50.0 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.882 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.51 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.491 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.51 HD11 ' HB ' ' A' ' 16' ' ' VAL . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.481 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 ' N ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.419 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.422 ' ND2' ' CD1' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.422 ' CD1' ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.419 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.454 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.574 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.485 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.453 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.485 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.453 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.423 ' HB3' ' CD1' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' CD1' ' HB3' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.468 HG22 HD12 ' A' ' 68' ' ' ILE . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.454 ' HB1' ' CD1' ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.403 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.422 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.429 ' O ' ' HG2' ' A' ' 91' ' ' MET . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.429 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.445 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.46 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.9 t-20 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.435 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.463 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.428 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.92 112.08 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -62.02 160.42 12.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' HB ' ' O ' ' A' ' 7' ' ' GLY . 6.9 mm -116.51 162.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.95 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.853 -179.87 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.601 ' HB ' HD13 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -135.33 141.87 45.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.999 0.428 . . . . 0.0 110.987 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.412 ' CA ' HD11 ' A' ' 109' ' ' ILE . 5.3 mtm105 -137.87 140.24 40.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.403 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.415 ' CE2' HG23 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.528 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.515 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.401 ' N ' HD21 ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.528 HD13 ' HB ' ' A' ' 16' ' ' VAL . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.44 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.469 HG12 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.455 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.469 ' HA ' HG12 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.488 HD11 ' N ' ' A' ' 50' ' ' ILE . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB1' HG22 ' A' ' 49' ' ' ILE . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.408 ' CB ' HD21 ' A' ' 61' ' ' LEU . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.425 ' CD1' ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.408 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.4 ' NE2' ' CD1' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.4 ' CD1' ' NE2' ' A' ' 66' ' ' GLN . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.409 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.408 ' O ' ' CE ' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.442 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.408 ' CE ' ' O ' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.442 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.438 ' O ' ' HG2' ' A' ' 91' ' ' MET . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.422 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.49 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.4 t-20 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.629 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.629 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.526 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.425 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.415 HG23 ' CE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -141.92 142.18 33.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -87.11 131.58 34.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.601 HD13 ' HB ' ' A' ' 8' ' ' THR . 3.6 mp -92.93 157.24 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.047 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.998 0.428 . . . . 0.0 110.882 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.414 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 23.0 p -151.61 61.7 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.967 0.413 . . . . 0.0 110.988 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.48 102.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.638 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.412 ' CE2' HD11 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.413 ' CD1' ' O ' ' A' ' 13' ' ' THR . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.405 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.409 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.529 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.445 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.441 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.445 ' HA2' ' HB ' ' A' ' 50' ' ' ILE . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.465 ' HB ' HG21 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.483 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' NZ ' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.47 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.402 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.461 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.465 HG21 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.578 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.4 p30 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.45 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.462 ' HB3' HG21 ' A' ' 49' ' ' ILE . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.578 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.45 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.411 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.428 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.551 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.412 HD11 ' CE2' ' A' ' 11' ' ' PHE . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.441 ' CG1' ' CG2' ' A' ' 86' ' ' THR . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 83' ' ' ALA . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.457 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.47 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.651 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.457 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.445 ' O ' ' HG2' ' A' ' 91' ' ' MET . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.456 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.445 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.445 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.7 t-20 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.529 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -142.99 138.45 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -58.88 166.29 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.414 ' CG1' ' HA ' ' A' ' 8' ' ' THR . 9.1 mm -118.63 162.83 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.1 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.048 179.919 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.463 ' HB ' ' N ' ' A' ' 109' ' ' ILE . 18.9 p -77.53 78.9 4.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.443 ' N ' HD11 ' A' ' 109' ' ' ILE . 2.5 mtt85 -170.32 101.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.411 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.421 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.457 HG13 HD13 ' A' ' 26' ' ' LEU . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.575 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.502 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.434 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.427 HG13 HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.499 ' HA ' ' O ' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.514 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.427 HG22 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.604 HD11 ' N ' ' A' ' 50' ' ' ILE . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.563 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.443 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' HB2' HG22 ' A' ' 49' ' ' ILE . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.563 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.443 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.461 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.468 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.446 HD11 HG21 ' A' ' 68' ' ' ILE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 10.5 p30 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.5 HD23 ' HE2' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.447 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.3 p30 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.48 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.506 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.491 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.497 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.491 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.575 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.474 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.527 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.531 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.571 HG22 HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -131.27 153.81 49.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.99 122.68 31.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.074 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.463 ' N ' ' HB ' ' A' ' 8' ' ' THR . 2.0 mp -63.88 151.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 67.3 p -67.83 66.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.205 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.07 112.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.417 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.44 ' CZ ' ' CB ' ' A' ' 12' ' ' LEU . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.485 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.518 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.463 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.461 ' N ' HD11 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.488 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.427 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.488 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.404 ' CG2' HG11 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 50' ' ' ILE . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.491 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.8 OUTLIER -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.4 ' CB ' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.491 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.423 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 33.8 m-20 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' CG2' HD12 ' A' ' 101' ' ' ILE . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.443 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.427 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.443 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.527 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.527 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.439 ' O ' ' HG2' ' A' ' 91' ' ' MET . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.422 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.439 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.486 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.442 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.4 t-20 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.414 ' HG3' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.418 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.518 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.434 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.412 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -136.2 141.0 43.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.75 138.17 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 28.1 mm -63.21 -68.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.937 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.5 p -155.4 170.11 22.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 110.678 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 62.47 124.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.401 ' CG2' ' CG ' ' A' ' 102' ' ' GLN . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.459 ' CE2' ' CG2' ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.401 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.502 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.481 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.447 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.502 HD11 ' HB ' ' A' ' 16' ' ' VAL . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.449 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.557 HG13 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.474 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.483 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.412 ' ND2' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.43 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' N ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.492 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.483 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.557 ' HA ' HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.656 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.451 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' HD13 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.489 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.451 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.454 HD13 ' HB3' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.492 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.404 HG11 ' CG2' ' A' ' 86' ' ' THR . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.434 ' HA ' ' CD2' ' A' ' 75' ' ' LEU . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' MET . . . . . . . . . . . . . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.672 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.404 ' CG2' HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.453 ' O ' ' HG2' ' A' ' 91' ' ' MET . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.672 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.503 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.453 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.503 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.446 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.3 t-20 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.469 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.413 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 25.3 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.459 ' CG2' ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -135.73 152.06 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 149.87 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.4 HD12 HG21 ' A' ' 109' ' ' ILE . 9.5 mt -102.95 159.78 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 86.7 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 -180.0 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 1.8 t -176.39 52.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.024 0.44 . . . . 0.0 110.872 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.37 101.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.602 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.431 ' CD2' HD13 ' A' ' 68' ' ' ILE . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.405 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.421 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.528 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.455 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' HA2' ' HB ' ' A' ' 50' ' ' ILE . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.468 ' HA ' ' O ' ' A' ' 48' ' ' SER . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.435 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.463 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.415 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.413 ' CD1' ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.464 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.463 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . 0.468 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.437 HG21 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.455 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.458 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.45 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.426 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.431 HD13 ' CD2' ' A' ' 11' ' ' PHE . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.407 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.403 ' O ' ' CE ' ' A' ' 84' ' ' MET . 4.6 m120 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.464 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.403 ' CE ' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.539 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' MET . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.539 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.406 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.425 ' CE ' ' CD2' ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.571 ' O ' ' HG3' ' A' ' 97' ' ' LYS . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.484 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.492 HG21 HD11 ' A' ' 101' ' ' ILE . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.401 ' CD2' ' CD2' ' A' ' 87' ' ' LEU . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.0 mtt180 -124.82 135.76 53.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.85 128.38 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.6 mm -91.83 163.45 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.02 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.2 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.944 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.426 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 37.5 p -157.9 45.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -172.78 107.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.514 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.514 HD12 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.405 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.434 HG11 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.44 HD11 HG22 ' A' ' 49' ' ' ILE . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.545 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.411 ' CB ' HD13 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.545 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' CB ' HD21 ' A' ' 61' ' ' LEU . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.411 HD13 ' CB ' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.408 ' CG2' ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.473 HD22 ' HE2' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.408 ' CD1' ' CG2' ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.473 ' HE2' HD22 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.453 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.415 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.4 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.4 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.426 ' O ' ' CG2' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.4 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.43 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.487 ' C ' ' H ' ' A' ' 98' ' ' ARG . 2.1 t-20 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 96' ' ' ASN . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.488 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.437 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -127.25 147.06 50.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -75.48 149.55 38.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.426 ' CG1' ' HA ' ' A' ' 8' ' ' THR . 19.5 mm -81.84 159.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.461 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -178.9 79.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.85 109.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 68' ' ' ILE . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.431 ' HB ' HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.514 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.503 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.424 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.464 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.429 HG12 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.417 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.438 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.429 HG23 HG12 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.64 HD11 ' N ' ' A' ' 50' ' ' ILE . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.433 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.416 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.433 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.458 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.41 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.415 HD11 ' CE2' ' A' ' 11' ' ' PHE . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.424 ' CD2' ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.507 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 84' ' ' MET . 14.5 m-20 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.433 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.438 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.43 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.507 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.416 ' O ' ' HG2' ' A' ' 91' ' ' MET . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.416 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.452 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.503 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.5 t-20 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.422 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.514 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 ' CG2' HD22 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 14' ' ' PHE . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.407 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.15 136.27 36.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 110.45 23.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' HB ' ' HA ' ' A' ' 8' ' ' THR . 24.2 mm -55.32 162.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.446 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 43.9 p -156.86 40.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 177.22 114.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.427 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.469 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.481 HG13 ' HB1' ' A' ' 54' ' ' ALA . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.583 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.583 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.439 ' O ' HG23 ' A' ' 49' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.448 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.41 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' C ' ' CD ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.433 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.471 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.433 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.41 ' HA ' ' CG1' ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.439 HG23 ' O ' ' A' ' 27' ' ' GLY . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.448 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.608 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.2 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.52 ' HB2' ' HA ' ' A' ' 18' ' ' LEU . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.608 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.401 ' HE2' ' N ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.46 ' HB3' HD11 ' A' ' 61' ' ' LEU . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.469 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.473 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.558 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.558 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.408 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.418 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.495 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.413 ' HG2' ' N ' ' A' ' 82' ' ' GLU . 3.0 pm0 -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.418 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.471 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.495 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.439 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.518 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.475 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 2.3 t-20 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.445 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.431 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.502 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.422 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.411 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 122.07 32.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.38 132.78 37.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.601 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.446 ' CG1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mm -90.31 164.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.2 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 -179.944 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 N-CA-C 114.18 0.432 . . . . 0.0 114.18 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.554 ' OG1' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -131.22 106.26 8.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.731 0.765 . . . . 0.0 111.507 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mtt180 -84.0 136.43 34.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.285 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.42 ' CE2' HD12 ' A' ' 68' ' ' ILE . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.427 ' CE2' HG22 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.519 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.406 HD21 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD11 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.506 HG13 ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.416 ' CG1' ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.435 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.467 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.489 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.428 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.435 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.506 ' HA ' HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.449 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.56 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.415 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.405 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.403 ' CD1' ' CG1' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.428 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 11' ' ' PHE . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.481 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.425 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 18.9 m-80 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.481 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.467 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.425 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.402 ' HB3' ' CE ' ' A' ' 91' ' ' MET . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.48 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.402 ' CE ' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.527 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.4 t-20 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.65 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.65 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.519 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.438 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.427 HG22 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.42 ' CB ' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -136.0 122.66 20.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.477 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 3.4 tpp180 -68.03 155.61 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.554 HG12 ' OG1' ' A' ' 8' ' ' THR . 1.2 mm -104.51 -94.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.385 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.434 ' N ' ' CG2' ' A' ' 109' ' ' ILE . 24.0 m . . . . . 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 110.933 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.441 ' HA ' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -65.19 79.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 177.33 120.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.496 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.47 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.496 HD12 ' HB ' ' A' ' 16' ' ' VAL . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.512 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.1 p30 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.41 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.408 HG23 HG11 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.613 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.44 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.401 ' CB ' HG23 ' A' ' 28' ' ' VAL . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.613 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.44 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.432 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.52 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.436 ' H ' ' C ' ' A' ' 62' ' ' ARG . 41.5 m-80 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.41 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 69.1 m-80 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 83' ' ' ALA . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.464 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.426 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.455 ' HA ' ' HE3' ' A' ' 78' ' ' LYS . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.444 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 86' ' ' THR . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.464 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.442 ' O ' ' HG2' ' A' ' 91' ' ' MET . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.442 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.476 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.467 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.2 t-20 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.415 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.487 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.451 ' CG2' ' CE1' ' A' ' 14' ' ' PHE . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -109.54 128.2 55.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HB3' ' NH1' ' A' ' 108' ' ' ARG . 0.3 OUTLIER -88.71 127.31 35.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 8' ' ' THR . 1.6 mt -98.04 -177.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 -179.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 24.5 p -155.42 36.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.586 0.232 . . . . 0.0 111.406 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 109' ' ' ILE . 9.2 mtt180 -169.38 122.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.173 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.418 ' CE2' HG22 ' A' ' 68' ' ' ILE . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HB3' ' CZ ' ' A' ' 14' ' ' PHE . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.415 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.43 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.45 ' HB ' HD13 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.504 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.523 ' HG ' ' OD1' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.442 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.466 HD11 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.431 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.471 HG11 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.411 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.411 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.472 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.422 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.471 HG21 HG11 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.626 HD11 ' N ' ' A' ' 50' ' ' ILE . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.561 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.43 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.403 ' HB1' ' CG2' ' A' ' 49' ' ' ILE . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.561 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.43 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.43 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.477 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.422 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.415 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.418 HG22 ' CE2' ' A' ' 11' ' ' PHE . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.418 ' ND2' ' HA3' ' A' ' 95' ' ' GLY . 70.0 m-80 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.42 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 3.0 p30 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.472 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.42 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.507 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.498 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.507 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.523 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.577 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.577 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.504 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.488 HG23 HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.4 ' CD1' ' CG2' ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.27 141.78 47.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.81 144.83 28.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.42 HG12 ' N ' ' A' ' 9' ' ' ARG . 12.0 mm -83.7 159.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.305 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' THR . . . . . 0.419 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 12.5 p -154.02 174.92 14.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 62.95 110.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.04 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.423 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.491 HG13 ' HB2' ' A' ' 54' ' ' ALA . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.589 ' HB3' HD11 ' A' ' 26' ' ' LEU . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.589 HD11 ' HB3' ' A' ' 18' ' ' LEU . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.436 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.541 HG13 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.476 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG21 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.662 ' N ' HD13 ' A' ' 50' ' ' ILE . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.478 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.491 ' HB2' HG13 ' A' ' 16' ' ' VAL . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.441 ' HB2' HD12 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.478 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.426 ' CB ' HD22 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.441 HD12 ' HB2' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.555 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.555 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.436 ' CG2' ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . 0.463 ' ND2' ' HA3' ' A' ' 95' ' ' GLY . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.437 ' HB2' ' HE1' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.5 pm0 -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.476 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.437 ' HE1' ' HB2' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.561 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.468 ' O ' ' HG2' ' A' ' 91' ' ' MET . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.423 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.496 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.463 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.544 ' OD1' ' HG ' ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.452 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.51 ' O ' ' HA ' ' A' ' 96' ' ' ASN . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.477 HG21 HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.91 128.0 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 128.5 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.419 ' HB ' ' HA ' ' A' ' 8' ' ' THR . 7.4 mt -97.99 159.54 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.4 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 11.1 p -153.07 54.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -179.84 102.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.406 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.452 HG12 HD11 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.471 ' HA ' ' HA ' ' A' ' 100' ' ' MET . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.479 ' HA ' ' HB3' ' A' ' 54' ' ' ALA . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.452 HD11 HG12 ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.419 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.487 HG11 HG21 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.43 ' CD1' ' HB2' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.474 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG21 HG11 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.603 ' N ' HD13 ' A' ' 50' ' ' ILE . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.539 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.479 ' HB3' ' HA ' ' A' ' 18' ' ' LEU . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.42 ' HB1' HD13 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.539 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.427 ' CB ' HD21 ' A' ' 61' ' ' LEU . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.406 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.427 HD21 ' CB ' ' A' ' 58' ' ' ASP . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.425 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.442 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.407 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.43 ' HB2' ' CD1' ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.407 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.434 ' O ' ' HG2' ' A' ' 91' ' ' MET . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.434 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.491 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.415 ' O ' ' N ' ' A' ' 98' ' ' ARG . 3.4 t-20 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.471 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' CG2' ' CD2' ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.72 129.74 37.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 121.62 25.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.667 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.9 mm -59.27 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.185 -179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.186 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 21.5 p -153.81 47.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -177.09 113.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CG ' ' HG3' ' A' ' 60' ' ' ARG . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.428 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.493 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.489 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.404 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.489 ' CD1' ' HB3' ' A' ' 18' ' ' LEU . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.446 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.476 HG12 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . 0.42 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.459 ' CD1' ' HB1' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.448 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.416 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.476 HG23 HG12 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.517 HD11 ' N ' ' A' ' 50' ' ' ILE . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.441 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.433 ' HB3' HG23 ' A' ' 49' ' ' ILE . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.441 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.419 HD12 ' CB ' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.416 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.424 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.418 HG11 ' CG2' ' A' ' 86' ' ' THR . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 HD21 ' HB2' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.477 ' HE3' ' HB ' ' A' ' 86' ' ' THR . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.449 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.9 pm0 -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.428 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.465 ' HA ' ' CE ' ' A' ' 78' ' ' LYS . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.449 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.703 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.477 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.451 ' O ' ' HG2' ' A' ' 91' ' ' MET . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.703 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.567 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 87' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.567 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.462 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.3 t-20 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.41 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.493 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . 0.422 HG23 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -143.75 149.7 37.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -90.92 151.05 21.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.8 mm -85.35 160.69 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.982 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 16.8 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.9 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 39.2 p -59.23 166.5 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 0.0 110.973 -179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 62.78 136.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.429 ' CG1' ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.432 ' CD2' ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.414 ' O ' HG22 ' A' ' 49' ' ' ILE . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.457 ' N ' ' CD1' ' A' ' 50' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.473 ' CD1' ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.438 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.414 HG22 ' O ' ' A' ' 27' ' ' GLY . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.457 ' CD1' ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.574 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.7 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.447 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.414 ' CB ' ' CD1' ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.574 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.447 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.417 ' CB ' HD22 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.417 HD22 ' CB ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.438 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.431 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.446 ' CD2' ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.468 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.473 ' HB3' ' CD1' ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.468 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.403 ' HB3' ' CE ' ' A' ' 91' ' ' MET . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 94' ' ' GLU . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.403 ' CE ' ' HB3' ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.481 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.488 ' O ' ' HG2' ' A' ' 97' ' ' LYS . 3.5 t-20 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.488 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.467 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.428 ' CG2' HD21 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . . . . . . . . . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 6.6 ttm180 -140.69 143.47 35.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . 0.422 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.4 OUTLIER -78.02 152.99 32.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 26.2 mm -79.76 157.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.844 0.354 . . . . 0.0 111.073 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 42.7 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.978 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 p 54.74 38.39 30.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.779 0.323 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.64 135.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.831 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.409 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.464 ' HB ' HD12 ' A' ' 26' ' ' LEU . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.502 ' HA ' ' CB ' ' A' ' 100' ' ' MET . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.449 ' HB3' ' CD1' ' A' ' 26' ' ' LEU . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 25' ' ' GLY . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.451 ' CA ' ' HB ' ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.418 ' HD3' ' CD2' ' A' ' 39' ' ' HIS . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ILE . . . . . 0.451 ' CD1' ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.419 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.417 ' CG2' HG12 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.598 HD12 ' N ' ' A' ' 50' ' ' ILE . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . 0.601 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.452 ' HA ' ' CG ' ' A' ' 57' ' ' LYS . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.601 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.452 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.46 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.419 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.46 HD12 HG23 ' A' ' 68' ' ' ILE . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.403 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASN . . . . . 0.413 ' HB2' ' HE2' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ALA . . . . . 0.451 ' CB ' ' CD1' ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' MET . . . . . 0.413 ' HE2' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.433 ' O ' ' HG2' ' A' ' 91' ' ' MET . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' MET . . . . . 0.439 ' CE ' HD11 ' A' ' 101' ' ' ILE . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.443 ' O ' ' CG ' ' A' ' 94' ' ' GLU . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLY . . . . . 0.439 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.438 ' HB2' ' CD2' ' A' ' 18' ' ' LEU . 3.2 t-20 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.406 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' MET . . . . . 0.502 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.439 ' HB ' ' CA ' ' A' ' 95' ' ' GLY . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.403 ' HA ' ' HA ' ' A' ' 70' ' ' VAL . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -133.08 148.97 52.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 146.95 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 10.7 mm -94.64 159.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.166 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 68' ' ' ILE . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.716 HG23 HD11 ' A' ' 104' ' ' ILE . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' A' ' 105' ' ' VAL . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.903 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.777 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.873 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 54' ' ' ALA . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 67' ' ' LEU . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.644 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.644 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.017 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.899 HG23 HG13 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.903 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 58' ' ' ASP . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 ' CG1' ' A' ' 105' ' ' VAL . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.869 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.616 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 m120 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.746 HD12 ' HB3' ' A' ' 67' ' ' LEU . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' NZ ' HD23 ' A' ' 75' ' ' LEU . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.017 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.465 ' HA ' HD12 ' A' ' 87' ' ' LEU . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.583 HD21 HD13 ' A' ' 67' ' ' LEU . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.697 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.873 ' HB2' HD21 ' A' ' 18' ' ' LEU . 40.7 t30 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.576 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.486 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.724 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.616 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.904 ' CG1' HD23 ' A' ' 67' ' ' LEU . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.697 HG23 ' CD1' ' A' ' 104' ' ' ILE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.911 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.939 HG11 HD11 ' A' ' 67' ' ' LEU . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.136 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 30' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.911 HG23 HG13 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.8 p-10 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.675 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.662 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 HG11 ' A' ' 30' ' ' VAL . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 106' ' ' ALA . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.645 ' HB ' HD23 ' A' ' 103' ' ' LEU . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' HG22 ' A' ' 70' ' ' VAL . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.136 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 75' ' ' LEU . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.83 ' CE ' HD22 ' A' ' 26' ' ' LEU . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.898 ' HB2' HD21 ' A' ' 18' ' ' LEU . 21.1 t30 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.627 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.57 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 ' HB ' ' A' ' 70' ' ' VAL . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.697 ' CD1' HG23 ' A' ' 13' ' ' THR . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.955 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 15.2 ttm180 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 22.6 ptt180 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.51 0.672 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 104' ' ' ILE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.926 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.809 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.737 HD22 ' SD ' ' A' ' 91' ' ' MET . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 67' ' ' LEU . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD12 ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.064 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 30' ' ' VAL . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.98 HD13 HD23 ' A' ' 61' ' ' LEU . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.747 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.2 m120 -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.926 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' H ' HD13 ' A' ' 61' ' ' LEU . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.98 HD23 HD13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 68' ' ' ILE . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.795 HD11 HG11 ' A' ' 30' ' ' VAL . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.702 HG23 HD12 ' A' ' 76' ' ' LEU . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.777 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 103' ' ' LEU . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 70' ' ' VAL . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 67' ' ' LEU . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD12 HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.064 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 30' ' ' VAL . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.636 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.737 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.842 ' HB2' HD21 ' A' ' 18' ' ' LEU . 12.7 t30 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.679 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.432 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.706 0.288 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' HG21 ' A' ' 68' ' ' ILE . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 105' ' ' VAL . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.464 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.794 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 26' ' ' LEU . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD22 ' SD ' ' A' ' 91' ' ' MET . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.654 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.982 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 46' ' ' VAL . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.622 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.779 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.779 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.097 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.93 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 HG13 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.8 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.625 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.498 ' OE1' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 87' ' ' LEU . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.699 HG21 ' HE2' ' A' ' 11' ' ' PHE . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 103' ' ' LEU . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.6 m120 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 77' ' ' GLY . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 76' ' ' LEU . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.097 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.425 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD11 ' CD1' ' A' ' 67' ' ' LEU . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.449 ' HG ' HD12 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.853 ' HB2' HD21 ' A' ' 18' ' ' LEU . 33.9 t30 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.642 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.642 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 70' ' ' VAL . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.791 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.829 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.772 HD22 ' CE ' ' A' ' 91' ' ' MET . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.015 HG12 ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 40' ' ' ALA . 10.7 p-10 -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 1.015 ' HA ' HG12 ' A' ' 30' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 58' ' ' ASP . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 87' ' ' LEU . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG23 ' HG ' ' A' ' 103' ' ' LEU . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m120 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.802 HD23 ' CE ' ' A' ' 78' ' ' LYS . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.802 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 67' ' ' LEU . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.772 ' CE ' HD22 ' A' ' 26' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.799 ' HB2' HD21 ' A' ' 18' ' ' LEU . 29.1 t30 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.52 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.702 HG12 HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HG ' HG23 ' A' ' 70' ' ' VAL . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 67' ' ' LEU . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.83 0.347 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.518 ' HE2' HG21 ' A' ' 68' ' ' ILE . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.501 HD11 ' CD ' ' A' ' 107' ' ' ARG . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.726 HG23 HD11 ' A' ' 104' ' ' ILE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.731 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.867 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.976 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' LEU . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.84 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 67' ' ' LEU . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.13 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 30' ' ' VAL . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 63' ' ' VAL . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' OD2' HG21 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 30' ' ' VAL . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 11' ' ' PHE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.655 HG22 ' OD1' ' A' ' 71' ' ' ASN . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.655 ' OD1' HG22 ' A' ' 70' ' ' VAL . 2.6 p-10 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.633 ' HB2' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD23 ' CE ' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.82 ' CE ' HD23 ' A' ' 75' ' ' LEU . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.455 ' O ' ' HE2' ' A' ' 84' ' ' MET . 1.8 p-10 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.13 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.455 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.486 ' CB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 67' ' ' LEU . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.586 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.976 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.625 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 67' ' ' LEU . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.501 ' CD ' HD11 ' A' ' 12' ' ' LEU . 8.2 ptp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.832 0.349 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.792 HG23 HD11 ' A' ' 104' ' ' ILE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.829 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.837 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.648 HD22 ' SD ' ' A' ' 91' ' ' MET . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.801 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 67' ' ' LEU . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.834 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.044 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 30' ' ' VAL . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.866 HG23 HG13 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD13 ' C ' ' A' ' 27' ' ' GLY . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.1 m120 -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m120 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.927 HD11 HG11 ' A' ' 30' ' ' VAL . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 67' ' ' LEU . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 70' ' ' VAL . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.834 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.509 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.044 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.509 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 30' ' ' VAL . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 101' ' ' ILE . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 26' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.93 ' HB2' HD21 ' A' ' 18' ' ' LEU . 13.4 t30 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 16' ' ' VAL . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.792 HD11 HG23 ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 67' ' ' LEU . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.922 0.392 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 12' ' ' LEU . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 11' ' ' PHE . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' HD13 ' A' ' 104' ' ' ILE . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.758 ' CE2' HG21 ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.856 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.784 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.458 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 10.3 p-10 -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.458 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD22 ' SD ' ' A' ' 91' ' ' MET . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.976 HG12 ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.046 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.976 ' HA ' HG12 ' A' ' 30' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 1.042 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.042 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-20 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 87' ' ' LEU . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.703 HG23 ' HG ' ' A' ' 103' ' ' LEU . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' ND2' HG22 ' A' ' 70' ' ' VAL . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 82' ' ' GLU . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.5 ' O ' ' HE2' ' A' ' 84' ' ' MET . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.046 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.554 HG22 HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 67' ' ' LEU . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.49 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.765 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.801 ' HB2' HD21 ' A' ' 18' ' ' LEU . 22.2 t30 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.728 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 3.5 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.703 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 13' ' ' THR . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.758 HG21 ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.797 0.332 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 107' ' ' ARG . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.644 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.698 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.981 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 91' ' ' MET . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.791 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.455 ' OD1' ' ND2' ' A' ' 80' ' ' ASN . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD12 ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 30' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.671 HD13 HD11 ' A' ' 87' ' ' LEU . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG22 ' ND2' ' A' ' 71' ' ' ASN . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 70' ' ' VAL . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB3' HG13 ' A' ' 70' ' ' VAL . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HE2' ' A' ' 84' ' ' MET . 15.0 m-20 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.559 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.671 HD11 HD13 ' A' ' 67' ' ' LEU . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 93' ' ' THR . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.981 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.562 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.763 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.644 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 67' ' ' LEU . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' HD11 ' A' ' 12' ' ' LEU . 41.0 mtt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.709 HG23 ' CD1' ' A' ' 104' ' ' ILE . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.864 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.839 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.003 HG11 HD11 ' A' ' 67' ' ' LEU . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.896 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HA ' HG12 ' A' ' 30' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.839 HG23 HG13 ' A' ' 28' ' ' VAL . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.864 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.646 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG11 ' A' ' 30' ' ' VAL . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.803 HG23 ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.589 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' ND2' HG22 ' A' ' 70' ' ' VAL . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 86' ' ' THR . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.662 HD23 ' CE ' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CE ' HD23 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.89 HD11 HD13 ' A' ' 67' ' ' LEU . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.755 ' HB3' HD12 ' A' ' 101' ' ' ILE . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.671 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 18' ' ' LEU . 16.8 t30 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.466 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.762 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 13' ' ' THR . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.801 0.334 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.812 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 91' ' ' MET . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 67' ' ' LEU . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.2 m120 -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.717 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 30' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 1.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.978 HD11 HG11 ' A' ' 30' ' ' VAL . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 106' ' ' ALA . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 76' ' ' LEU . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.555 ' CE ' HD23 ' A' ' 75' ' ' LEU . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' O ' ' HE2' ' A' ' 84' ' ' MET . 4.5 m120 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.923 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.503 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 30' ' ' VAL . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 101' ' ' ILE . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.818 ' HB2' HD21 ' A' ' 18' ' ' LEU . 55.0 t30 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.499 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.783 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.638 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 67' ' ' LEU . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.938 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 HD11 ' A' ' 104' ' ' ILE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.763 ' CG1' HD11 ' A' ' 26' ' ' LEU . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.547 HD22 ' HB2' ' A' ' 40' ' ' ALA . 10.2 p-10 -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 35' ' ' SER . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.892 ' HA ' HG12 ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HE3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.929 HG23 HG13 ' A' ' 28' ' ' VAL . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.3 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' O ' HD21 ' A' ' 61' ' ' LEU . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD2' HG22 ' A' ' 16' ' ' VAL . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.818 HD11 HG11 ' A' ' 30' ' ' VAL . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 67' ' ' LEU . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' ND2' HG22 ' A' ' 70' ' ' VAL . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.576 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.442 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 67' ' ' LEU . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 101' ' ' ILE . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.65 ' SD ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.862 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.685 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 13' ' ' THR . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.766 HD11 HG23 ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 67' ' ' LEU . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE1' HD21 ' A' ' 12' ' ' LEU . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 10' ' ' GLU . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.7 ' HA ' HD13 ' A' ' 104' ' ' ILE . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.771 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.854 HG12 ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.981 HD22 ' HB2' ' A' ' 40' ' ' ALA . 9.6 p-10 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.981 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.898 HD11 ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.854 ' HA ' HG12 ' A' ' 30' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' SER . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.87 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.593 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.87 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 87' ' ' LEU . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.946 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.57 HD22 ' CB ' ' A' ' 83' ' ' ALA . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HE2' ' A' ' 84' ' ' MET . 9.5 m120 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.496 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.487 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 67' ' ' LEU . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.68 ' HB3' HD12 ' A' ' 101' ' ' ILE . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.717 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 93' ' ' THR . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.856 ' HB2' HD21 ' A' ' 18' ' ' LEU . 31.1 t30 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.663 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.49 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.705 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 70' ' ' VAL . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 13' ' ' THR . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG21 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.946 ' HB2' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.806 0.336 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 68' ' ' ILE . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 104' ' ' ILE . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.912 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' A' ' 91' ' ' MET . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.822 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 1.043 HD22 ' HB2' ' A' ' 40' ' ' ALA . 12.5 p-10 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.077 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' VAL . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.78 HG23 HG13 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.912 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' HG ' ' A' ' 61' ' ' LEU . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 49' ' ' ILE . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 63' ' ' VAL . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 62' ' ' ARG . 12.6 m120 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 105' ' ' VAL . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.805 HD23 ' CE ' ' A' ' 78' ' ' LYS . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 68' ' ' ILE . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.805 ' CE ' HD23 ' A' ' 75' ' ' LEU . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.474 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.077 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 30' ' ' VAL . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.742 ' HB3' HD12 ' A' ' 101' ' ' ILE . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.693 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.866 ' HB2' HD21 ' A' ' 18' ' ' LEU . 20.9 t30 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' CG ' HG23 ' A' ' 13' ' ' THR . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 13' ' ' THR . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 67' ' ' LEU . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 107' ' ' ARG . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.723 HG23 ' CD1' ' A' ' 104' ' ' ILE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.769 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.855 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.851 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.803 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.911 HG11 HD11 ' A' ' 67' ' ' LEU . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.714 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.092 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.75 ' HA ' HG12 ' A' ' 30' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG13 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.851 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.462 ' OE1' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.911 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' ALA . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.701 HD22 ' H ' ' A' ' 102' ' ' GLN . 34.4 m120 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 86' ' ' THR . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 1.7 p-10 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.092 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.492 HG23 ' OE2' ' A' ' 73' ' ' GLU . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 67' ' ' LEU . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.613 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 93' ' ' THR . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.564 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.867 ' HB2' HD21 ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.586 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.701 ' H ' HD22 ' A' ' 71' ' ' ASN . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.441 HD21 HD11 ' A' ' 101' ' ' ILE . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.723 ' CD1' HG23 ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 67' ' ' LEU . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.611 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.646 HG23 HD11 ' A' ' 104' ' ' ILE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 ' OD2' ' A' ' 58' ' ' ASP . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.802 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.774 HD11 ' CG1' ' A' ' 16' ' ' VAL . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.876 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 67' ' ' LEU . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.611 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.876 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.844 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.84 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.948 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.912 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.912 ' ND2' HG22 ' A' ' 70' ' ' VAL . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.553 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.575 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 67' ' ' LEU . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.835 ' HB3' HD12 ' A' ' 101' ' ' ILE . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.763 ' SD ' HD22 ' A' ' 26' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 93' ' ' THR . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.974 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.719 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.647 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.84 HG12 HD23 ' A' ' 67' ' ' LEU . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.948 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.712 HG23 HD11 ' A' ' 104' ' ' ILE . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.806 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.877 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.764 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.953 HG11 HD11 ' A' ' 67' ' ' LEU . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.045 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HG13 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.877 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.891 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.596 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.458 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD11 HG11 ' A' ' 30' ' ' VAL . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.747 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.498 ' O ' ' HE2' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.747 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 HG11 ' A' ' 70' ' ' VAL . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 30' ' ' VAL . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 101' ' ' ILE . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.756 ' HB2' HD21 ' A' ' 18' ' ' LEU . 18.5 t30 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.455 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.712 HD11 HG23 ' A' ' 13' ' ' THR . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 67' ' ' LEU . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.264 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 68' ' ' ILE . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' CD ' ' A' ' 10' ' ' GLU . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.642 HD22 ' SD ' ' A' ' 91' ' ' MET . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.669 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' A' ' 46' ' ' VAL . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.734 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' ND2' ' A' ' 33' ' ' ASN . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.126 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.8 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.738 HD11 HG11 ' A' ' 30' ' ' VAL . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HG21 ' HE2' ' A' ' 11' ' ' PHE . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.71 ' ND2' HG22 ' A' ' 70' ' ' VAL . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.779 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.126 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 30' ' ' VAL . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.642 ' SD ' HD22 ' A' ' 26' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.804 ' HB2' HD21 ' A' ' 18' ' ' LEU . 25.1 t30 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' ' 104' ' ' ILE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.751 HG12 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.838 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 67' ' ' LEU . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.798 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.798 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.082 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 30' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 28' ' ' VAL . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' NH1' ' HA ' ' A' ' 62' ' ' ARG . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG11 ' A' ' 30' ' ' VAL . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 103' ' ' LEU . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.606 ' ND2' HG22 ' A' ' 70' ' ' VAL . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.082 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.548 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.436 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD13 ' A' ' 67' ' ' LEU . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.773 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD21 ' A' ' 18' ' ' LEU . 10.2 t30 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.698 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 13' ' ' THR . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HE ' ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.755 0.312 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' CD1' ' HD2' ' A' ' 107' ' ' ARG . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.759 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LEU . . . . . 0.782 HD23 ' CG2' ' A' ' 101' ' ' ILE . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD11 ' HB ' ' A' ' 16' ' ' VAL . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.85 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . 0.836 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.987 HG11 HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ILE . . . . . 1.123 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.836 HG23 HG13 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.85 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.987 HD11 HG11 ' A' ' 30' ' ' VAL . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.533 HG23 ' HG ' ' A' ' 76' ' ' LEU . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 104' ' ' ILE . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.658 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' ND2' HG22 ' A' ' 70' ' ' VAL . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 83' ' ' ALA . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 68' ' ' ILE . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ALA . . . . . 1.123 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 30' ' ' VAL . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.714 ' HB3' HD12 ' A' ' 101' ' ' ILE . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 18' ' ' LEU . 29.9 t30 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' MET . . . . . 0.552 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.782 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.774 HD11 HG12 ' A' ' 101' ' ' ILE . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 13' ' ' THR . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.597 ' HB1' ' HE ' ' A' ' 9' ' ' ARG . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -123.28 139.41 54.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -129.08 162.12 28.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.824 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 68' ' ' ILE . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.716 HG23 HD11 ' A' ' 104' ' ' ILE . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' A' ' 105' ' ' VAL . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.903 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.777 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.873 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 p-10 -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 54' ' ' ALA . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 67' ' ' LEU . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.644 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.644 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.017 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.899 HG23 HG13 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.903 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 58' ' ' ASP . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 ' CG1' ' A' ' 105' ' ' VAL . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.869 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.616 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 33.6 m120 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.746 HD12 ' HB3' ' A' ' 67' ' ' LEU . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' NZ ' HD23 ' A' ' 75' ' ' LEU . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.017 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.465 ' HA ' HD12 ' A' ' 87' ' ' LEU . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.583 HD21 HD13 ' A' ' 67' ' ' LEU . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.697 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.873 ' HB2' HD21 ' A' ' 18' ' ' LEU . 40.7 t30 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.576 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.486 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.724 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.616 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.904 ' CG1' HD23 ' A' ' 67' ' ' LEU . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 -120.69 137.02 54.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 166.13 24.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 8' ' ' THR . 3.7 mp -133.6 156.61 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 109' ' ' ILE . 73.0 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.441 ' HA ' HG13 ' A' ' 109' ' ' ILE . 8.8 p -154.25 54.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.7 108.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.697 HG23 ' CD1' ' A' ' 104' ' ' ILE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.911 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.939 HG11 HD11 ' A' ' 67' ' ' LEU . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.136 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 30' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.911 HG23 HG13 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.8 p-10 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.675 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.662 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 HG11 ' A' ' 30' ' ' VAL . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 106' ' ' ALA . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.645 ' HB ' HD23 ' A' ' 103' ' ' LEU . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' HG22 ' A' ' 70' ' ' VAL . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.136 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 75' ' ' LEU . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.83 ' CE ' HD22 ' A' ' 26' ' ' LEU . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.898 ' HB2' HD21 ' A' ' 18' ' ' LEU . 21.1 t30 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.627 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.57 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 ' HB ' ' A' ' 70' ' ' VAL . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.697 ' CD1' HG23 ' A' ' 13' ' ' THR . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.955 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 15.2 ttm180 -147.12 143.63 28.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 6.6 mtm-85 -74.87 -176.02 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.775 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 8' ' ' THR . 2.1 mt -137.28 159.4 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 109' ' ' ILE . 26.9 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 7' ' ' GLY . 37.0 p -164.19 138.37 5.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.766 0.317 . . . . 0.0 110.873 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' H ' ' HA ' ' A' ' 108' ' ' ARG . 22.6 ptt180 50.0 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.882 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 109' ' ' ILE . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 104' ' ' ILE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.926 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.809 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.737 HD22 ' SD ' ' A' ' 91' ' ' MET . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 67' ' ' LEU . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD12 ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.064 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 30' ' ' VAL . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.98 HD13 HD23 ' A' ' 61' ' ' LEU . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.747 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.2 m120 -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.926 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' H ' HD13 ' A' ' 61' ' ' LEU . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.98 HD23 HD13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 68' ' ' ILE . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.795 HD11 HG11 ' A' ' 30' ' ' VAL . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.702 HG23 HD12 ' A' ' 76' ' ' LEU . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.777 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 103' ' ' LEU . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 70' ' ' VAL . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 67' ' ' LEU . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD12 HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.064 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 30' ' ' VAL . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.636 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.737 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.842 ' HB2' HD21 ' A' ' 18' ' ' LEU . 12.7 t30 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.679 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.432 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -139.92 112.08 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.531 ' HA ' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -62.02 160.42 12.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.778 HD11 ' HG2' ' A' ' 10' ' ' GLU . 6.9 mm -116.51 162.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.95 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 109' ' ' ILE . 13.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.621 ' HB ' HD13 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -135.33 141.87 45.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.999 0.428 . . . . 0.0 110.987 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' CA ' HD12 ' A' ' 109' ' ' ILE . 5.3 mtm105 -137.87 140.24 40.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' HG21 ' A' ' 68' ' ' ILE . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 105' ' ' VAL . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.464 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.794 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 26' ' ' LEU . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD22 ' SD ' ' A' ' 91' ' ' MET . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.654 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.982 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 46' ' ' VAL . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.622 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.779 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.779 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.097 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.93 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 HG13 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.8 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.625 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.498 ' OE1' HD13 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 87' ' ' LEU . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.699 HG21 ' HE2' ' A' ' 11' ' ' PHE . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 103' ' ' LEU . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 34.6 m120 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 77' ' ' GLY . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 76' ' ' LEU . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.097 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.425 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD11 ' CD1' ' A' ' 67' ' ' LEU . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.449 ' HG ' HD12 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.853 ' HB2' HD21 ' A' ' 18' ' ' LEU . 33.9 t30 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.642 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.642 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 70' ' ' VAL . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -141.92 142.18 33.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -87.11 131.58 34.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.621 HD13 ' HB ' ' A' ' 8' ' ' THR . 3.6 mp -92.93 157.24 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.047 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.998 0.428 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.425 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 23.0 p -151.61 61.7 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.967 0.413 . . . . 0.0 110.988 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.48 102.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.638 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' CG ' HD11 ' A' ' 109' ' ' ILE . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.791 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.829 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.772 HD22 ' CE ' ' A' ' 91' ' ' MET . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.015 HG12 ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.599 HD22 ' HB2' ' A' ' 40' ' ' ALA . 10.7 p-10 -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.599 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 1.015 ' HA ' HG12 ' A' ' 30' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 58' ' ' ASP . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 87' ' ' LEU . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG23 ' HG ' ' A' ' 103' ' ' LEU . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 36.0 m120 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.802 HD23 ' CE ' ' A' ' 78' ' ' LYS . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.802 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 67' ' ' LEU . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.772 ' CE ' HD22 ' A' ' 26' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.799 ' HB2' HD21 ' A' ' 18' ' ' LEU . 29.1 t30 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.52 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.702 HG12 HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HG ' HG23 ' A' ' 70' ' ' VAL . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 67' ' ' LEU . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -142.99 138.45 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -58.88 166.29 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 110' ' ' SER . 9.1 mm -118.63 162.83 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.048 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.502 ' HB ' ' N ' ' A' ' 109' ' ' ILE . 18.9 p -77.53 78.9 4.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -170.32 101.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.518 ' HE2' HG21 ' A' ' 68' ' ' ILE . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.501 HD11 ' CD ' ' A' ' 107' ' ' ARG . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.726 HG23 HD11 ' A' ' 104' ' ' ILE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.731 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.867 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.976 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 p-10 -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' LEU . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.84 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 67' ' ' LEU . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.13 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 30' ' ' VAL . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 63' ' ' VAL . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' OD2' HG21 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 30' ' ' VAL . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 11' ' ' PHE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.655 HG22 ' OD1' ' A' ' 71' ' ' ASN . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.655 ' OD1' HG22 ' A' ' 70' ' ' VAL . 2.6 p-10 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.633 ' HB2' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD23 ' CE ' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.82 ' CE ' HD23 ' A' ' 75' ' ' LEU . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.455 ' O ' ' HE2' ' A' ' 84' ' ' MET . 1.8 p-10 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.13 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.455 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.486 ' CB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 67' ' ' LEU . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.586 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.976 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.625 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 67' ' ' LEU . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.501 ' CD ' HD11 ' A' ' 12' ' ' LEU . 8.2 ptp180 -131.27 153.81 49.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.99 122.68 31.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.074 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' N ' ' HB ' ' A' ' 8' ' ' THR . 2.0 mp -63.88 151.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 109' ' ' ILE . 67.3 p -67.83 66.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.205 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.07 112.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.792 HG23 HD11 ' A' ' 104' ' ' ILE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.829 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.837 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.9 p-10 -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.648 HD22 ' SD ' ' A' ' 91' ' ' MET . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.801 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 67' ' ' LEU . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.834 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.044 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 30' ' ' VAL . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.866 HG23 HG13 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD13 ' C ' ' A' ' 27' ' ' GLY . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 1.1 m120 -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 10.3 m120 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.927 HD11 HG11 ' A' ' 30' ' ' VAL . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 67' ' ' LEU . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 70' ' ' VAL . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.834 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.509 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.044 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.509 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 30' ' ' VAL . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 101' ' ' ILE . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 26' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.93 ' HB2' HD21 ' A' ' 18' ' ' LEU . 13.4 t30 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 16' ' ' VAL . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.792 HD11 HG23 ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 67' ' ' LEU . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -136.2 141.0 43.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -82.75 138.17 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.858 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 8' ' ' THR . 28.1 mm -63.21 -68.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.937 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 1.5 p -155.4 170.11 22.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 110.678 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 62.47 124.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 12' ' ' LEU . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 11' ' ' PHE . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' HD13 ' A' ' 104' ' ' ILE . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.758 ' CE2' HG21 ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.856 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.784 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.458 ' ND2' ' OD2' ' A' ' 20' ' ' ASP . 10.3 p-10 -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.458 ' OD2' ' ND2' ' A' ' 19' ' ' ASN . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD22 ' SD ' ' A' ' 91' ' ' MET . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.976 HG12 ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.046 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.976 ' HA ' HG12 ' A' ' 30' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 1.042 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.042 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 2.1 m-20 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 87' ' ' LEU . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.703 HG23 ' HG ' ' A' ' 103' ' ' LEU . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' ND2' HG22 ' A' ' 70' ' ' VAL . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 82' ' ' GLU . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' O ' ' HE2' ' A' ' 84' ' ' MET . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.046 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.554 HG22 HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 67' ' ' LEU . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.49 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.765 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.801 ' HB2' HD21 ' A' ' 18' ' ' LEU . 22.2 t30 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.728 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 3.5 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.703 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 13' ' ' THR . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.758 HG21 ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -135.73 152.06 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 149.87 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 110' ' ' SER . 9.5 mt -102.95 159.78 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.468 ' N ' HG22 ' A' ' 109' ' ' ILE . 86.7 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 1.8 t -176.39 52.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.024 0.44 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.37 101.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.602 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' HD11 ' A' ' 109' ' ' ILE . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 107' ' ' ARG . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.644 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.698 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.981 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 91' ' ' MET . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.791 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.455 ' OD1' ' ND2' ' A' ' 80' ' ' ASN . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD12 ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 30' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.671 HD13 HD11 ' A' ' 87' ' ' LEU . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG22 ' ND2' ' A' ' 71' ' ' ASN . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 70' ' ' VAL . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB3' HG13 ' A' ' 70' ' ' VAL . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HE2' ' A' ' 84' ' ' MET . 15.0 m-20 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.559 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.671 HD11 HD13 ' A' ' 67' ' ' LEU . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 93' ' ' THR . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.981 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.562 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.763 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.644 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 67' ' ' LEU . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' HD11 ' A' ' 12' ' ' LEU . 41.0 mtt180 -124.82 135.76 53.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.85 128.38 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 10' ' ' GLU . 5.6 mm -91.83 163.45 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 109' ' ' ILE . 70.2 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.436 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 37.5 p -157.9 45.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -172.78 107.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.709 HG23 ' CD1' ' A' ' 104' ' ' ILE . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.5 p-10 -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.864 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.839 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.003 HG11 HD11 ' A' ' 67' ' ' LEU . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.896 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HA ' HG12 ' A' ' 30' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.839 HG23 HG13 ' A' ' 28' ' ' VAL . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.864 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.646 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG11 ' A' ' 30' ' ' VAL . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.803 HG23 ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.589 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' ND2' HG22 ' A' ' 70' ' ' VAL . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 86' ' ' THR . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.662 HD23 ' CE ' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CE ' HD23 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.89 HD11 HD13 ' A' ' 67' ' ' LEU . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.755 ' HB3' HD12 ' A' ' 101' ' ' ILE . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.671 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 18' ' ' LEU . 16.8 t30 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.466 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.762 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 13' ' ' THR . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -127.25 147.06 50.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -75.48 149.55 38.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 110' ' ' SER . 19.5 mm -81.84 159.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -178.9 79.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.85 109.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.812 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.7 p-10 -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 91' ' ' MET . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 67' ' ' LEU . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.2 m120 -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.717 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 30' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 1.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.978 HD11 HG11 ' A' ' 30' ' ' VAL . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 106' ' ' ALA . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 76' ' ' LEU . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' CE ' HD23 ' A' ' 75' ' ' LEU . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' O ' ' HE2' ' A' ' 84' ' ' MET . 4.5 m120 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.923 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.503 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 30' ' ' VAL . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 101' ' ' ILE . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.818 ' HB2' HD21 ' A' ' 18' ' ' LEU . 55.0 t30 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.499 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.783 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.638 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 67' ' ' LEU . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.938 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.15 136.27 36.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 110.45 23.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 110' ' ' SER . 24.2 mm -55.32 162.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.461 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 43.9 p -156.86 40.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 177.22 114.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 HD11 ' A' ' 104' ' ' ILE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.763 ' CG1' HD11 ' A' ' 26' ' ' LEU . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.9 p-10 -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.547 HD22 ' HB2' ' A' ' 40' ' ' ALA . 10.2 p-10 -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.547 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 35' ' ' SER . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.892 ' HA ' HG12 ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HE3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.929 HG23 HG13 ' A' ' 28' ' ' VAL . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.3 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' O ' HD21 ' A' ' 61' ' ' LEU . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD2' HG22 ' A' ' 16' ' ' VAL . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.818 HD11 HG11 ' A' ' 30' ' ' VAL . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 67' ' ' LEU . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' ND2' HG22 ' A' ' 70' ' ' VAL . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.442 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.576 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.442 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 67' ' ' LEU . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 101' ' ' ILE . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.65 ' SD ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.862 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.685 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 13' ' ' THR . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.766 HD11 HG23 ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 67' ' ' LEU . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 122.07 32.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HD3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -78.38 132.78 37.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.601 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' CG1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mm -90.31 164.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 109' ' ' ILE . 5.2 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 N-CA-C 114.18 0.432 . . . . 0.0 114.18 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -131.22 106.26 8.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.731 0.765 . . . . 0.0 111.507 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mtt180 -84.0 136.43 34.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.285 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE1' HD21 ' A' ' 12' ' ' LEU . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 10' ' ' GLU . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.7 ' HA ' HD13 ' A' ' 104' ' ' ILE . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.878 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.771 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.7 p-10 -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.854 HG12 ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.981 HD22 ' HB2' ' A' ' 40' ' ' ALA . 9.6 p-10 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.981 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.898 HD11 ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.854 ' HA ' HG12 ' A' ' 30' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' SER . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.87 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.593 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.87 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 87' ' ' LEU . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.946 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD22 ' CB ' ' A' ' 83' ' ' ALA . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HE2' ' A' ' 84' ' ' MET . 9.5 m120 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.496 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.487 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 67' ' ' LEU . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.68 ' HB3' HD12 ' A' ' 101' ' ' ILE . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.717 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 93' ' ' THR . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.856 ' HB2' HD21 ' A' ' 18' ' ' LEU . 31.1 t30 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.663 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.49 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.705 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 70' ' ' VAL . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 13' ' ' THR . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG21 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.946 ' HB2' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -136.0 122.66 20.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 3.4 tpp180 -68.03 155.61 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 110' ' ' SER . 1.2 mm -104.51 -94.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.385 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 109' ' ' ILE . 24.0 m . . . . . 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 110.933 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -65.19 79.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 177.33 120.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 68' ' ' ILE . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 104' ' ' ILE . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.912 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' A' ' 91' ' ' MET . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.822 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 1.043 HD22 ' HB2' ' A' ' 40' ' ' ALA . 12.5 p-10 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 1.043 ' HB2' HD22 ' A' ' 38' ' ' ASN . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.077 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' VAL . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.78 HG23 HG13 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 1.7 p-10 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.912 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' HG ' ' A' ' 61' ' ' LEU . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 49' ' ' ILE . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 63' ' ' VAL . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 62' ' ' ARG . 12.6 m120 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 105' ' ' VAL . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASN . . . . . . . . . . . . . 31.5 m120 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.805 HD23 ' CE ' ' A' ' 78' ' ' LYS . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 68' ' ' ILE . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.805 ' CE ' HD23 ' A' ' 75' ' ' LEU . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.474 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.077 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 30' ' ' VAL . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.742 ' HB3' HD12 ' A' ' 101' ' ' ILE . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.693 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.866 ' HB2' HD21 ' A' ' 18' ' ' LEU . 20.9 t30 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' CG ' HG23 ' A' ' 13' ' ' THR . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 13' ' ' THR . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 67' ' ' LEU . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -109.54 128.2 55.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.411 ' HB3' ' NH1' ' A' ' 108' ' ' ARG . 0.3 OUTLIER -88.71 127.31 35.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 110' ' ' SER . 1.6 mt -98.04 -177.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.724 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HB ' ' HD3' ' A' ' 108' ' ' ARG . 24.5 p -155.42 36.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.586 0.232 . . . . 0.0 111.406 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 109' ' ' ILE . 9.2 mtt180 -169.38 122.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.173 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 107' ' ' ARG . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.723 HG23 ' CD1' ' A' ' 104' ' ' ILE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.769 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.855 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.851 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.803 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.911 HG11 HD11 ' A' ' 67' ' ' LEU . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.714 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.092 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.75 ' HA ' HG12 ' A' ' 30' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG13 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.851 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.462 ' OE1' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.911 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' ALA . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.701 HD22 ' H ' ' A' ' 102' ' ' GLN . 34.4 m120 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 86' ' ' THR . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 1.7 p-10 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.092 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.492 HG23 ' OE2' ' A' ' 73' ' ' GLU . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 67' ' ' LEU . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.613 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 93' ' ' THR . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.564 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.867 ' HB2' HD21 ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.586 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.701 ' H ' HD22 ' A' ' 71' ' ' ASN . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.441 HD21 HD11 ' A' ' 101' ' ' ILE . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.723 ' CD1' HG23 ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 67' ' ' LEU . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.611 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.27 141.78 47.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HD3' ' HB ' ' A' ' 8' ' ' THR . 0.3 OUTLIER -84.81 144.83 28.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 110' ' ' SER . 12.0 mm -83.7 159.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.305 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 12.5 p -154.02 174.92 14.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 62.95 110.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.04 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.646 HG23 HD11 ' A' ' 104' ' ' ILE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 ' OD2' ' A' ' 58' ' ' ASP . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.802 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.9 p-10 -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.774 HD11 ' CG1' ' A' ' 16' ' ' VAL . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.876 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 67' ' ' LEU . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.611 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.876 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.7 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.844 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.452 ' NE2' ' O ' ' A' ' 67' ' ' LEU . 0.5 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.84 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.948 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.912 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.912 ' ND2' HG22 ' A' ' 70' ' ' VAL . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.553 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.477 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.477 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.575 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 67' ' ' LEU . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.835 ' HB3' HD12 ' A' ' 101' ' ' ILE . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.763 ' SD ' HD22 ' A' ' 26' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 93' ' ' THR . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.974 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.719 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.647 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.84 HG12 HD23 ' A' ' 67' ' ' LEU . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.948 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.91 128.0 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 128.5 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 110' ' ' SER . 7.4 mt -97.99 159.54 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.4 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 11.1 p -153.07 54.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -179.84 102.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.712 HG23 HD11 ' A' ' 104' ' ' ILE . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.806 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.877 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.764 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.953 HG11 HD11 ' A' ' 67' ' ' LEU . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.045 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HG13 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.877 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.891 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.596 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.458 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD11 HG11 ' A' ' 30' ' ' VAL . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.747 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.498 ' O ' ' HE2' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.747 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 HG11 ' A' ' 70' ' ' VAL . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 30' ' ' VAL . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 101' ' ' ILE . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.756 ' HB2' HD21 ' A' ' 18' ' ' LEU . 18.5 t30 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.455 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.712 HD11 HG23 ' A' ' 13' ' ' THR . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 67' ' ' LEU . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.72 129.74 37.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 121.62 25.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.667 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 8' ' ' THR . 26.9 mm -59.27 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.186 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 21.5 p -153.81 47.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -177.09 113.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 68' ' ' ILE . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' CD ' ' A' ' 10' ' ' GLU . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 p-10 -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.642 HD22 ' SD ' ' A' ' 91' ' ' MET . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.669 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' A' ' 46' ' ' VAL . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.734 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' ND2' ' A' ' 33' ' ' ASN . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.126 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.8 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.503 ' NE2' ' N ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.738 HD11 HG11 ' A' ' 30' ' ' VAL . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HG21 ' HE2' ' A' ' 11' ' ' PHE . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.71 ' ND2' HG22 ' A' ' 70' ' ' VAL . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.779 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.448 ' HB3' ' OE1' ' A' ' 81' ' ' GLN . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.448 ' OE1' ' HB3' ' A' ' 79' ' ' ALA . 0.0 OUTLIER -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.126 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 30' ' ' VAL . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.642 ' SD ' HD22 ' A' ' 26' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.804 ' HB2' HD21 ' A' ' 18' ' ' LEU . 25.1 t30 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 27.3 ttm180 -143.75 149.7 37.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.404 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -90.92 151.05 21.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 110' ' ' SER . 8.8 mm -85.35 160.69 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.982 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 109' ' ' ILE . 16.8 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 39.2 p -59.23 166.5 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 0.0 110.973 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' H ' ' HA ' ' A' ' 108' ' ' ARG . 13.4 mtt180 62.78 136.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' ' 104' ' ' ILE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.751 HG12 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.838 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 8.3 p-10 -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 67' ' ' LEU . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.798 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.798 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.082 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 30' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 28' ' ' VAL . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' NH1' ' HA ' ' A' ' 62' ' ' ARG . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG11 ' A' ' 30' ' ' VAL . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 103' ' ' LEU . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.606 ' ND2' HG22 ' A' ' 70' ' ' VAL . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.082 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.548 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.436 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD13 ' A' ' 67' ' ' LEU . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.773 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD21 ' A' ' 18' ' ' LEU . 10.2 t30 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.698 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 13' ' ' THR . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 6.6 ttm180 -140.69 143.47 35.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HA ' ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -78.02 152.99 32.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 110' ' ' SER . 26.2 mm -79.76 157.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.844 0.354 . . . . 0.0 111.073 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 109' ' ' ILE . 42.7 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 p 54.74 38.39 30.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.779 0.323 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HE ' ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -168.64 135.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.831 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' CD1' ' HD2' ' A' ' 107' ' ' ARG . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.759 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.782 HD23 ' CG2' ' A' ' 101' ' ' ILE . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD11 ' HB ' ' A' ' 16' ' ' VAL . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.85 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . 0.836 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.987 HG11 HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ILE . . . . . 1.123 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.836 HG23 HG13 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.85 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.987 HD11 HG11 ' A' ' 30' ' ' VAL . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.533 HG23 ' HG ' ' A' ' 76' ' ' LEU . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 104' ' ' ILE . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.658 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' ND2' HG22 ' A' ' 70' ' ' VAL . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 83' ' ' ALA . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 68' ' ' ILE . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ALA . . . . . 1.123 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 30' ' ' VAL . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.714 ' HB3' HD12 ' A' ' 101' ' ' ILE . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 18' ' ' LEU . 29.9 t30 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' MET . . . . . 0.552 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.782 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.774 HD11 HG12 ' A' ' 101' ' ' ILE . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 13' ' ' THR . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.597 ' HB1' ' HE ' ' A' ' 9' ' ' ARG . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -133.08 148.97 52.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 146.95 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 110' ' ' SER . 10.7 mm -94.64 159.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.166 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 . . . . . 0 CA--C 1.526 0.055 0 CA-C-O 120.774 0.321 . . . . 0.0 110.824 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 68' ' ' ILE . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.716 HG23 HD11 ' A' ' 104' ' ' ILE . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' A' ' 105' ' ' VAL . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.903 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.777 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.873 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 54' ' ' ALA . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 67' ' ' LEU . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.644 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.644 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.567 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.017 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.899 HG23 HG13 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.903 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.582 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 58' ' ' ASP . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 ' CG1' ' A' ' 105' ' ' VAL . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.869 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.616 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.2 m-80 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.746 HD12 ' HB3' ' A' ' 67' ' ' LEU . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.548 ' NZ ' HD23 ' A' ' 75' ' ' LEU . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.017 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.465 ' HA ' HD12 ' A' ' 87' ' ' LEU . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.583 HD21 HD13 ' A' ' 67' ' ' LEU . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.697 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.873 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.0 t-20 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.576 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.486 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.724 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.616 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.904 ' CG1' HD23 ' A' ' 67' ' ' LEU . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 . . . . . 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.068 0 CA-C-O 120.806 0.336 . . . . 0.0 110.7 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.697 HG23 ' CD1' ' A' ' 104' ' ' ILE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.911 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.939 HG11 HD11 ' A' ' 67' ' ' LEU . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.136 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 30' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.911 HG23 HG13 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.505 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 3.4 p30 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.675 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.662 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 HG11 ' A' ' 30' ' ' VAL . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 106' ' ' ALA . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.645 ' HB ' HD23 ' A' ' 103' ' ' LEU . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' HG22 ' A' ' 70' ' ' VAL . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.136 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 75' ' ' LEU . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.83 ' CE ' HD22 ' A' ' 26' ' ' LEU . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.898 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.0 t-20 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.627 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.57 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 ' HB ' ' A' ' 70' ' ' VAL . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.697 ' CD1' HG23 ' A' ' 13' ' ' THR . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.955 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 15.2 ttm180 . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 9' ' ' ARG . 22.6 ptt180 . . . . . 0 N--CA 1.464 0.268 0 CA-C-O 121.51 0.672 . . . . 0.0 111.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 104' ' ' ILE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.926 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.809 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.737 HD22 ' SD ' ' A' ' 91' ' ' MET . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 67' ' ' LEU . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.657 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD12 ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.064 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 30' ' ' VAL . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.98 HD13 HD23 ' A' ' 61' ' ' LEU . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.747 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.926 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.493 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.436 ' H ' HD13 ' A' ' 61' ' ' LEU . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.98 HD23 HD13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 68' ' ' ILE . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.795 HD11 HG11 ' A' ' 30' ' ' VAL . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.702 HG23 HD12 ' A' ' 76' ' ' LEU . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.777 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 103' ' ' LEU . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 70' ' ' VAL . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 67' ' ' LEU . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.702 HD12 HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.064 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 30' ' ' VAL . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.636 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.737 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.842 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.9 t-20 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.679 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.432 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtm105 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.706 0.288 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' HG21 ' A' ' 68' ' ' ILE . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 105' ' ' VAL . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.464 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.794 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 26' ' ' LEU . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.702 HD22 ' SD ' ' A' ' 91' ' ' MET . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.654 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.982 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 46' ' ' VAL . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.622 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.779 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.779 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.498 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.097 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.93 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 HG13 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.625 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.655 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 87' ' ' LEU . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.699 HG21 ' HE2' ' A' ' 11' ' ' PHE . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 103' ' ' LEU . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.595 HD22 HG22 ' A' ' 70' ' ' VAL . 70.5 m-80 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 77' ' ' GLY . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 76' ' ' LEU . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.097 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.425 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.644 HD11 ' CD1' ' A' ' 67' ' ' LEU . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.853 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.642 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.642 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.464 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 70' ' ' VAL . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.504 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.162 0 CA-C-O 120.778 0.323 . . . . 0.0 110.638 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.791 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.829 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.772 HD22 ' CE ' ' A' ' 91' ' ' MET . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.015 HG12 ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 1.015 ' HA ' HG12 ' A' ' 30' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.4 p30 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.576 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 58' ' ' ASP . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 87' ' ' LEU . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.715 HG23 ' HG ' ' A' ' 103' ' ' LEU . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.588 HD22 HG22 ' A' ' 70' ' ' VAL . 71.0 m-80 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.802 HD23 ' CE ' ' A' ' 78' ' ' LYS . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.802 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 67' ' ' LEU . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.772 ' CE ' HD22 ' A' ' 26' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.799 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.7 t-20 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.52 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.702 HG12 HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HG ' HG23 ' A' ' 70' ' ' VAL . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 67' ' ' LEU . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.83 0.347 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.518 ' HE2' HG21 ' A' ' 68' ' ' ILE . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.501 HD11 ' CD ' ' A' ' 107' ' ' ARG . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.726 HG23 HD11 ' A' ' 104' ' ' ILE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.731 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.867 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.976 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' LEU . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.84 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 67' ' ' LEU . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.13 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 30' ' ' VAL . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.559 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 63' ' ' VAL . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.452 ' OD2' HG21 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 30' ' ' VAL . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 11' ' ' PHE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.814 HG22 ' ND2' ' A' ' 71' ' ' ASN . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.814 ' ND2' HG22 ' A' ' 70' ' ' VAL . 10.5 p30 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.633 ' HB2' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.82 HD23 ' CE ' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.82 ' CE ' HD23 ' A' ' 75' ' ' LEU . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.455 ' O ' ' HE2' ' A' ' 84' ' ' MET . 3.3 p30 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.13 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.455 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.486 ' CB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 67' ' ' LEU . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.586 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.976 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.625 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 67' ' ' LEU . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.501 ' CD ' HD11 ' A' ' 12' ' ' LEU . 8.2 ptp180 . . . . . 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.098 0 CA-C-O 120.832 0.349 . . . . 0.0 110.725 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.792 HG23 HD11 ' A' ' 104' ' ' ILE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.829 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.837 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.648 HD22 ' SD ' ' A' ' 91' ' ' MET . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.801 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 67' ' ' LEU . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.834 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.044 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 30' ' ' VAL . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.866 HG23 HG13 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.801 HD13 ' C ' ' A' ' 27' ' ' GLY . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.8 OUTLIER -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.591 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 33.8 m-20 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.927 HD11 HG11 ' A' ' 30' ' ' VAL . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 67' ' ' LEU . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 70' ' ' VAL . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.834 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.509 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.044 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.509 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 30' ' ' VAL . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 101' ' ' ILE . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 26' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.93 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.4 t-20 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 16' ' ' VAL . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.792 HD11 HG23 ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 67' ' ' LEU . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.922 0.392 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 12' ' ' LEU . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 11' ' ' PHE . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' HD13 ' A' ' 104' ' ' ILE . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.758 ' CE2' HG21 ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.856 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.784 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.765 HD22 ' SD ' ' A' ' 91' ' ' MET . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.976 HG12 ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' ND2' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.551 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.046 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.976 ' HA ' HG12 ' A' ' 30' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 1.042 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.551 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.042 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 87' ' ' LEU . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.703 HG23 ' HG ' ' A' ' 103' ' ' LEU . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.5 ' ND2' HG22 ' A' ' 70' ' ' VAL . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 82' ' ' GLU . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.5 ' O ' ' HE2' ' A' ' 84' ' ' MET . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.046 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.554 HG22 HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 67' ' ' LEU . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.49 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.765 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.801 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.3 t-20 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.728 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 25.3 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.703 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 13' ' ' THR . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.758 HG21 ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 . . . . . 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.797 0.332 . . . . 0.0 110.602 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 107' ' ' ARG . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.644 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.698 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.981 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 91' ' ' MET . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.791 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 HD12 ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.413 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 30' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.671 HD13 HD11 ' A' ' 87' ' ' LEU . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.599 HG22 ' ND2' ' A' ' 71' ' ' ASN . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 70' ' ' VAL . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB3' HG13 ' A' ' 70' ' ' VAL . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HE2' ' A' ' 84' ' ' MET . 4.6 m120 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.559 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.671 HD11 HD13 ' A' ' 67' ' ' LEU . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 93' ' ' THR . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.981 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.562 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.763 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.644 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 67' ' ' LEU . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' HD11 ' A' ' 12' ' ' LEU . 41.0 mtt180 . . . . . 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.781 0.324 . . . . 0.0 110.798 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.709 HG23 ' CD1' ' A' ' 104' ' ' ILE . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.812 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.864 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.839 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.003 HG11 HD11 ' A' ' 67' ' ' LEU . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.896 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HA ' HG12 ' A' ' 30' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.839 HG23 HG13 ' A' ' 28' ' ' VAL . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.864 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.646 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG11 ' A' ' 30' ' ' VAL . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.803 HG23 ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.589 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.589 ' ND2' HG22 ' A' ' 70' ' ' VAL . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 86' ' ' THR . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.662 HD23 ' CE ' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CE ' HD23 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.89 HD11 HD13 ' A' ' 67' ' ' LEU . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.755 ' HB3' HD12 ' A' ' 101' ' ' ILE . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.671 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.1 t-20 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.466 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 96' ' ' ASN . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.762 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 13' ' ' THR . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.801 0.334 . . . . 0.0 110.558 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.535 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.812 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 91' ' ' MET . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 67' ' ' LEU . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.717 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.463 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 30' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.978 HD11 HG11 ' A' ' 30' ' ' VAL . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 106' ' ' ALA . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 76' ' ' LEU . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.555 ' CE ' HD23 ' A' ' 75' ' ' LEU . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.503 ' O ' ' HE2' ' A' ' 84' ' ' MET . 14.5 m-20 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.44 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.923 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.503 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 30' ' ' VAL . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 101' ' ' ILE . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.818 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.5 t-20 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.428 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.499 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.783 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.638 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 67' ' ' LEU . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.938 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.687 0.28 . . . . 0.0 110.654 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 HD11 ' A' ' 104' ' ' ILE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.763 ' CG1' HD11 ' A' ' 26' ' ' LEU . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 35' ' ' SER . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.892 ' HA ' HG12 ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HE3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.929 HG23 HG13 ' A' ' 28' ' ' VAL . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.2 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.923 ' O ' HD21 ' A' ' 61' ' ' LEU . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD2' HG22 ' A' ' 16' ' ' VAL . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.818 HD11 HG11 ' A' ' 30' ' ' VAL . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 67' ' ' LEU . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.585 ' ND2' HG22 ' A' ' 70' ' ' VAL . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.708 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.576 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.708 HE22 ' HB3' ' A' ' 79' ' ' ALA . 3.0 pm0 -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 67' ' ' LEU . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 101' ' ' ILE . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.65 ' SD ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.862 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.3 t-20 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.448 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.685 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 13' ' ' THR . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.766 HD11 HG23 ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 67' ' ' LEU . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.1 mtt180 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.944 0.402 . . . . 0.0 111.285 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE1' HD21 ' A' ' 12' ' ' LEU . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 10' ' ' GLU . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.7 ' HA ' HD13 ' A' ' 104' ' ' ILE . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.878 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.771 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.854 HG12 ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.3 p30 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.432 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.898 HD11 ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.854 ' HA ' HG12 ' A' ' 30' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' SER . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.87 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.593 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.87 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 87' ' ' LEU . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.946 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.57 HD22 ' CB ' ' A' ' 83' ' ' ALA . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HE2' ' A' ' 84' ' ' MET . 18.9 m-80 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.496 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.487 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 67' ' ' LEU . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.68 ' HB3' HD12 ' A' ' 101' ' ' ILE . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.717 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 93' ' ' THR . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.856 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.663 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.49 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.705 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 70' ' ' VAL . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 13' ' ' THR . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.595 HG21 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.946 ' HB2' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 . . . . . 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.806 0.336 . . . . 0.0 110.522 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 68' ' ' ILE . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 104' ' ' ILE . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.912 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' A' ' 91' ' ' MET . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.822 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.1 p30 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.077 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' VAL . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.78 HG23 HG13 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.912 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' HG ' ' A' ' 61' ' ' LEU . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 49' ' ' ILE . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 63' ' ' VAL . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 62' ' ' ARG . 41.5 m-80 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 105' ' ' VAL . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.638 HD22 HG22 ' A' ' 70' ' ' VAL . 69.1 m-80 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.805 HD23 ' CE ' ' A' ' 78' ' ' LYS . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 68' ' ' ILE . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.805 ' CE ' HD23 ' A' ' 75' ' ' LEU . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.474 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.077 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 30' ' ' VAL . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.742 ' HB3' HD12 ' A' ' 101' ' ' ILE . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.693 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.866 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.2 t-20 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.441 ' CG ' HG23 ' A' ' 13' ' ' THR . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 13' ' ' THR . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 67' ' ' LEU . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.749 0.309 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 107' ' ' ARG . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.723 HG23 ' CD1' ' A' ' 104' ' ' ILE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.769 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.855 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.851 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.803 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.911 HG11 HD11 ' A' ' 67' ' ' LEU . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.714 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.092 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.75 ' HA ' HG12 ' A' ' 30' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG13 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.851 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.579 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.601 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.911 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' ALA . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.56 HD22 HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 86' ' ' THR . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.0 p30 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.479 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.092 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.492 HG23 ' OE2' ' A' ' 73' ' ' GLU . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 67' ' ' LEU . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.613 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 93' ' ' THR . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.564 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.867 ' HB2' HD21 ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.586 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.441 HD21 HD11 ' A' ' 101' ' ' ILE . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.723 ' CD1' HG23 ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 67' ' ' LEU . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.611 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 . . . . . 0 C--O 1.232 0.172 0 CA-C-O 120.906 0.384 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.646 HG23 HD11 ' A' ' 104' ' ' ILE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 ' OD2' ' A' ' 58' ' ' ASP . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.802 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.974 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.774 HD11 ' CG1' ' A' ' 16' ' ' VAL . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.876 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 67' ' ' LEU . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.498 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.611 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.876 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.844 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.84 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.948 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.912 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.912 ' ND2' HG22 ' A' ' 70' ' ' VAL . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.553 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.622 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.5 pm0 -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.575 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 67' ' ' LEU . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.835 ' HB3' HD12 ' A' ' 101' ' ' ILE . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.763 ' SD ' HD22 ' A' ' 26' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 93' ' ' THR . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.974 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.719 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.647 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.84 HG12 HD23 ' A' ' 67' ' ' LEU . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.948 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.232 0.183 0 CA-C-O 120.837 0.351 . . . . 0.0 110.822 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.712 HG23 HD11 ' A' ' 104' ' ' ILE . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.806 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.418 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.877 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.764 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.953 HG11 HD11 ' A' ' 67' ' ' LEU . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.477 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.045 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HG13 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.877 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.891 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.596 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.458 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.953 HD11 HG11 ' A' ' 30' ' ' VAL . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.747 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.498 ' O ' ' HE2' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.747 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.498 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 HG11 ' A' ' 70' ' ' VAL . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 30' ' ' VAL . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 101' ' ' ILE . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.756 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.455 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.712 HD11 HG23 ' A' ' 13' ' ' THR . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 67' ' ' LEU . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.653 0.264 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 68' ' ' ILE . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' CD ' ' A' ' 10' ' ' GLU . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.642 HD22 ' SD ' ' A' ' 91' ' ' MET . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.669 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' A' ' 46' ' ' VAL . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.734 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' ND2' ' A' ' 33' ' ' ASN . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.126 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.738 HD11 HG11 ' A' ' 30' ' ' VAL . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HG21 ' HE2' ' A' ' 11' ' ' PHE . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.71 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.71 ' ND2' HG22 ' A' ' 70' ' ' VAL . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.779 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' A' ' 79' ' ' ALA . 2.9 pm0 -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.126 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 30' ' ' VAL . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.642 ' SD ' HD22 ' A' ' 26' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.804 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.3 t-20 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.4 mtt180 . . . . . 0 CA--C 1.521 -0.143 0 CA-C-O 121.068 0.461 . . . . 0.0 111.418 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' ' 104' ' ' ILE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.751 HG12 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.838 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 67' ' ' LEU . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.798 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.798 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.488 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.082 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 30' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 28' ' ' VAL . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.7 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.555 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.402 ' NH1' ' HA ' ' A' ' 62' ' ' ARG . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.484 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG11 ' A' ' 30' ' ' VAL . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' NE2' ' A' ' 66' ' ' GLN . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 103' ' ' LEU . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.606 ' ND2' HG22 ' A' ' 70' ' ' VAL . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.082 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.548 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.436 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD13 ' A' ' 67' ' ' LEU . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.773 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.5 t-20 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.698 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 13' ' ' THR . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.6 ttm180 . . . . . 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HE ' ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.755 0.312 . . . . 0.0 110.831 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.404 ' CD1' ' HD2' ' A' ' 107' ' ' ARG . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.759 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LEU . . . . . 0.782 HD23 ' CG2' ' A' ' 101' ' ' ILE . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD11 ' HB ' ' A' ' 16' ' ' VAL . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.85 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . 0.836 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.987 HG11 HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HD3' ' CD2' ' A' ' 39' ' ' HIS . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.438 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.503 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ILE . . . . . 1.123 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.836 HG23 HG13 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.85 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.987 HD11 HG11 ' A' ' 30' ' ' VAL . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.533 HG23 ' HG ' ' A' ' 76' ' ' LEU . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 104' ' ' ILE . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.658 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASN . . . . . 0.622 ' ND2' HG22 ' A' ' 70' ' ' VAL . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 83' ' ' ALA . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 68' ' ' ILE . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ALA . . . . . 1.123 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 30' ' ' VAL . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.714 ' HB3' HD12 ' A' ' 101' ' ' ILE . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.2 t-20 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' MET . . . . . 0.552 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.782 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.774 HD11 HG12 ' A' ' 101' ' ' ILE . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 13' ' ' THR . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.597 ' HB1' ' HE ' ' A' ' 9' ' ' ARG . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.423 0 N-CA-C 111.585 -0.606 . . . . 0.0 111.585 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.578 ' C ' HD12 ' A' ' 109' ' ' ILE . 0.2 OUTLIER -123.28 139.41 54.07 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.922 0.391 . . . . 0.0 111.055 -179.416 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 63.1 mtm-85 -129.08 162.12 28.44 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.824 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -147.34 128.83 14.98 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.486 ' CE1' HD12 ' A' ' 68' ' ' ILE . 42.9 m-85 -75.03 144.44 43.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.835 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.7 mt -140.15 139.79 35.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.032 0.444 . . . . 0.0 111.271 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.716 HG23 HD11 ' A' ' 104' ' ' ILE . 26.2 m -111.03 133.29 53.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.235 179.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' HE2' HG21 ' A' ' 105' ' ' VAL . 16.6 m-85 -132.88 125.96 31.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.059 0.457 . . . . 0.0 112.025 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 33.7 mp0 -96.77 104.49 16.49 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.663 178.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.903 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.4 OUTLIER -100.06 111.67 62.59 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.712 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.777 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.7 Cg_endo -83.56 99.09 0.82 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.819 2.346 . . . . 0.0 112.933 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.873 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -90.92 24.05 2.93 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 121.031 0.443 . . . . 0.0 110.965 179.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.404 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.06 -30.03 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.955 179.609 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.3 p30 -147.49 23.56 1.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.5 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 60.4 p -112.56 -13.43 13.32 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.63 0.252 . . . . 0.0 111.117 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -49.99 -26.16 8.34 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.824 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 32.9 t -54.62 -30.56 55.24 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.976 0.417 . . . . 0.0 110.806 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.05 -27.72 10.96 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.955 179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.436 ' O ' ' CB ' ' A' ' 26' ' ' LEU . . . 114.75 43.7 0.73 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.352 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.558 HD12 ' HB3' ' A' ' 54' ' ' ALA . 17.8 tp 87.01 -24.05 0.12 Allowed 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 122.979 0.512 . . . . 0.0 112.058 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.622 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 90.09 48.65 3.52 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.199 -1.001 . . . . 0.0 112.148 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.899 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -167.18 155.69 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.983 0.42 . . . . 0.0 111.386 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.21 133.25 47.46 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.114 179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.587 HG11 HD12 ' A' ' 67' ' ' LEU . 2.4 t -115.59 155.15 16.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.994 0.426 . . . . 0.0 111.807 -179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.38 134.31 37.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.517 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.33 147.41 16.57 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.625 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -136.75 -175.39 4.01 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.929 0.395 . . . . 0.0 110.998 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.33 166.37 24.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.753 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.5 t -47.04 141.58 4.12 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.22 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -78.83 -7.23 57.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.279 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -102.85 -29.43 11.46 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.896 0.379 . . . . 0.0 110.971 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.644 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.56 -169.11 3.08 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.886 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.0 m80 -95.83 41.88 1.1 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.813 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.644 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.95 101.43 13.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.204 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -55.81 125.67 22.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.808 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.0 mt -89.19 -34.69 16.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.032 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.567 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 142.82 -157.72 26.88 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.599 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.017 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.29 144.86 28.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.906 0.384 . . . . 0.0 110.937 -179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -131.23 142.46 50.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.339 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.418 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 16.9 t -52.01 111.86 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.976 0.417 . . . . 0.0 110.877 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.5 tptt -83.16 -42.32 17.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.142 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.99 170.93 20.29 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.938 0.399 . . . . 0.0 111.165 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.899 HG23 HG13 ' A' ' 28' ' ' VAL . 7.8 mt -136.63 151.09 27.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.98 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.575 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.7 mp -107.14 103.14 15.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.341 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.501 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.97 72.81 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.108 0.48 . . . . 0.0 110.839 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -166.89 -27.72 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.724 -179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -116.49 -166.23 14.34 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.481 -0.866 . . . . 0.0 112.984 -179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.903 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.6 -53.57 2.71 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.054 0.761 . . . . 0.0 113.054 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.622 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.38 -32.86 27.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.744 0.307 . . . . 0.0 111.446 -179.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 26.1 p -77.31 -58.0 3.52 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.141 0.496 . . . . 0.0 110.69 179.631 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.508 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.55 -24.41 63.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.024 -179.869 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.582 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -56.12 -45.76 79.41 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.736 179.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 57.58 20.25 37.8 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.875 -0.679 . . . . 0.0 112.96 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.433 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 5.5 ptp180 -128.65 3.59 5.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.69 0.245 . . . . 0.0 111.403 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.51 HD23 ' HB3' ' A' ' 58' ' ' ASP . 3.7 mm? -89.62 155.23 19.38 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.776 0.322 . . . . 0.0 110.946 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.46 ' HA ' ' NE ' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -138.03 124.87 21.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.724 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.418 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 28.1 t -67.86 70.04 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.263 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.57 -20.74 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.569 179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -56.62 143.29 36.49 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.878 0.371 . . . . 0.0 111.38 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.0 tp60 -88.44 130.51 35.17 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.664 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.904 HD23 ' CG1' ' A' ' 105' ' ' VAL . 93.1 mt -83.95 131.41 34.85 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.658 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.869 HD11 ' HB2' ' A' ' 106' ' ' ALA . 21.8 mt -125.44 -22.62 2.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.739 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -158.33 156.53 30.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.032 0.444 . . . . 0.0 111.721 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.616 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.1 p -153.38 115.79 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.947 179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.2 m-80 60.94 34.79 19.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.068 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.57 -24.64 28.43 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.622 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.425 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 3.5 mm-40 -70.87 155.39 40.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.767 0.317 . . . . 0.0 110.62 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 6.9 t -111.69 111.48 22.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.996 -179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.746 HD12 ' HB3' ' A' ' 67' ' ' LEU . 32.5 mt -76.86 -24.28 52.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.356 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -69.82 0.12 Allowed 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.456 -179.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -52.06 -25.35 17.21 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.458 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.548 ' NZ ' HD23 ' A' ' 75' ' ' LEU . 20.8 mtmm -81.31 143.21 32.4 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 121.173 0.511 . . . . 0.0 111.092 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -76.09 -169.95 1.27 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.522 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 84' ' ' MET . 7.4 p30 -63.33 -44.94 93.48 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.51 179.681 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.9 -40.23 75.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.326 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -68.18 -42.89 79.31 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.677 0.275 . . . . 0.0 111.224 -178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.017 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.81 -32.83 71.49 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.124 0.488 . . . . 0.0 110.047 179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.465 ' HA ' HD12 ' A' ' 87' ' ' LEU . 2.8 mtm -68.7 -30.57 69.25 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.44 179.499 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.593 ' O ' ' HB3' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -78.76 -40.0 34.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.568 179.513 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.52 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.77 -34.86 78.83 Favored 'General case' 0 N--CA 1.45 -0.475 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.583 HD21 HD13 ' A' ' 67' ' ' LEU . 16.8 mt -69.24 -51.27 39.31 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-N 115.27 -0.877 . . . . 0.0 108.792 178.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.587 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 10.4 ptp180 -61.89 -29.78 70.43 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.593 ' HB3' ' O ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -72.53 -39.81 67.26 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.981 178.846 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.697 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -71.96 -39.89 69.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.383 179.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.431 ' HE1' HD23 ' A' ' 26' ' ' LEU . 0.0 OUTLIER -77.96 -15.29 59.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.558 179.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 13.8 t -85.03 -53.72 5.1 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 112.589 0.589 . . . . 0.0 112.589 -178.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.446 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -173.67 56.1 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.5 mm-40 -157.22 -49.45 0.07 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.432 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -65.7 -26.86 72.2 Favored Glycine 0 N--CA 1.441 -1.031 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 177.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.873 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.0 t-20 -91.72 -111.69 0.09 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.576 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 6.5 mmpt? 54.76 10.03 0.33 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 111.669 0.248 . . . . 0.0 111.669 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.576 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -151.42 -43.68 0.11 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-O 121.111 0.481 . . . . 0.0 110.449 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.6 16.67 1.0 Allowed Glycine 0 CA--C 1.521 0.452 0 CA-C-N 115.54 -0.755 . . . . 0.0 112.276 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.486 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.38 160.37 1.29 Allowed 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 120.632 0.253 . . . . 0.0 110.737 -179.764 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.724 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.4 143.89 28.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.808 179.729 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -87.9 140.43 29.51 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.629 -179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.616 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -144.18 112.75 6.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.16 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.739 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.9 mm -94.72 142.27 13.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.36 179.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.904 ' CG1' HD23 ' A' ' 67' ' ' LEU . 15.0 m -141.45 179.44 2.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.818 -179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.869 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -131.23 133.9 45.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.766 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.413 ' HA ' ' HD3' ' A' ' 107' ' ' ARG . 1.4 tpp85 -120.69 137.02 54.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.656 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.29 166.13 24.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.133 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.578 HD12 ' C ' ' A' ' 8' ' ' THR . 3.7 mp -133.6 156.61 41.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.841 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.441 ' N ' HG22 ' A' ' 109' ' ' ILE . 73.0 p . . . . . 0 C--N 1.33 -0.25 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.007 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.415 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.441 ' HA ' HG13 ' A' ' 109' ' ' ILE . 8.8 p -154.25 54.27 0.69 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.959 0.409 . . . . 0.0 111.03 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -177.7 108.07 0.06 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.7 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -141.43 150.39 42.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.031 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 36.7 m-85 -85.02 146.45 27.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.496 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.493 HD12 HG23 ' A' ' 105' ' ' VAL . 0.9 OUTLIER -130.85 119.2 21.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.389 . . . . 0.0 111.231 -179.565 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.697 HG23 ' CD1' ' A' ' 104' ' ' ILE . 18.5 m -101.13 129.86 47.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.326 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' CZ ' ' HB3' ' A' ' 12' ' ' LEU . 22.1 m-85 -135.91 144.99 45.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 111.975 -179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 19.5 mp0 -102.17 108.01 19.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.823 179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 1.1 t -99.97 111.0 61.21 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.394 -179.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.758 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 89.0 Cg_endo -83.08 98.14 0.85 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.792 2.328 . . . . 0.0 113.337 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.898 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -90.45 24.51 2.58 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 121.102 0.477 . . . . 0.0 110.64 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.403 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -38.04 -30.92 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.903 179.586 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 21.9 p30 -146.73 20.81 1.3 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.156 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.408 ' HB2' ' HA ' ' A' ' 26' ' ' LEU . 1.1 m -108.68 -15.39 14.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.91 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -29.9 44.91 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.569 179.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 90.3 p -52.49 -33.33 44.35 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.911 0.386 . . . . 0.0 110.472 179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.45 -27.6 10.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.656 179.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 117.7 53.28 0.31 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 121.008 -0.615 . . . . 0.0 112.367 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.886 HD12 ' HB3' ' A' ' 18' ' ' LEU . 12.9 tp 76.91 -58.17 0.51 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 111.828 0.307 . . . . 0.0 111.828 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.634 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 124.36 47.78 0.23 Allowed Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.187 -179.256 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.911 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.91 152.63 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-O 120.875 0.369 . . . . 0.0 111.148 179.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -128.23 147.08 50.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.31 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.939 HG11 HD11 ' A' ' 67' ' ' LEU . 16.4 m -138.97 141.26 36.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.088 0.47 . . . . 0.0 111.958 -179.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 151.51 32.26 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.081 179.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.88 142.06 16.66 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.067 -179.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.62 -172.45 2.56 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.71 0.29 . . . . 0.0 110.722 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.432 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -138.55 166.19 24.94 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.016 0.436 . . . . 0.0 111.018 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.4 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.5 t -50.46 135.26 22.67 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.177 -179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.0 mmtt -72.58 -9.31 58.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.271 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -98.38 -27.2 14.2 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.696 0.284 . . . . 0.0 110.876 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -156.42 161.7 40.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.898 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 21.3 m170 -68.83 72.72 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.686 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.4 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -128.18 98.17 5.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.121 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 34' ' ' ARG . 3.5 t70 -49.88 122.56 6.72 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.088 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.2 mt -87.52 -66.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.923 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.418 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.42 -164.4 28.61 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.428 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.136 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -109.75 154.46 11.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.862 0.363 . . . . 0.0 110.982 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.465 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -136.3 138.71 42.01 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.308 179.833 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.821 ' HA ' HG12 ' A' ' 30' ' ' VAL . 29.7 t -51.84 104.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.975 0.417 . . . . 0.0 110.959 -179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.2 tppt? -80.3 -38.29 31.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.781 -179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -159.64 165.86 31.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.167 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.911 HG23 HG13 ' A' ' 28' ' ' VAL . 8.0 mt -130.91 150.72 34.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.793 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.656 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.3 mp -105.66 98.84 7.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.47 179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.505 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 3.4 p30 -65.32 76.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.043 0.449 . . . . 0.0 110.848 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.401 ' H ' ' HB3' ' A' ' 56' ' ' SER . . . -176.37 -27.73 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.22 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.96 -168.62 19.88 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.79 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -42.2 -53.45 4.05 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.351 0.871 . . . . 0.0 113.351 -179.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.634 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.85 -37.07 50.63 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.811 0.338 . . . . 0.0 111.509 -178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 27.6 p -69.96 -55.86 8.52 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.255 0.55 . . . . 0.0 110.579 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -64.44 -24.06 67.5 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.397 -0.82 . . . . 0.0 111.052 -179.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.675 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -58.19 -48.37 80.51 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.067 -179.936 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.1 24.65 61.1 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.602 -0.808 . . . . 0.0 112.329 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 26.4 mtm180 -120.21 -44.11 2.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.825 0.345 . . . . 0.0 110.947 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.662 ' H ' HD13 ' A' ' 61' ' ' LEU . 0.0 OUTLIER -60.07 152.94 22.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.769 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.73 138.12 40.63 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.582 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.435 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.2 t -67.23 70.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.216 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.34 -23.18 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.371 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -58.13 138.06 56.45 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 0.0 111.06 -179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.459 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -92.87 112.2 24.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.044 -0.526 . . . . 0.0 111.09 -179.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.939 HD11 HG11 ' A' ' 30' ' ' VAL . 38.8 mt -59.63 131.7 51.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.693 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.955 HD11 ' CB ' ' A' ' 106' ' ' ALA . 25.5 mt -119.14 -36.79 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.51 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -150.51 169.25 21.95 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.059 0.457 . . . . 0.0 111.663 -179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.645 ' HB ' HD23 ' A' ' 103' ' ' LEU . 7.3 p -158.15 104.87 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.766 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.45 ' ND2' HG22 ' A' ' 70' ' ' VAL . 53.6 m-80 57.66 36.56 26.81 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.851 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.38 -22.51 40.42 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.357 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.416 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -69.07 95.75 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.038 0.447 . . . . 0.0 110.374 179.814 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -69.4 97.78 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.809 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.475 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.5 mt -62.26 -17.27 57.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.127 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.8 mt -52.6 99.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.898 0.38 . . . . 0.0 110.699 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 129.84 -43.03 1.34 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.946 -0.645 . . . . 0.0 111.757 -179.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.41 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 25.3 mttp -62.9 134.46 56.25 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.983 0.42 . . . . 0.0 110.613 179.534 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -70.39 -170.02 0.35 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.105 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.452 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.3 p30 -60.73 -48.22 82.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.58 179.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -41.8 76.74 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.958 -179.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.41 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 46.1 mt-10 -62.77 -50.36 71.34 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-O 121.0 0.429 . . . . 0.0 111.276 -179.562 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.136 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -65.36 -33.35 75.76 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.331 -179.555 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.452 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 4.0 mtm -68.15 -28.03 66.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.196 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.416 ' O ' ' N ' ' A' ' 89' ' ' ARG . 1.1 pt-20 -82.95 -34.78 26.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.632 -0.713 . . . . 0.0 109.597 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.433 ' HB ' HD21 ' A' ' 75' ' ' LEU . 3.7 m -63.18 -38.93 93.11 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.519 ' CD1' HG21 ' A' ' 30' ' ' VAL . 13.4 mt -69.13 -51.11 41.67 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 178.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.1 mtt180 -58.4 -30.41 66.82 Favored 'General case' 0 N--CA 1.453 -0.324 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.158 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' GLU . 6.3 mtt180 -69.33 -44.65 71.23 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.783 178.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.67 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -64.59 -48.84 73.47 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.348 179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.83 ' CE ' HD22 ' A' ' 26' ' ' LEU . 18.9 mmt -69.89 -16.21 63.2 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.512 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.9 m -79.79 -54.93 5.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.934 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.479 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.18 57.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.404 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 7.2 mm-40 -157.48 -48.21 0.07 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.419 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -81.32 -28.41 44.53 Favored Glycine 0 N--CA 1.443 -0.837 0 N-CA-C 110.399 -1.081 . . . . 0.0 110.399 178.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.898 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.0 t-20 -86.41 -99.6 0.07 Allowed 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.627 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 42.5 pttt 43.76 14.84 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.627 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.81 -44.32 0.09 Allowed 'General case' 0 N--CA 1.463 0.177 0 CA-C-O 121.207 0.527 . . . . 0.0 110.491 -179.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 135.38 18.78 0.79 Allowed Glycine 0 CA--C 1.521 0.439 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.118 -179.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.57 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -176.33 160.33 2.11 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 122.337 0.255 . . . . 0.0 110.819 -179.764 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.67 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.0 OUTLIER -145.77 149.01 16.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-O 120.88 0.371 . . . . 0.0 111.058 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -96.34 135.79 37.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.423 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 ' HB ' ' A' ' 70' ' ' VAL . 3.8 mt -136.21 131.33 34.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.21 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.697 ' CD1' HG23 ' A' ' 13' ' ' THR . 35.7 mm -103.4 142.46 17.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.616 179.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.771 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.3 m -141.36 164.92 19.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.679 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.955 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -117.32 135.53 53.77 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.456 179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HB3' HD11 ' A' ' 12' ' ' LEU . 15.2 ttm180 -147.12 143.63 28.43 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.823 0.344 . . . . 0.0 111.161 -179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.401 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 6.6 mtm-85 -74.87 -176.02 2.74 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.775 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.441 HG13 ' HA ' ' A' ' 8' ' ' THR . 2.1 mt -137.28 159.4 35.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.204 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.424 ' N ' HG22 ' A' ' 109' ' ' ILE . 26.9 t . . . . . 0 C--N 1.326 -0.422 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.87 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.618 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 112.544 -0.222 . . . . 0.0 112.544 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.618 HG23 ' O ' ' A' ' 7' ' ' GLY . 37.0 p -164.19 138.37 5.53 Favored 'General case' 0 CA--C 1.528 0.117 0 CA-C-O 120.766 0.317 . . . . 0.0 110.873 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.531 ' H ' ' HA ' ' A' ' 108' ' ' ARG . 22.6 ptt180 50.0 122.67 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.882 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.778 ' HG2' HD11 ' A' ' 109' ' ' ILE . 2.5 pt-20 -143.59 139.37 29.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.833 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 17.0 m-85 -78.47 140.48 38.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.786 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.3 mt -139.24 138.7 37.05 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.974 0.416 . . . . 0.0 111.285 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.713 ' HA ' HD13 ' A' ' 104' ' ' ILE . 15.7 m -99.54 141.1 32.78 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.29 179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.432 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.2 m-85 -139.05 127.81 23.4 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.985 0.421 . . . . 0.0 111.808 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -101.56 105.6 16.58 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.753 178.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.926 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.84 112.05 64.83 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.332 -0.394 . . . . 0.0 111.635 -178.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.809 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 85.9 Cg_endo -80.74 96.75 0.99 Allowed 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.791 2.327 . . . . 0.0 112.787 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.842 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -89.27 24.61 2.13 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.968 0.413 . . . . 0.0 111.048 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -39.87 -30.51 0.09 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.756 179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -140.27 25.64 2.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.962 -179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.1 t -112.56 -18.03 12.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.121 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.97 -40.74 10.01 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.802 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.0 t -56.93 -31.8 65.31 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.881 0.372 . . . . 0.0 110.462 179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.16 -27.49 14.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.849 179.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 105.92 37.78 2.48 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.386 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.737 HD22 ' SD ' ' A' ' 91' ' ' MET . 30.4 tp 84.12 -18.26 0.43 Allowed 'General case' 0 N--CA 1.466 0.337 0 C-N-CA 122.865 0.466 . . . . 0.0 112.206 179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.73 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 80.68 56.72 3.06 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.22 -0.99 . . . . 0.0 112.426 -179.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.976 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.37 161.86 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.963 0.411 . . . . 0.0 111.198 179.329 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.22 149.12 40.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.201 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.795 HG11 HD11 ' A' ' 67' ' ' LEU . 2.4 m -136.69 150.53 27.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.997 0.427 . . . . 0.0 111.66 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.12 134.02 47.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.707 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -93.97 129.92 10.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.295 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.532 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -114.64 144.26 43.69 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.751 0.31 . . . . 0.0 110.743 -179.696 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.421 ' HD2' ' CD2' ' A' ' 39' ' ' HIS . 10.7 mtt85 -99.6 166.25 11.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.044 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.3 t -47.78 154.21 0.52 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.315 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.9 mmtm -80.62 -21.53 41.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.118 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 17.1 mm-40 -95.41 -30.14 14.05 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.932 -179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.657 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -142.06 -168.47 2.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.973 -179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' CD2' ' HD2' ' A' ' 34' ' ' ARG . 0.0 OUTLIER -97.25 34.12 1.84 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.817 179.869 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.657 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -75.96 120.36 21.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.122 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -56.38 132.54 51.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.978 179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD12 ' ND2' ' A' ' 33' ' ' ASN . 16.4 mt -108.85 -38.15 5.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.046 -179.78 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.433 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 139.91 177.99 16.35 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.479 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.064 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.89 145.57 13.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.973 0.416 . . . . 0.0 111.053 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.21 143.42 50.77 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.274 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.513 ' HA ' HG12 ' A' ' 30' ' ' VAL . 16.4 t -52.03 104.72 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.944 0.402 . . . . 0.0 110.793 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -80.39 -39.42 28.41 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.033 -179.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 13.3 p -158.9 158.3 33.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.902 0.382 . . . . 0.0 111.231 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.98 HD13 HD23 ' A' ' 61' ' ' LEU . 5.0 mt -128.85 151.23 35.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.854 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.747 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.3 mp -107.3 109.69 29.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.272 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.49 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -71.07 65.64 0.37 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.935 0.398 . . . . 0.0 110.685 -179.962 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.68 -27.98 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.768 -0.729 . . . . 0.0 113.059 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.23 -167.76 16.08 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.874 -179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.926 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.75 -52.27 2.99 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.743 ' O ' HD11 ' A' ' 61' ' ' LEU . . . -51.67 -29.98 20.1 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.821 0.343 . . . . 0.0 111.59 -179.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.49 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.6 p -80.5 -58.24 3.21 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.234 0.54 . . . . 0.0 110.547 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.493 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.57 -24.5 65.48 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.62 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.643 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -57.88 -50.15 74.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.946 0.403 . . . . 0.0 110.938 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.14 21.44 68.08 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.941 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.436 ' H ' HD13 ' A' ' 61' ' ' LEU . 6.0 ptp180 -127.94 3.49 5.95 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.545 0.212 . . . . 0.0 111.487 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.98 HD23 HD13 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -99.27 152.71 19.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.912 0.387 . . . . 0.0 110.472 179.525 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -141.09 134.99 30.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 5.2 t -66.76 73.81 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.156 -179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.3 p30 167.37 -21.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.37 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.43 138.21 40.55 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.922 0.392 . . . . 0.0 111.314 -179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.463 ' HG2' HD11 ' A' ' 68' ' ' ILE . 2.2 tp60 -89.66 119.3 29.95 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.898 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.795 HD11 HG11 ' A' ' 30' ' ' VAL . 91.7 mt -68.5 124.08 22.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.482 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.702 HG23 HD12 ' A' ' 76' ' ' LEU . 12.8 mm -117.45 -26.59 2.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.817 -179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.777 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -162.61 163.95 26.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.039 0.447 . . . . 0.0 111.613 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG23 ' HG ' ' A' ' 103' ' ' LEU . 8.3 p -156.14 104.69 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.775 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.55 ' ND2' HG22 ' A' ' 70' ' ' VAL . 60.7 m-80 61.43 33.55 18.61 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.678 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.07 -21.35 45.61 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.457 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -78.2 96.47 5.22 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.939 0.399 . . . . 0.0 110.741 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.2 t -57.15 143.99 36.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.973 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.736 HD12 ' HB3' ' A' ' 67' ' ' LEU . 12.3 mt -112.87 -20.39 11.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.318 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.702 HD12 HG23 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.54 -48.3 38.6 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.812 0.339 . . . . 0.0 110.832 -179.928 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.5 -25.89 66.86 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.947 179.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.511 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 7.3 mttp -69.01 133.53 48.26 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.054 179.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.55 -171.77 1.62 Allowed 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.526 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.426 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 4.9 p30 -59.9 -49.7 76.68 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.82 0.343 . . . . 0.0 110.705 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.8 -42.58 73.54 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.6 mt-10 -65.48 -43.36 90.47 Favored 'General case' 0 C--N 1.33 -0.242 0 C-N-CA 121.154 -0.218 . . . . 0.0 111.475 -179.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.064 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.06 -33.5 73.68 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.064 0.459 . . . . 0.0 110.096 -179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.426 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.1 mtm -68.79 -29.68 68.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.286 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.436 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.4 pt-20 -83.3 -39.15 21.18 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.08 179.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.2 m -61.53 -37.38 83.56 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.77 HD13 HG21 ' A' ' 30' ' ' VAL . 11.2 mt -69.37 -55.15 11.22 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 115.344 -0.844 . . . . 0.0 108.797 178.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 18.0 ptt85 -55.86 -29.72 60.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.286 178.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 8.3 mtt85 -69.76 -44.45 70.17 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 115.296 -0.865 . . . . 0.0 109.915 178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.636 ' HB3' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER -65.54 -48.48 72.31 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.469 -0.787 . . . . 0.0 110.353 179.831 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.737 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.4 mmt -68.16 -18.04 64.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.59 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 31.2 t -88.48 -54.09 4.35 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.104 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.572 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.68 65.15 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -179.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 78.0 mt-10 -161.79 -36.02 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.159 0.505 . . . . 0.0 109.841 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.429 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -98.51 -37.15 4.35 Favored Glycine 0 N--CA 1.442 -0.928 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 177.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.842 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.9 t-20 -71.76 -94.77 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 178.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 40.21 25.05 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 112.696 0.628 . . . . 0.0 112.696 178.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.1 -33.15 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 120.807 0.337 . . . . 0.0 111.616 -179.771 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.444 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.87 17.24 2.57 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 121.045 -0.597 . . . . 0.0 112.339 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.513 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.8 ptm -172.38 157.64 4.12 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-O 120.482 0.182 . . . . 0.0 110.975 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.679 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.05 147.82 17.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.979 0.418 . . . . 0.0 111.18 -179.974 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.0 tt0 -95.55 140.08 30.91 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.294 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.602 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.0 OUTLIER -140.72 121.77 14.66 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.854 0.359 . . . . 0.0 111.627 -179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.777 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 36.0 mm -92.63 141.03 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.477 . . . . 0.0 109.856 178.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.432 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -141.93 165.48 17.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -179.171 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -115.86 141.69 47.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.531 -0.758 . . . . 0.0 110.041 178.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 9' ' ' ARG . 0.3 OUTLIER -139.92 112.08 7.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.736 0.303 . . . . 0.0 111.002 -179.444 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.531 ' HA ' ' H ' ' A' ' 9' ' ' ARG . 0.0 OUTLIER -62.02 160.42 12.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.035 -179.872 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.778 HD11 ' HG2' ' A' ' 10' ' ' GLU . 6.9 mm -116.51 162.9 14.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.95 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.454 ' N ' HG22 ' A' ' 109' ' ' ILE . 13.7 m . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.853 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.393 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.621 ' HB ' HD13 ' A' ' 109' ' ' ILE . 0.4 OUTLIER -135.33 141.87 45.69 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.999 0.428 . . . . 0.0 110.987 -179.448 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' CA ' HD12 ' A' ' 109' ' ' ILE . 5.3 mtm105 -137.87 140.24 40.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.756 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -125.76 153.62 43.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.908 0.385 . . . . 0.0 111.23 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.699 ' HE2' HG21 ' A' ' 68' ' ' ILE . 24.1 m-85 -108.41 146.7 32.69 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.671 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.43 HD12 HG23 ' A' ' 105' ' ' VAL . 1.6 mt -139.57 140.67 37.13 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.887 0.375 . . . . 0.0 111.339 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.464 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.2 m -111.52 140.88 45.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.311 179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.504 ' HE2' HG21 ' A' ' 105' ' ' VAL . 19.3 m-85 -135.85 129.96 33.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.085 0.469 . . . . 0.0 112.07 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -99.44 104.59 16.45 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.717 -0.674 . . . . 0.0 109.374 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.83 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.95 106.32 49.97 Favored Pre-proline 0 C--N 1.329 -0.306 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -178.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.794 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 5.8 Cg_exo -77.79 97.22 1.13 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.916 2.411 . . . . 0.0 112.541 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.853 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -89.19 24.06 2.27 Favored 'General case' 0 C--O 1.231 0.122 0 CA-C-O 121.22 0.533 . . . . 0.0 111.008 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.407 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -39.13 -29.51 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.187 179.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -146.07 21.99 1.39 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.267 -179.785 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.414 ' OG ' ' HA ' ' A' ' 26' ' ' LEU . 54.8 p -113.85 -10.2 13.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.145 179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.86 -27.74 45.18 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.635 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.12 -43.35 74.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.989 0.423 . . . . 0.0 110.627 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.78 -26.45 18.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.74 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 111.94 50.86 0.58 Allowed Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.974 -0.632 . . . . 0.0 112.41 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.702 HD22 ' SD ' ' A' ' 91' ' ' MET . 16.6 tp 80.27 -51.93 0.36 Allowed 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 179.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.654 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 115.61 51.54 0.42 Allowed Glycine 0 N--CA 1.443 -0.846 0 C-N-CA 120.337 -0.935 . . . . 0.0 111.906 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.982 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -165.8 158.63 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.17 0 CA-C-O 120.986 0.422 . . . . 0.0 111.31 179.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -139.38 133.05 30.54 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.009 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.93 HG12 ' HA ' ' A' ' 46' ' ' VAL . 28.6 m -129.76 157.61 42.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.238 0.542 . . . . 0.0 111.934 -179.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.457 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.6 160.23 35.95 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.334 -0.848 . . . . 0.0 109.801 179.044 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.2 154.05 17.09 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.378 -0.915 . . . . 0.0 113.023 -179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -136.22 174.55 10.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.808 0.337 . . . . 0.0 110.688 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -113.34 166.25 11.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.051 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.622 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -59.05 -19.05 40.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.296 179.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.0 mttt 67.61 13.73 9.35 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-O 120.884 0.373 . . . . 0.0 111.054 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -139.99 -43.61 0.43 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.851 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.779 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.1 p30 -124.89 19.06 8.52 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.334 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 9.0 m80 55.57 36.07 26.44 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.159 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.779 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -96.81 110.1 22.66 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -58.19 97.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.941 179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 50.1 mt -57.07 -29.33 63.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.919 -180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.498 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 136.67 -160.77 24.92 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.526 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.097 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -105.77 162.42 4.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-O 120.766 0.317 . . . . 0.0 110.793 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.42 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.7 OUTLIER -141.95 134.46 28.17 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.546 -179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.93 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.3 t -51.93 105.74 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-O 120.971 0.415 . . . . 0.0 111.043 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.4 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.5 OUTLIER -79.6 -40.75 28.6 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.887 -179.64 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.3 m -166.01 163.85 18.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.82 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.982 HG23 HG13 ' A' ' 28' ' ' VAL . 7.4 mt -128.49 154.11 38.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.984 0.421 . . . . 0.0 111.198 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.681 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.1 mp -104.07 104.85 17.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.562 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.624 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -68.04 71.99 0.17 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.857 179.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -167.74 -29.85 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.99 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -112.74 -169.06 17.56 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.551 -0.833 . . . . 0.0 113.008 -179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.72 -54.75 2.55 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.61 -31.21 24.13 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.927 0.394 . . . . 0.0 111.348 -179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.624 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 25.2 t -78.34 -59.1 2.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.059 0.457 . . . . 0.0 110.557 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.472 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.73 -24.14 63.76 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.937 179.815 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.625 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.6 OUTLIER -56.19 -50.27 71.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.911 179.901 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.58 33.54 85.28 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.524 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 4.8 mtm180 -128.23 -39.38 1.72 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.45 . . . . 0.0 110.644 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD13 ' N ' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -57.82 146.15 32.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.088 179.91 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -126.95 131.91 50.97 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.336 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.432 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.4 t -67.92 66.95 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.254 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.4 p30 171.2 -22.07 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.805 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -58.76 151.17 21.8 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.757 0.313 . . . . 0.0 111.07 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.655 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.2 OUTLIER -102.06 118.21 36.42 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.194 -179.867 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.644 ' CD1' HD11 ' A' ' 87' ' ' LEU . 79.9 mt -61.47 129.35 40.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.334 -0.394 . . . . 0.0 110.61 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.699 HG21 ' HE2' ' A' ' 11' ' ' PHE . 14.6 mm -117.39 -27.9 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.822 -179.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.49 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -161.54 164.67 29.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.05 0.453 . . . . 0.0 111.614 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.714 HG23 ' HG ' ' A' ' 103' ' ' LEU . 10.0 p -155.67 109.28 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.164 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.595 HD22 HG22 ' A' ' 70' ' ' VAL . 70.5 m-80 61.97 40.02 12.8 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.999 -0.546 . . . . 0.0 111.18 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.1 -20.53 42.46 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.615 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' O ' ' HB1' ' A' ' 69' ' ' ALA . 0.0 OUTLIER -77.52 145.53 36.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.707 0.289 . . . . 0.0 110.493 179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 4.8 t -99.5 139.99 34.35 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.993 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.657 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.6 mt -112.47 -27.12 8.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.124 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.496 HD12 ' N ' ' A' ' 77' ' ' GLY . 3.3 pp -48.05 -43.34 30.31 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.086 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . 0.496 ' N ' HD12 ' A' ' 76' ' ' LEU . . . -76.28 -30.56 56.76 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.001 179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.408 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 15.6 mttp -73.13 140.75 47.3 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.152 0.501 . . . . 0.0 110.973 179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.54 -169.85 0.92 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.062 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 1.7 m120 -61.78 -45.15 95.1 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.84 0.352 . . . . 0.0 110.354 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.58 -45.59 68.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.391 -179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.469 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 67.3 mm-40 -63.54 -44.62 93.66 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.753 0.311 . . . . 0.0 111.433 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.097 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.31 -33.33 74.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.077 0.465 . . . . 0.0 110.036 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.48 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.1 mtm -69.05 -28.97 67.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.006 178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.469 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.4 pt-20 -83.1 -37.61 23.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.863 179.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.425 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.6 m -64.84 -38.75 92.02 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.644 HD11 ' CD1' ' A' ' 67' ' ' LEU . 47.5 mt -67.66 -51.89 44.54 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.3 mtt-85 -57.43 -32.31 66.77 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.116 177.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 9.2 mtt180 -67.96 -41.51 82.32 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.265 179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.05 -45.27 64.12 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.855 -179.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.702 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -74.32 -12.52 60.56 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.152 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.7 p -87.76 -49.71 6.94 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.544 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -176.82 62.72 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.774 0.321 . . . . 0.0 111.855 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.422 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.5 mt-10 -165.06 -51.27 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.441 0 N-CA-C 109.4 -0.593 . . . . 0.0 109.4 179.352 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.405 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -64.82 -30.66 78.57 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.543 -1.023 . . . . 0.0 110.543 178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.853 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -87.86 -108.22 0.07 Allowed 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.642 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 50.73 12.97 0.12 Allowed 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.642 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -154.39 -43.9 0.09 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-O 121.292 0.567 . . . . 0.0 110.417 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 133.29 17.58 1.11 Allowed Glycine 0 CA--C 1.52 0.371 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.129 -179.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.51 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -178.72 161.26 1.25 Allowed 'General case' 0 N--CA 1.454 -0.251 0 CA-C-O 120.693 0.282 . . . . 0.0 110.951 -179.741 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.748 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.36 142.56 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.68 179.735 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.464 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.4 tt0 -96.1 143.49 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.793 -179.669 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.714 ' HG ' HG23 ' A' ' 70' ' ' VAL . 2.5 mp -144.03 127.2 16.61 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.082 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.6 mm -94.68 142.77 12.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.574 179.511 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.504 HG21 ' HE2' ' A' ' 14' ' ' PHE . 29.4 m -135.73 155.01 35.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.455 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.661 ' HB3' HD11 ' A' ' 68' ' ' ILE . . . -119.48 145.83 45.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.775 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.6 ttm180 -141.92 142.18 33.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.821 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 tpp180 -87.11 131.58 34.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.023 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.621 HD13 ' HB ' ' A' ' 8' ' ' THR . 3.6 mp -92.93 157.24 2.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.047 179.859 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.466 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.377 0 CA-C-O 120.998 0.428 . . . . 0.0 110.882 179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.409 0 N-CA-C 112.367 -0.293 . . . . 0.0 112.367 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.425 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 23.0 p -151.61 61.7 0.87 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.967 0.413 . . . . 0.0 110.988 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -179.48 102.21 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.638 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.431 ' CG ' HD11 ' A' ' 109' ' ' ILE . 8.4 pt-20 -113.44 144.03 43.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.193 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.427 ' CE2' HG21 ' A' ' 68' ' ' ILE . 5.3 m-85 -87.13 133.63 33.6 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.442 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.9 mt -130.3 135.61 48.27 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.922 0.392 . . . . 0.0 111.345 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.413 ' O ' ' CD1' ' A' ' 14' ' ' PHE . 16.4 m -102.75 136.87 41.78 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.452 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.429 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 22.6 m-85 -134.9 129.97 35.18 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.069 0.462 . . . . 0.0 111.82 -179.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.404 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 3.3 mp0 -97.1 107.79 20.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.825 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.791 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.55 105.32 43.38 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.661 -178.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.829 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.1 Cg_exo -75.92 96.53 1.06 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.644 2.229 . . . . 0.0 112.487 -179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.799 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.48 24.55 1.63 Allowed 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 121.047 0.451 . . . . 0.0 110.982 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.76 -27.08 0.29 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.906 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -142.27 17.88 2.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.538 -0.301 . . . . 0.0 111.546 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 54.7 p -114.05 -10.64 12.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.736 0.303 . . . . 0.0 111.17 179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.89 -31.25 54.83 Favored Glycine 0 C--N 1.333 0.4 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.695 179.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.9 p -53.83 -36.89 63.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.027 0.441 . . . . 0.0 110.636 179.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.1 -21.82 14.35 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.848 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 134.52 -58.63 0.68 Allowed Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.102 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.772 HD22 ' CE ' ' A' ' 91' ' ' MET . 42.1 tp -177.26 -35.28 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.54 0.209 . . . . 0.0 111.437 179.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.539 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.38 44.03 0.57 Allowed Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.33 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.613 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.3 p 173.01 156.67 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 121.34 0.59 . . . . 0.0 111.654 179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.464 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 0.6 OUTLIER -131.86 154.72 48.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.879 179.602 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.015 HG12 ' HA ' ' A' ' 46' ' ' VAL . 34.5 m -138.77 149.19 23.78 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.879 0.371 . . . . 0.0 111.751 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.439 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -113.92 163.84 14.58 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.015 179.071 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.45 147.58 18.9 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.814 -179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -132.66 170.39 15.28 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.847 0.356 . . . . 0.0 110.869 179.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.86 166.19 18.72 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.767 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.2 t -49.19 134.67 17.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -179.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.62 -12.63 61.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.242 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 -98.24 -29.9 12.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.748 0.309 . . . . 0.0 111.062 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -150.33 161.33 42.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.055 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -69.49 70.37 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.704 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.405 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -122.14 98.21 5.83 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.209 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -52.99 113.77 1.21 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.96 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 20.7 mt -79.47 -66.54 0.86 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.016 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.442 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -173.03 -160.28 21.28 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.513 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.05 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.39 162.17 8.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 120.762 0.315 . . . . 0.0 111.056 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.504 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -144.92 136.82 25.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.47 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 1.015 ' HA ' HG12 ' A' ' 30' ' ' VAL . 23.3 t -51.8 112.29 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.975 0.416 . . . . 0.0 110.824 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.419 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 9.8 tppt? -91.4 -34.72 14.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.902 -178.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.2 OUTLIER -168.53 135.51 1.97 Allowed 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.776 -0.37 . . . . 0.0 111.126 -179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.613 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.6 mt -110.05 151.6 12.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.165 0.507 . . . . 0.0 111.36 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.517 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -102.83 102.17 13.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.459 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.576 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.4 p30 -65.44 75.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.946 0.403 . . . . 0.0 110.996 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.01 -27.41 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.818 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -113.9 -169.4 16.78 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.019 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.829 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.08 -55.66 2.53 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 112.806 0.669 . . . . 0.0 112.806 -179.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.539 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.03 -29.94 14.03 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.859 0.361 . . . . 0.0 111.316 -179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.576 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.5 t -80.31 -58.97 2.89 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.464 179.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -57.84 -24.01 55.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.65 179.712 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.472 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -53.64 -50.43 65.76 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.602 179.742 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 68.61 9.64 59.1 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.975 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.6 OUTLIER -115.8 -8.2 12.0 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.774 0.321 . . . . 0.0 110.8 179.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.448 HD23 ' HB3' ' A' ' 58' ' ' ASP . 2.3 mm? -89.44 146.05 24.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.101 0.477 . . . . 0.0 111.271 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.5 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.0 OUTLIER -144.34 136.73 26.58 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.077 179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.588 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 2.7 m -67.42 58.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.24 0 N-CA-C 111.738 0.273 . . . . 0.0 111.738 -179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -167.6 -27.38 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -60.76 147.94 40.69 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.836 0.35 . . . . 0.0 111.427 -178.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -101.12 129.28 46.98 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.784 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.74 HD13 HD11 ' A' ' 87' ' ' LEU . 78.0 mt -74.06 142.76 45.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.829 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 1.013 HD11 ' HB2' ' A' ' 106' ' ' ALA . 34.1 mt -128.77 -40.7 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.578 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.58 167.78 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.965 0.412 . . . . 0.0 111.546 -179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.715 HG23 ' HG ' ' A' ' 103' ' ' LEU . 6.2 p -158.26 116.44 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.26 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.588 HD22 HG22 ' A' ' 70' ' ' VAL . 71.0 m-80 55.4 39.75 31.24 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.076 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.87 -15.29 59.6 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.575 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -76.51 137.19 39.46 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.717 0.294 . . . . 0.0 110.346 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 p -98.71 114.94 27.66 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.105 0.478 . . . . 0.0 111.214 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.802 HD23 ' CE ' ' A' ' 78' ' ' LYS . 60.3 mt -83.39 -26.1 30.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.798 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -45.26 -42.21 9.31 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.316 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.71 44.59 2.72 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.337 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.802 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.3 mtmm -150.62 141.19 22.56 Favored 'General case' 0 CA--C 1.517 -0.31 0 CA-C-O 121.047 0.451 . . . . 0.0 111.132 -179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.42 -169.75 1.53 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.674 -0.694 . . . . 0.0 109.645 179.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 3.0 p30 -57.53 -52.33 65.82 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.907 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.67 -39.19 84.5 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 -179.164 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 35.8 mt-10 -67.9 -44.51 76.79 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.773 0.32 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.05 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.67 -33.28 72.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.138 0.494 . . . . 0.0 110.032 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.4 mtm -68.34 -28.61 67.29 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.146 179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.644 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.2 mm-40 -75.63 -39.24 58.13 Favored 'General case' 0 CA--C 1.51 -0.587 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.857 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.469 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -60.95 -40.98 95.35 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.554 179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.74 HD11 HD13 ' A' ' 67' ' ' LEU . 77.1 mt -67.94 -54.33 19.52 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 52.9 mtt180 -57.55 -30.34 65.13 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.513 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.4 OUTLIER -72.82 -39.0 66.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.219 179.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.556 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.2 m -71.33 -44.87 64.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.254 179.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.772 ' CE ' HD22 ' A' ' 26' ' ' LEU . 15.5 mmt -72.92 -17.29 61.52 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.405 178.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 1.5 m -76.16 -52.49 9.98 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.976 -0.556 . . . . 0.0 112.378 -178.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 93' ' ' THR . 8.9 t -176.97 55.65 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.401 ' HB2' ' HA ' ' A' ' 90' ' ' SER . 77.7 mm-40 -157.63 -57.0 0.08 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.417 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.54 -30.7 77.34 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 110.551 -1.019 . . . . 0.0 110.551 178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.799 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.7 t-20 -83.76 -103.89 0.04 OUTLIER 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 178.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm 42.92 23.5 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.376 0.51 . . . . 0.0 112.376 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.4 OUTLIER -167.4 -33.49 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.231 0 CA-C-O 120.786 0.327 . . . . 0.0 111.377 179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.405 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.84 16.45 3.66 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.061 -0.59 . . . . 0.0 112.308 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.52 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -178.02 158.92 1.28 Allowed 'General case' 0 N--CA 1.453 -0.283 0 CA-C-O 120.675 0.274 . . . . 0.0 111.196 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.702 HG12 HD11 ' A' ' 103' ' ' LEU . 0.0 OUTLIER -142.91 148.48 19.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.729 179.463 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.409 ' OE1' HG21 ' A' ' 13' ' ' THR . 17.6 tt0 -102.26 142.5 33.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.832 -179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.715 ' HG ' HG23 ' A' ' 70' ' ' VAL . 3.5 mp -144.51 131.02 19.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.332 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 36.1 mm -94.85 142.59 13.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.506 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.591 HG12 ' HA ' ' A' ' 67' ' ' LEU . 36.0 m -141.04 163.49 21.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.688 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 1.013 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -114.82 143.24 45.42 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.8 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -142.99 138.45 30.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.857 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 13.8 mmm-85 -58.88 166.29 2.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.097 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.532 HG22 ' N ' ' A' ' 110' ' ' SER . 9.1 mm -118.63 162.83 16.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.006 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.532 ' N ' HG22 ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 C--N 1.331 -0.215 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.048 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.455 0 N-CA-C 112.006 -0.438 . . . . 0.0 112.006 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.502 ' HB ' ' N ' ' A' ' 109' ' ' ILE . 18.9 p -77.53 78.9 4.04 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 120.94 0.4 . . . . 0.0 111.045 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.5 mtt85 -170.32 101.0 0.27 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.667 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.6 pt-20 -119.93 138.14 53.62 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.064 -179.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.518 ' HE2' HG21 ' A' ' 68' ' ' ILE . 69.5 m-85 -86.92 148.82 25.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.92 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.501 HD11 ' CD ' ' A' ' 107' ' ' ARG . 2.3 mt -139.93 141.04 36.51 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.085 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.726 HG23 HD11 ' A' ' 104' ' ' ILE . 19.5 m -113.87 132.54 55.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.583 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.438 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 14.3 m-85 -134.81 150.08 50.46 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.111 0.482 . . . . 0.0 112.033 -179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.402 ' OE1' ' NH1' ' A' ' 60' ' ' ARG . 2.7 mp0 -112.64 110.09 20.02 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.534 -0.757 . . . . 0.0 109.84 179.259 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.731 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.1 OUTLIER -103.08 104.37 39.87 Favored Pre-proline 0 C--N 1.328 -0.332 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -178.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.867 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.9 Cg_exo -76.73 96.16 1.08 Allowed 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 122.876 2.384 . . . . 0.0 112.029 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.976 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.57 24.8 1.59 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.951 0.405 . . . . 0.0 110.955 179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.84 -29.43 0.32 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.463 179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 33.8 p30 -136.94 25.11 3.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.007 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -116.54 -16.53 10.76 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.315 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.51 -43.23 20.63 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.804 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 35.3 t -55.54 -28.51 55.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.822 0.344 . . . . 0.0 110.718 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -99.53 -24.09 14.87 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.094 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.517 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.45 39.2 2.64 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.201 -179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.62 HD13 ' HB3' ' A' ' 18' ' ' LEU . 23.8 tp 82.32 -14.79 0.74 Allowed 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 122.882 0.473 . . . . 0.0 111.944 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.84 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 75.31 62.6 2.7 Favored Glycine 0 N--CA 1.448 -0.504 0 C-N-CA 120.474 -0.87 . . . . 0.0 112.731 179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.892 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.59 158.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.064 0.459 . . . . 0.0 111.503 179.278 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.2 t -139.04 149.92 45.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.988 HG11 HD11 ' A' ' 67' ' ' LEU . 16.5 m -140.03 158.42 26.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 121.207 0.527 . . . . 0.0 112.049 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.66 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -131.47 164.11 26.48 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.849 178.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.46 151.09 18.43 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.546 -0.835 . . . . 0.0 112.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 45' ' ' PHE . 1.1 m-80 -130.24 138.47 50.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.871 0.367 . . . . 0.0 110.995 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.0 166.18 12.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.816 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 10.0 t -54.02 143.03 23.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.864 -179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -16.63 60.93 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.293 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -97.26 -30.92 12.7 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.026 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.49 176.32 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.994 -179.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.58 75.72 7.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.79 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -125.84 104.66 8.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.179 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -58.84 110.22 0.97 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.926 -179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 1.9 mt -77.24 -66.76 0.79 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.895 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.471 ' C ' HD13 ' A' ' 44' ' ' ILE . . . -168.48 -167.89 29.76 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.457 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.13 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -115.77 137.64 48.76 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.892 0.377 . . . . 0.0 111.087 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -114.66 150.18 35.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.464 179.521 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.894 ' HA ' HG12 ' A' ' 30' ' ' VAL . 5.1 t -60.86 116.75 2.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.394 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 8.6 tppt? -87.24 -45.3 10.75 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.058 -179.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -157.09 159.13 37.58 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.028 -179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.892 HG23 HG13 ' A' ' 28' ' ' VAL . 8.5 mt -127.35 155.18 38.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.946 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.84 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -103.95 99.65 8.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.336 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.553 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.86 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.113 0.482 . . . . 0.0 110.857 179.88 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -172.78 -29.13 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.286 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.01 -172.42 21.03 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.63 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.867 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.78 -53.07 2.91 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 112.778 0.658 . . . . 0.0 112.778 -179.593 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.524 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.19 -28.83 12.24 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.388 -179.161 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 40.4 t -81.63 -59.56 2.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.609 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.69 -24.37 61.23 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.211 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.559 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -56.01 -50.28 71.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.84 0.352 . . . . 0.0 110.853 179.96 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.34 15.61 59.25 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.857 -0.687 . . . . 0.0 112.998 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 8.6 mtm180 -117.67 -9.56 10.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.726 0.298 . . . . 0.0 110.988 179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.624 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.2 mm? -87.84 146.38 25.62 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.499 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.1 OUTLIER -120.0 160.83 22.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.709 179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.543 HG12 ' O ' ' A' ' 63' ' ' VAL . 10.7 t -94.65 30.64 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.948 0.404 . . . . 0.0 111.273 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.5 m-80 -163.44 18.14 0.07 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.743 179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.452 ' OD2' HG21 ' A' ' 105' ' ' VAL . 0.3 OUTLIER -86.67 144.18 27.25 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.888 0.375 . . . . 0.0 110.61 -179.93 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.476 ' HG2' ' CE1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -91.59 109.89 21.2 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.063 -179.8 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.988 HD11 HG11 ' A' ' 30' ' ' VAL . 12.4 mt -62.72 120.62 11.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.402 -0.363 . . . . 0.0 110.665 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.518 HG21 ' HE2' ' A' ' 11' ' ' PHE . 29.9 mm -100.62 -38.28 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.49 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -156.79 173.16 17.39 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.0 0.429 . . . . 0.0 111.476 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.814 HG22 ' ND2' ' A' ' 71' ' ' ASN . 10.8 p -148.69 106.2 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.871 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.814 ' ND2' HG22 ' A' ' 70' ' ' VAL . 10.5 p30 46.21 41.66 9.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.756 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 104.14 -21.07 38.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.581 -0.819 . . . . 0.0 113.236 179.405 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.633 ' HB2' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -79.53 101.8 8.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.958 0.409 . . . . 0.0 110.766 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 80.4 p -69.46 113.31 6.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.937 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.82 HD23 ' CE ' ' A' ' 78' ' ' LYS . 31.5 mt -75.87 -26.23 56.89 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.891 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 mt -46.12 -42.47 13.81 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.464 -179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.85 43.8 2.72 Favored Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.444 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.82 ' CE ' HD23 ' A' ' 75' ' ' LEU . 18.6 mtmm -150.54 144.96 25.65 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.078 0.466 . . . . 0.0 111.419 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.23 -169.78 1.75 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.286 178.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.455 ' O ' ' HE2' ' A' ' 84' ' ' MET . 3.3 p30 -61.47 -47.09 87.25 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 120.781 -0.368 . . . . 0.0 110.643 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.2 -37.95 78.37 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -72.17 -40.81 67.7 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.865 -0.334 . . . . 0.0 111.003 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.13 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.87 -33.04 71.71 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.104 0.478 . . . . 0.0 110.015 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.455 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -74.99 -34.51 61.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.614 179.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -76.6 -37.21 56.82 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.486 ' CB ' ' HE3' ' A' ' 78' ' ' LYS . 1.2 m -62.62 -38.02 88.57 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.131 178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.885 HD11 HD13 ' A' ' 67' ' ' LEU . 33.9 mt -68.0 -55.83 11.22 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 66.9 mtt-85 -53.92 -31.98 52.0 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.343 177.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.81 -49.27 54.34 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.344 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.586 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 10.4 m -63.07 -30.6 71.73 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.756 178.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.736 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -83.11 -15.45 50.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.583 179.241 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 93' ' ' THR . 28.3 t -89.65 -50.26 6.17 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 112.508 0.559 . . . . 0.0 112.508 -178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.576 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -178.64 68.78 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.497 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.2 mt-10 -169.02 -59.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.366 0.603 . . . . 0.0 109.661 178.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.586 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -68.07 -26.2 74.13 Favored Glycine 0 N--CA 1.443 -0.884 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 177.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.976 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.4 t30 -98.71 -91.92 0.27 Allowed 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.356 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.467 ' CD ' ' HA ' ' A' ' 94' ' ' GLU . 8.0 mtpt 64.12 -11.48 0.12 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.518 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -138.53 -30.33 0.77 Allowed 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 112.552 0.575 . . . . 0.0 112.552 -179.731 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 136.05 15.95 0.88 Allowed Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.439 -0.886 . . . . 0.0 112.974 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.515 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -165.45 151.13 9.38 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.776 0.322 . . . . 0.0 111.289 179.501 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.625 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.0 OUTLIER -141.06 149.37 20.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.082 -179.84 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 tt0 -95.97 141.41 29.41 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.288 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.478 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.4 mt -140.25 125.46 18.71 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.931 0.396 . . . . 0.0 111.294 -179.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.726 HD11 HG23 ' A' ' 13' ' ' THR . 38.9 mm -98.58 142.22 15.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.484 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.587 HG12 ' HA ' ' A' ' 67' ' ' LEU . 11.7 m -141.37 176.79 4.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.53 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.09 138.12 26.44 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.8 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.501 ' CD ' HD11 ' A' ' 12' ' ' LEU . 8.2 ptp180 -131.27 153.81 49.15 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.059 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 1.7 mpp_? -87.99 122.68 31.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.074 -179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' N ' ' HB ' ' A' ' 8' ' ' THR . 2.0 mp -63.88 151.68 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.668 179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.989 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.356 0 N-CA-C 112.105 -0.398 . . . . 0.0 112.105 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.425 ' HA ' HG12 ' A' ' 109' ' ' ILE . 67.3 p -67.83 66.21 0.09 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.918 0.39 . . . . 0.0 111.205 -179.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 171.07 112.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.725 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -128.32 126.2 40.3 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.984 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -81.24 151.1 28.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.626 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' CB ' ' CZ ' ' A' ' 14' ' ' PHE . 8.0 mt -140.86 139.41 34.43 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.935 0.398 . . . . 0.0 111.332 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.792 HG23 HD11 ' A' ' 104' ' ' ILE . 10.7 m -116.02 137.0 52.51 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.517 179.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.445 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 8.1 m-85 -139.99 146.07 38.63 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.152 0.501 . . . . 0.0 111.832 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.4 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 22.4 mp0 -105.53 107.33 18.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.656 178.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.829 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.06 105.68 43.64 Favored Pre-proline 0 C--N 1.328 -0.328 0 N-CA-C 111.864 0.32 . . . . 0.0 111.864 -178.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.837 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 4.7 Cg_exo -77.09 97.99 1.19 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.849 2.366 . . . . 0.0 112.56 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.93 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -90.4 24.03 2.74 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 121.069 0.461 . . . . 0.0 111.141 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.85 -30.69 0.05 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.783 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -140.76 27.24 2.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.908 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.3 t -113.93 -17.47 11.99 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.251 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -46.13 -40.75 10.49 Favored Glycine 0 C--N 1.335 0.512 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.86 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.6 t -56.71 -31.47 64.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.989 0.423 . . . . 0.0 110.669 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.36 -25.33 15.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.998 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.82 36.78 3.13 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.308 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.648 HD22 ' SD ' ' A' ' 91' ' ' MET . 27.3 tp 86.1 -31.02 0.05 Allowed 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 122.985 0.514 . . . . 0.0 112.035 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.801 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 93.4 57.26 1.37 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.363 -0.923 . . . . 0.0 112.429 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.866 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.57 150.69 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 111.25 179.451 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 62.0 m -131.63 134.07 45.61 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.271 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.927 HG11 HD11 ' A' ' 67' ' ' LEU . 4.6 m -123.66 156.81 30.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.272 -179.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.507 ' CG ' ' HB2' ' A' ' 47' ' ' LYS . 3.6 mmpt? -129.35 140.4 51.39 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.809 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -103.02 148.41 17.24 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.446 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.23 -175.6 4.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.098 0.475 . . . . 0.0 111.204 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.63 166.07 22.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.537 179.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 11.9 t -56.61 127.61 32.22 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.928 0.394 . . . . 0.0 110.795 179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 16.6 mmtm -64.22 -15.78 60.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.321 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -95.42 -13.12 24.9 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.562 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -175.55 158.73 2.27 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.799 0.333 . . . . 0.0 111.111 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -63.68 81.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.866 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -137.16 100.18 4.19 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.834 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.5 m-20 -53.19 121.86 8.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.146 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.1 mt -92.22 -39.81 11.33 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.987 -179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.462 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 151.51 -166.16 30.64 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.471 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.044 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.1 OUTLIER -103.26 156.62 5.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 120.677 0.275 . . . . 0.0 110.771 179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -131.17 137.57 49.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.283 -179.592 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.689 ' HA ' HG12 ' A' ' 30' ' ' VAL . 46.3 t -60.41 103.79 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.507 ' HB2' ' CG ' ' A' ' 31' ' ' LYS . 14.6 tppt? -91.24 -21.46 21.09 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.886 -177.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -170.86 159.22 6.19 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.135 0.493 . . . . 0.0 111.747 179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.866 HG23 HG13 ' A' ' 28' ' ' VAL . 9.6 mt -133.55 151.53 33.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.411 179.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.801 HD13 ' C ' ' A' ' 27' ' ' GLY . 3.0 mp -104.72 110.4 30.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.394 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.496 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.8 OUTLIER -73.19 64.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.653 -179.876 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -159.28 -29.03 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.911 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -114.22 -166.55 15.76 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.966 -179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.837 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.86 -51.98 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.87 0.693 . . . . 0.0 112.87 -179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.39 -31.77 23.7 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.806 0.336 . . . . 0.0 111.565 -179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.496 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 29.3 p -79.67 -58.19 3.31 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.175 0.512 . . . . 0.0 110.762 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.45 -24.15 65.0 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.533 -0.758 . . . . 0.0 111.262 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.591 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.64 -50.21 73.92 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.789 0.328 . . . . 0.0 111.124 -179.872 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.4 20.0 58.28 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.337 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.445 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 15.7 mtm180 -119.75 -20.46 7.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.854 0.359 . . . . 0.0 110.938 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.53 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.9 mm? -68.4 164.46 20.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.689 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.7 tpp180 -145.45 133.21 21.1 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.102 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.495 ' O ' ' CB ' ' A' ' 64' ' ' ASN . 5.7 t -73.48 132.31 33.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.952 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 33.8 m-20 90.64 -13.68 0.26 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.238 -179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -59.63 145.38 44.85 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-O 120.744 0.307 . . . . 0.0 110.444 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.89 129.31 36.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.86 0.362 . . . . 0.0 111.312 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.927 HD11 HG11 ' A' ' 30' ' ' VAL . 49.5 mt -77.66 142.75 38.66 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.425 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.523 HD13 ' O ' ' A' ' 67' ' ' LEU . 26.4 mm -130.05 -40.83 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.614 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -148.9 169.52 20.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.02 0.438 . . . . 0.0 111.816 -179.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.585 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -158.27 107.26 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.826 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.557 ' ND2' HG22 ' A' ' 70' ' ' VAL . 59.5 m-80 59.96 34.26 21.54 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.727 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.91 -13.76 65.15 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.642 -0.79 . . . . 0.0 112.353 -179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -81.85 100.84 9.82 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.893 0.378 . . . . 0.0 110.737 179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 92.4 p -59.17 142.79 50.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.941 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 83' ' ' ALA . 11.4 mt -111.78 -18.15 12.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.254 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 13.7 mt -46.72 -52.75 13.24 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.767 0.318 . . . . 0.0 111.262 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.62 -30.37 76.26 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.304 179.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 26.1 mttp -76.42 134.14 39.68 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 121.095 0.474 . . . . 0.0 111.255 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.834 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -76.0 -169.86 1.23 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.923 179.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.509 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -56.38 -54.16 48.86 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.844 0.354 . . . . 0.0 111.223 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.24 -43.84 85.43 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.112 0.412 . . . . 0.0 112.112 -179.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -59.74 -53.39 58.52 Favored 'General case' 0 CA--C 1.515 -0.389 0 CA-C-O 121.007 0.432 . . . . 0.0 110.879 -179.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.044 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -58.3 -33.2 69.2 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.364 0.602 . . . . 0.0 109.479 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.509 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -66.16 -29.65 69.98 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.196 -0.911 . . . . 0.0 110.118 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.529 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -83.18 -35.14 25.73 Favored 'General case' 0 N--CA 1.455 -0.199 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.259 179.806 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.529 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -66.75 -36.65 82.95 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD13 HG21 ' A' ' 30' ' ' VAL . 11.1 mt -69.22 -54.71 13.4 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.436 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -56.48 -30.51 63.03 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 115.645 -0.707 . . . . 0.0 109.328 178.213 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.426 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 11.7 mtt-85 -68.94 -43.41 75.12 Favored 'General case' 0 CA--C 1.518 -0.283 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.804 178.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.787 ' HB3' HD12 ' A' ' 101' ' ' ILE . 3.2 m -67.51 -50.48 58.67 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.514 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.648 ' SD ' HD22 ' A' ' 26' ' ' LEU . 11.1 mmt -65.06 -19.71 66.12 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.631 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 4.3 m -83.44 -58.03 3.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.074 -179.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.595 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -174.73 71.18 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.571 -178.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.486 ' CG ' ' O ' ' A' ' 93' ' ' THR . 22.7 mt-10 -168.15 -47.11 0.02 OUTLIER 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.457 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -81.13 -32.38 32.07 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.021 -1.231 . . . . 0.0 110.021 178.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.93 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.4 t-20 -78.46 -93.63 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 32.52 33.24 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.594 0.591 . . . . 0.0 112.594 179.054 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.437 ' N ' ' O ' ' A' ' 96' ' ' ASN . 1.1 ptm180 -174.69 -34.54 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 120.838 0.352 . . . . 0.0 111.283 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.433 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.32 19.03 2.68 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.123 -0.561 . . . . 0.0 112.139 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.502 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -178.48 161.43 1.35 Allowed 'General case' 0 N--CA 1.453 -0.281 0 CA-C-O 120.586 0.231 . . . . 0.0 111.031 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.787 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.09 145.78 19.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.924 179.583 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 23.6 tt0 -90.31 139.59 30.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.565 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.429 HD12 HG21 ' A' ' 16' ' ' VAL . 2.4 mt -134.83 128.63 33.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.279 -179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.792 HD11 HG23 ' A' ' 13' ' ' THR . 40.7 mm -108.69 142.19 21.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.624 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.653 HG12 ' HA ' ' A' ' 67' ' ' LEU . 14.6 m -141.31 179.26 2.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.693 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -137.66 139.05 40.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.376 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -136.2 141.0 43.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.132 -179.564 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.419 ' HG3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -82.75 138.17 34.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.858 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' A' ' 8' ' ' THR . 28.1 mm -63.21 -68.57 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.987 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 92.7 p . . . . . 0 C--N 1.327 -0.402 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.937 179.976 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.469 0 N-CA-C 111.803 -0.519 . . . . 0.0 111.803 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.417 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 1.5 p -155.4 170.11 22.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.851 0.357 . . . . 0.0 110.678 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.3 mtt-85 62.47 124.48 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.084 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.411 ' OE2' HD21 ' A' ' 12' ' ' LEU . 9.9 pt-20 -156.63 135.53 11.81 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.098 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.493 ' O ' HD23 ' A' ' 12' ' ' LEU . 6.2 m-85 -88.68 141.69 28.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.665 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.493 HD23 ' O ' ' A' ' 11' ' ' PHE . 1.5 mt -144.05 150.81 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.029 0.442 . . . . 0.0 111.243 -179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.474 ' HA ' HD13 ' A' ' 104' ' ' ILE . 28.2 m -104.57 143.04 33.59 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.292 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.758 ' CE2' HG21 ' A' ' 105' ' ' VAL . 20.7 m-85 -130.06 106.66 8.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.931 0.396 . . . . 0.0 111.786 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.406 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 2.0 mp0 -87.48 101.35 13.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.462 178.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.856 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -101.42 114.87 65.64 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.903 -178.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.784 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.3 Cg_endo -83.18 96.36 0.81 Allowed 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 122.801 2.334 . . . . 0.0 112.85 179.825 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.801 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.33 23.8 2.08 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-O 121.124 0.488 . . . . 0.0 110.779 179.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -36.02 -33.02 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.386 -0.824 . . . . 0.0 112.062 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -146.04 25.11 1.29 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.051 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.6 m -108.38 -15.63 14.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.844 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.63 -29.3 32.13 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.663 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.2 t -52.88 -33.26 49.3 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.999 0.428 . . . . 0.0 110.63 179.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.98 -22.44 12.67 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.852 179.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.46 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 108.36 51.82 0.7 Allowed Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.914 -0.66 . . . . 0.0 111.955 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.765 HD22 ' SD ' ' A' ' 91' ' ' MET . 28.7 tp 77.86 -57.24 0.49 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 122.427 0.291 . . . . 0.0 111.528 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 119.76 60.73 0.26 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.559 -0.829 . . . . 0.0 112.397 -179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.781 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -176.83 161.77 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.937 0.399 . . . . 0.0 111.502 179.444 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.22 146.76 33.94 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 109.638 -0.505 . . . . 0.0 109.638 179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.976 HG12 ' HA ' ' A' ' 46' ' ' VAL . 26.8 m -137.54 166.15 25.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.174 0.511 . . . . 0.0 112.152 -179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.519 ' HG2' ' HD3' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -133.57 150.19 51.64 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.326 179.545 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -110.67 139.12 15.35 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.474 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' ND2' ' HE2' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -123.82 177.73 5.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.911 0.386 . . . . 0.0 111.088 -179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -126.57 166.08 17.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.838 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.747 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 23.5 t -60.31 -21.52 62.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.019 179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 79.1 -51.5 0.44 Allowed 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.153 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -67.74 -28.34 67.55 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.125 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -144.03 26.69 1.5 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.219 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.43 ' CG ' ' O ' ' A' ' 38' ' ' ASN . 39.7 p-80 44.06 39.79 3.02 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.322 179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.747 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -87.06 105.6 17.27 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.149 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.551 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 0.9 OUTLIER -53.92 101.56 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.955 179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mt -69.73 -44.17 70.86 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.078 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 153.85 -160.88 29.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.645 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.046 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.98 161.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.678 0.275 . . . . 0.0 111.0 -179.863 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.413 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -140.58 145.43 36.7 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.677 179.956 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.976 ' HA ' HG12 ' A' ' 30' ' ' VAL . 3.7 t -62.03 111.54 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 120.989 0.423 . . . . 0.0 110.859 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.519 ' HD3' ' HG2' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -83.37 -47.08 11.83 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.331 -179.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.516 ' O ' HG12 ' A' ' 28' ' ' VAL . 4.1 m -149.33 175.11 11.72 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.018 -179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.72 HG23 HG13 ' A' ' 28' ' ' VAL . 22.1 mt -142.49 158.05 19.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.298 -179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -109.45 97.02 5.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.459 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.495 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.68 74.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.099 0.475 . . . . 0.0 110.808 -179.872 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.16 -28.05 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.251 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -106.96 -165.61 22.3 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.695 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.856 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -47.8 -53.48 15.27 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 1.042 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.24 -31.84 22.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.747 0.308 . . . . 0.0 111.518 -178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.495 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 37.3 p -75.39 -59.48 2.73 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.12 0.486 . . . . 0.0 110.176 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.77 -24.29 61.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.875 179.721 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.551 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.2 OUTLIER -58.72 -50.12 75.07 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.865 179.888 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.91 49.31 73.49 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.801 179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.428 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.9 ptp180 -150.53 -48.55 0.13 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.877 0.37 . . . . 0.0 111.098 179.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.042 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.3 OUTLIER -60.55 102.87 0.2 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.911 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -94.14 136.93 33.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.757 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.516 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 1.1 m -60.66 87.18 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.048 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 63' ' ' VAL . 0.5 OUTLIER 153.59 -23.66 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 123.364 0.666 . . . . 0.0 110.694 179.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -53.97 137.51 39.17 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.825 0.345 . . . . 0.0 111.084 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -86.74 126.66 34.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.8 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.792 HD13 HD11 ' A' ' 87' ' ' LEU . 28.0 mt -79.56 137.4 37.14 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.485 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 29.7 mm -121.8 -35.0 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.811 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.424 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -159.43 164.74 34.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.014 0.435 . . . . 0.0 111.7 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.703 HG23 ' HG ' ' A' ' 103' ' ' LEU . 7.3 p -149.09 107.24 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.774 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.5 ' ND2' HG22 ' A' ' 70' ' ' VAL . 61.2 m-80 58.73 36.01 24.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.81 -179.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.5 -17.53 58.3 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.475 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -78.35 93.04 4.62 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.898 0.38 . . . . 0.0 110.811 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.8 t -55.51 145.52 22.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.987 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.712 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.5 mt -113.23 -20.55 11.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.307 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.405 HD23 ' HA ' ' A' ' 76' ' ' LEU . 11.8 mt -48.16 -49.38 32.65 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-O 120.806 0.336 . . . . 0.0 111.145 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.39 -29.66 71.66 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.147 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.415 ' CG ' ' HB3' ' A' ' 82' ' ' GLU . 16.8 mttp -76.88 136.08 38.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.999 0.428 . . . . 0.0 111.076 179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.551 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -75.86 -170.02 1.24 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.147 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.5 ' O ' ' HE2' ' A' ' 84' ' ' MET . 85.0 m-20 -57.21 -51.84 67.72 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.747 0.308 . . . . 0.0 111.074 179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -45.2 78.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.265 -0.425 . . . . 0.0 112.031 -179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.415 ' HB3' ' CG ' ' A' ' 78' ' ' LYS . 1.2 mt-10 -60.86 -53.51 56.42 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-O 121.027 0.441 . . . . 0.0 110.979 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.046 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.47 -33.76 74.31 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.896 -179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.5 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 4.7 mtm -68.51 -29.25 67.8 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.441 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.673 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 5.8 mm-40 -80.5 -38.13 30.37 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.707 178.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.554 HG22 HG11 ' A' ' 70' ' ' VAL . 2.7 m -57.59 -39.75 77.49 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.691 179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.792 HD11 HD13 ' A' ' 67' ' ' LEU . 10.3 mt -69.11 -55.68 9.99 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 178.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.0 mtt180 -57.63 -27.86 63.17 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.683 178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.673 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.0 mtt180 -72.96 -42.48 63.34 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.813 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.49 ' HA ' ' HG3' ' A' ' 94' ' ' GLU . 0.1 OUTLIER -66.34 -44.88 82.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.729 -0.669 . . . . 0.0 109.797 179.23 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.765 ' SD ' HD22 ' A' ' 26' ' ' LEU . 10.3 mmt -71.07 -19.78 62.44 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.268 178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 2.2 m -77.07 -54.57 6.37 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.063 -179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -176.73 80.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -179.047 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.49 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 174.75 -53.08 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 179.136 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . . . . . . . . . . . -62.82 -31.12 79.23 Favored Glycine 0 N--CA 1.446 -0.647 0 N-CA-C 110.504 -1.038 . . . . 0.0 110.504 178.075 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.801 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.3 t-20 -81.88 -100.03 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 109.871 -0.418 . . . . 0.0 109.871 179.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.0 mmmm 41.89 25.77 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -171.39 -34.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.806 0.336 . . . . 0.0 111.387 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.425 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.95 18.45 3.17 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.066 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 10.1 ptm -177.0 159.91 1.73 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-O 120.757 0.313 . . . . 0.0 111.198 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.728 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.27 144.93 20.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.671 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.401 ' CG ' ' CG2' ' A' ' 13' ' ' THR . 25.3 tt0 -95.21 143.42 26.64 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.767 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.703 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.6 mp -144.34 114.24 7.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.199 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.474 HD13 ' HA ' ' A' ' 13' ' ' THR . 39.8 mm -82.92 142.58 13.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.516 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.758 HG21 ' CE2' ' A' ' 14' ' ' PHE . 28.3 m -141.38 177.36 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.156 0.503 . . . . 0.0 111.806 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -145.14 134.09 22.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.455 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 3.5 ptp180 -135.73 152.06 50.77 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.924 0.392 . . . . 0.0 111.113 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.06 149.87 23.72 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.721 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.468 HG22 ' N ' ' A' ' 110' ' ' SER . 9.5 mt -102.95 159.78 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.286 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.468 ' N ' HG22 ' A' ' 109' ' ' ILE . 86.7 p . . . . . 0 C--N 1.331 -0.224 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.89 -180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.425 -0.27 . . . . 0.0 112.425 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.418 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 1.8 t -176.39 52.59 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.024 0.44 . . . . 0.0 110.872 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 179.37 101.94 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.602 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.515 ' HG2' HD11 ' A' ' 109' ' ' ILE . 9.0 pt-20 -116.79 142.8 46.45 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.021 0.438 . . . . 0.0 111.105 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.436 ' O ' HD23 ' A' ' 12' ' ' LEU . 4.6 m-85 -100.86 133.37 45.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.723 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.562 HD11 ' HD2' ' A' ' 107' ' ' ARG . 15.4 mt -126.43 158.14 36.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.003 0.43 . . . . 0.0 111.307 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.644 HG23 ' CD1' ' A' ' 104' ' ' ILE . 19.3 m -124.91 133.03 53.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.398 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 7.6 m-85 -135.38 146.36 48.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.032 0.444 . . . . 0.0 111.548 -179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -109.31 110.06 21.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.705 -0.68 . . . . 0.0 109.985 179.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.698 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -99.1 105.86 34.72 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.641 -179.005 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.811 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 90.6 Cg_endo -80.02 96.68 1.03 Allowed 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.821 2.347 . . . . 0.0 112.623 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.981 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.0 OUTLIER -87.5 25.67 1.4 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.2 0.524 . . . . 0.0 110.923 179.404 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -44.17 -26.95 0.35 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.33 18.01 2.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.608 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.0 p -111.44 -16.3 13.36 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.635 0.255 . . . . 0.0 111.151 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.63 -28.65 5.25 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.874 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -53.89 -31.9 51.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.074 0.464 . . . . 0.0 110.803 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.57 -22.74 12.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.822 -0.627 . . . . 0.0 111.014 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 135.47 -54.48 0.74 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.104 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.795 HD22 ' SD ' ' A' ' 91' ' ' MET . 41.9 tp -178.23 -34.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.586 0.232 . . . . 0.0 111.315 179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.56 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 117.56 41.9 0.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.449 -0.882 . . . . 0.0 112.328 -179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.587 ' HB ' HG23 ' A' ' 49' ' ' ILE . 1.5 p 173.07 157.23 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.238 0.542 . . . . 0.0 111.49 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.466 ' N ' ' CG2' ' A' ' 28' ' ' VAL . 1.0 OUTLIER -130.74 151.86 50.71 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.263 -0.88 . . . . 0.0 110.195 179.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.796 HG12 ' HA ' ' A' ' 46' ' ' VAL . 5.8 m -134.88 156.29 39.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 120.94 0.4 . . . . 0.0 111.681 -179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.4 140.4 51.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.62 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -96.36 136.01 12.59 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.691 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.549 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.2 OUTLIER -125.34 158.84 33.23 Favored 'General case' 0 N--CA 1.452 -0.331 0 CA-C-O 120.672 0.273 . . . . 0.0 110.283 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.434 ' HA ' ' HA ' ' A' ' 41' ' ' ASP . 1.6 ptt180 -119.95 157.47 28.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.907 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.791 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -52.08 142.49 16.07 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.12 -179.679 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 9.3 mmtm -72.77 -21.09 61.05 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.93 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.09 -29.5 18.29 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.998 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -152.81 162.77 40.85 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.055 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 38.3 m170 -70.37 65.53 0.29 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.799 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.791 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -112.16 92.78 4.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.065 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.445 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 66.9 m-20 -51.39 93.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.086 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 HD12 ' ND2' ' A' ' 33' ' ' ASN . 30.1 mt -51.63 -30.9 23.17 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.982 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.413 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 134.64 -168.34 23.59 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 121.027 -0.606 . . . . 0.0 111.815 -179.517 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.01 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -104.85 138.93 27.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.962 0.41 . . . . 0.0 110.832 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.478 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -121.22 142.09 50.24 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.583 -179.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.796 ' HA ' HG12 ' A' ' 30' ' ' VAL . 22.0 t -54.28 109.89 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.003 0.43 . . . . 0.0 110.799 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -39.16 20.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.429 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 28' ' ' VAL . 0.3 OUTLIER -171.44 135.64 0.94 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 120.971 -0.292 . . . . 0.0 111.035 -179.796 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.587 HG23 ' HB ' ' A' ' 28' ' ' VAL . 6.0 mt -105.98 152.19 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 121.189 0.518 . . . . 0.0 111.361 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.506 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.6 mp -103.93 101.98 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.459 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -65.44 75.89 0.06 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.813 0.34 . . . . 0.0 110.856 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.51 -27.08 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.88 179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -115.23 -168.64 15.64 Favored Glycine 0 C--N 1.332 0.325 0 C-N-CA 120.617 -0.802 . . . . 0.0 113.079 -179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.811 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.65 -56.19 2.18 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.56 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -50.95 -31.66 18.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.8 0.333 . . . . 0.0 111.263 -179.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.8 t -77.44 -58.21 3.4 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.491 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.51 -23.94 59.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.743 179.716 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.39 -50.3 65.41 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.006 0.431 . . . . 0.0 110.6 179.847 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.64 14.43 54.78 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.934 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.465 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 7.4 mtm180 -117.44 -12.99 10.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.73 0.3 . . . . 0.0 110.956 179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.471 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -85.85 149.26 25.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.988 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.75 137.99 42.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.712 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.459 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 13.3 t -68.3 69.53 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.963 0.411 . . . . 0.0 111.037 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.94 -22.2 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.293 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.426 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 0.5 OUTLIER -54.57 142.96 25.94 Favored 'General case' 0 C--O 1.231 0.124 0 CA-C-O 120.729 0.3 . . . . 0.0 111.135 -179.667 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -97.0 112.42 24.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.009 -0.542 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.671 HD13 HD11 ' A' ' 87' ' ' LEU . 77.9 mt -61.72 135.72 57.72 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.387 179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.954 HD11 ' HB2' ' A' ' 106' ' ' ALA . 22.5 mt -124.63 -33.8 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.564 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -153.66 172.34 17.4 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.142 0.496 . . . . 0.0 111.848 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.599 HG22 ' ND2' ' A' ' 71' ' ' ASN . 7.7 p -158.19 105.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.692 179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.599 ' ND2' HG22 ' A' ' 70' ' ' VAL . 47.8 m-80 59.86 36.39 21.92 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.784 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.99 -16.83 59.52 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.618 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.449 ' HB3' HG13 ' A' ' 70' ' ' VAL . 16.5 tp10 -78.04 98.44 5.74 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.834 0.35 . . . . 0.0 110.771 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.1 t -62.76 122.64 16.4 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.995 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.772 HD22 ' HA ' ' A' ' 83' ' ' ALA . 15.0 mt -87.97 -14.92 37.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.373 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 6.3 mt -46.04 -61.75 1.62 Allowed 'General case' 0 N--CA 1.462 0.133 0 CA-C-O 120.776 0.322 . . . . 0.0 111.431 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -60.45 -26.78 64.79 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.617 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.7 mttp -78.7 132.33 36.95 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.093 0.473 . . . . 0.0 111.348 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.445 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -77.26 -171.99 2.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.185 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.457 ' O ' ' HE2' ' A' ' 84' ' ' MET . 4.6 m120 -51.46 -59.03 4.69 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.789 0.328 . . . . 0.0 111.036 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.407 ' HA ' ' HE3' ' A' ' 84' ' ' MET . 0.0 OUTLIER -62.02 -45.18 94.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.949 -179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 13.9 mt-10 -60.19 -53.42 57.87 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.994 0.426 . . . . 0.0 111.166 -179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.01 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -61.3 -33.8 74.16 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.085 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.457 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 6.0 mtm -70.9 -23.43 62.28 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.813 178.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.535 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 2.6 mm-40 -83.13 -45.56 13.8 Favored 'General case' 0 CA--C 1.514 -0.412 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.023 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.559 ' CG2' HD21 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -59.31 -36.51 75.76 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 179.359 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.671 HD11 HD13 ' A' ' 67' ' ' LEU . 18.9 mt -69.69 -54.79 12.18 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 13.2 mtt-85 -57.72 -30.57 65.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.492 -0.777 . . . . 0.0 109.73 178.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mtt85 -72.95 -39.61 66.06 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.119 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.525 ' HB3' HD12 ' A' ' 101' ' ' ILE . 15.8 m -69.72 -44.48 70.24 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.304 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.795 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -66.9 -25.2 66.27 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.048 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.421 ' O ' ' HB ' ' A' ' 93' ' ' THR . 1.4 m -73.41 -58.16 3.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.81 -0.632 . . . . 0.0 112.12 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.577 HG23 ' O ' ' A' ' 93' ' ' THR . 10.2 t -179.24 64.94 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 112.141 0.423 . . . . 0.0 112.141 -178.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -158.44 -51.27 0.06 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.498 0.666 . . . . 0.0 109.426 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.464 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -83.18 -28.71 36.0 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 178.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.981 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.0 t30 -92.22 -84.5 0.27 Allowed 'General case' 0 N--CA 1.449 -0.519 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.341 179.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 96' ' ' ASN . 12.0 pttt 38.9 26.97 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 111.652 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.496 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.51 -31.62 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.881 -179.517 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.453 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 126.11 19.15 2.22 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.345 -179.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.9 ptm -175.73 154.51 1.57 Allowed 'General case' 0 N--CA 1.454 -0.23 0 CA-C-O 120.765 0.317 . . . . 0.0 111.323 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.562 HD13 ' CE ' ' A' ' 91' ' ' MET . 0.1 OUTLIER -146.13 149.36 16.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.079 -179.843 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -95.95 137.75 34.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.564 179.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.763 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.2 mt -136.01 129.28 31.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.926 0.394 . . . . 0.0 111.294 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.644 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.1 mm -100.22 142.69 15.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.799 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 67' ' ' LEU . 16.4 m -140.43 179.38 2.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.471 -179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -135.11 141.89 46.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.942 179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.562 ' HD2' HD11 ' A' ' 12' ' ' LEU . 41.0 mtt180 -124.82 135.76 53.22 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.988 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.85 128.38 36.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.897 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.515 HD11 ' HG2' ' A' ' 10' ' ' GLU . 5.6 mm -91.83 163.45 2.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.02 -179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.422 ' H ' HG22 ' A' ' 109' ' ' ILE . 70.2 m . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.811 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.432 ' O ' HG23 ' A' ' 8' ' ' THR . . . . . . . . 0 N--CA 1.452 -0.272 0 N-CA-C 112.438 -0.265 . . . . 0.0 112.438 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.436 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 37.5 p -157.9 45.98 0.35 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.856 0.36 . . . . 0.0 111.006 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.1 mtt180 -172.78 107.91 0.18 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.798 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -120.6 134.03 55.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.1 m-85 -76.66 144.22 39.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.863 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.8 mt -135.12 112.35 10.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.96 0.41 . . . . 0.0 111.147 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.709 HG23 ' CD1' ' A' ' 104' ' ' ILE . 35.9 m -89.31 129.59 35.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.557 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.431 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 24.7 m-85 -128.83 153.61 47.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.124 0.487 . . . . 0.0 111.57 -179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -121.1 106.68 11.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.928 179.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.812 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.7 OUTLIER -99.85 110.51 59.4 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.885 -178.834 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.813 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.4 Cg_endo -80.87 95.18 0.97 Allowed 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.883 2.389 . . . . 0.0 112.9 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.82 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -85.35 24.08 1.21 Allowed 'General case' 0 N--CA 1.461 0.119 0 CA-C-O 121.198 0.523 . . . . 0.0 111.079 179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.67 -28.66 0.05 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.145 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -147.33 20.73 1.21 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 82.9 p -112.55 -10.56 13.69 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.572 0.225 . . . . 0.0 111.056 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.33 -29.15 45.48 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.787 -0.721 . . . . 0.0 112.732 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.63 -30.7 32.96 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.976 0.417 . . . . 0.0 110.776 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -106.51 -21.09 13.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.062 179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 107.5 55.33 0.63 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.249 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.52 HD11 ' HB ' ' A' ' 16' ' ' VAL . 11.9 tp 77.96 -55.53 0.5 Allowed 'General case' 0 C--N 1.332 -0.174 0 C-N-CA 122.258 0.223 . . . . 0.0 111.438 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.864 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 114.33 58.77 0.38 Allowed Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.525 -0.845 . . . . 0.0 112.393 -179.745 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.839 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -175.02 154.86 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.007 0.432 . . . . 0.0 111.4 179.557 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -130.63 144.84 51.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.062 179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.003 HG11 HD11 ' A' ' 67' ' ' LEU . 4.9 m -137.84 139.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.987 0.422 . . . . 0.0 111.682 -179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.414 ' HD2' ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -113.99 151.95 31.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.51 179.62 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -104.27 146.21 16.21 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.613 -179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.449 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 1.5 m-80 -132.26 146.61 52.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.955 0.407 . . . . 0.0 110.906 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -100.49 165.46 11.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.799 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.896 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.2 OUTLIER -56.36 127.81 32.8 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.006 179.961 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.95 -19.04 60.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.111 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -94.76 -21.46 18.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.329 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.39 158.1 15.73 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.83 0.348 . . . . 0.0 111.089 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -64.24 78.42 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.896 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -131.8 103.14 6.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.136 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 -55.67 109.15 0.52 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.019 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 3.3 mt -79.19 -38.54 35.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.953 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.556 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 156.98 -164.78 32.93 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.48 145.99 21.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 120.968 0.413 . . . . 0.0 110.971 -179.956 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.449 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.5 144.75 49.93 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.533 -179.947 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.709 ' HA ' HG12 ' A' ' 30' ' ' VAL . 36.7 t -56.59 104.74 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.916 0.388 . . . . 0.0 110.58 179.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -77.61 -40.15 42.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.956 -179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.57 173.01 16.15 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.891 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.839 HG23 HG13 ' A' ' 28' ' ' VAL . 16.0 mt -138.58 157.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.406 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.864 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -104.64 93.33 2.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.202 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.538 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.99 73.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.037 0.446 . . . . 0.0 110.922 -179.899 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.75 -28.09 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.315 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.85 -166.8 20.75 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.532 -0.842 . . . . 0.0 112.802 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.813 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.93 -54.58 8.01 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.899 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.38 -31.02 20.93 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.838 0.351 . . . . 0.0 111.298 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.538 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 37.3 t -76.25 -60.69 2.23 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.21 0.529 . . . . 0.0 110.329 179.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.476 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.71 -24.17 60.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.004 179.812 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.646 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.5 m-20 -57.12 -50.17 73.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.09 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.52 42.66 97.38 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.441 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -139.1 -61.25 0.56 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.088 0.471 . . . . 0.0 110.662 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.899 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -45.69 94.03 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.221 179.73 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.76 140.53 38.26 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.766 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.441 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 17.8 t -68.33 69.37 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.264 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.03 -24.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.393 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 76.6 m-20 -56.08 141.79 38.91 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.777 0.322 . . . . 0.0 111.15 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -94.59 113.68 25.54 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.974 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.003 HD11 HG11 ' A' ' 30' ' ' VAL . 13.6 mt -59.16 126.89 29.54 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.877 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.803 HG23 ' CD1' ' A' ' 76' ' ' LEU . 23.9 mm -107.11 -31.96 2.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.376 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.464 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -160.86 170.94 19.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.963 0.411 . . . . 0.0 111.522 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.589 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.2 p -158.14 112.81 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.933 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.589 ' ND2' HG22 ' A' ' 70' ' ' VAL . 43.7 m-80 53.67 33.89 17.6 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.806 -179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 96.9 -17.66 58.88 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.386 -179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.545 ' HG2' HG23 ' A' ' 86' ' ' THR . 1.0 OUTLIER -74.26 92.97 2.3 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.897 0.38 . . . . 0.0 110.638 179.778 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.3 t -62.3 109.57 1.37 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.902 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.662 HD23 ' CE ' ' A' ' 78' ' ' LYS . 22.8 mt -71.03 -23.01 62.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.79 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.803 ' CD1' HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -55.34 122.36 10.98 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.349 -0.387 . . . . 0.0 110.532 179.859 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 102.78 -31.29 8.9 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.832 -179.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.662 ' CE ' HD23 ' A' ' 75' ' ' LEU . 10.2 mtmm -73.03 137.44 45.36 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-O 121.082 0.468 . . . . 0.0 110.725 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -71.13 173.33 7.77 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.595 179.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 84' ' ' MET . 4.5 p30 -49.81 -46.13 50.74 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.874 0.368 . . . . 0.0 110.754 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -70.08 -36.16 74.71 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -179.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 18.5 mt-10 -72.05 -42.51 66.2 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-O 120.831 0.348 . . . . 0.0 111.161 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.96 -32.88 71.35 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.221 0.534 . . . . 0.0 109.953 179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.8 mtm -73.65 -32.97 64.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.613 -0.721 . . . . 0.0 110.472 179.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 5.9 pt-20 -75.48 -38.73 59.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 109.043 -0.725 . . . . 0.0 109.043 179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.545 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.2 m -59.85 -38.69 82.8 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.114 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.89 HD11 HD13 ' A' ' 67' ' ' LEU . 70.1 mt -65.51 -55.95 15.01 Favored 'General case' 0 CA--C 1.517 -0.318 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.411 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 8.8 ptt85 -55.17 -28.41 52.75 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 177.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -68.51 -54.17 18.51 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.116 178.526 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.755 ' HB3' HD12 ' A' ' 101' ' ' ILE . 74.0 m -62.41 -30.36 71.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.773 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.671 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -85.88 -10.75 54.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.101 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.464 ' O ' ' HB ' ' A' ' 93' ' ' THR . 5.2 m -96.46 -42.59 8.02 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 -178.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.657 HG23 ' O ' ' A' ' 93' ' ' THR . 9.5 t -179.95 79.59 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.972 0.415 . . . . 0.0 111.937 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.427 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.53 -49.09 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 179.589 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.412 ' O ' ' HB ' ' A' ' 101' ' ' ILE . . . -66.56 -32.53 81.86 Favored Glycine 0 N--CA 1.443 -0.861 0 N-CA-C 109.309 -1.516 . . . . 0.0 109.309 177.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.82 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.1 t-20 -86.3 -97.43 0.07 Allowed 'General case' 0 N--CA 1.451 -0.418 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 66.85 -38.17 0.32 Allowed 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 179.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.466 ' H ' ' C ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -125.16 -36.19 2.55 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.77 0.319 . . . . 0.0 111.548 -179.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.46 ' N ' ' ND2' ' A' ' 96' ' ' ASN . . . 140.79 14.61 0.49 Allowed Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.898 -0.667 . . . . 0.0 112.971 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 8.1 ptm -162.34 151.54 15.53 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 120.808 0.337 . . . . 0.0 111.283 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.762 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -141.57 142.64 28.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.097 -179.554 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -85.26 139.65 31.46 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.777 HD23 HD22 ' A' ' 67' ' ' LEU . 0.1 OUTLIER -137.13 112.05 8.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.358 -179.722 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.709 ' CD1' HG23 ' A' ' 13' ' ' THR . 44.3 mm -89.84 142.81 12.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.462 179.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 67' ' ' LEU . 28.8 m -141.08 168.17 16.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.713 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.754 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -128.99 127.58 41.94 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.548 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -127.25 147.06 50.23 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.219 -179.652 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 -75.48 149.55 38.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.886 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.511 HG22 ' N ' ' A' ' 110' ' ' SER . 19.5 mm -81.84 159.31 3.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.511 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.298 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.864 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.341 0 N-CA-C 112.38 -0.288 . . . . 0.0 112.38 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.49 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -178.9 79.41 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.03 0.443 . . . . 0.0 110.976 179.756 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 177.85 109.99 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.558 179.754 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -137.62 128.4 27.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.105 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -87.45 142.05 28.16 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.689 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.0 mt -138.69 135.24 34.59 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.905 0.383 . . . . 0.0 111.329 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.453 HG23 ' CD1' ' A' ' 104' ' ' ILE . 23.1 m -100.31 141.03 33.7 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.169 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.535 ' HE2' HG21 ' A' ' 105' ' ' VAL . 24.1 m-85 -133.02 118.87 19.32 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.062 0.458 . . . . 0.0 112.018 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 14.0 mp0 -97.96 101.61 13.14 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.405 178.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.875 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.74 113.76 65.69 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.512 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.812 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.3 Cg_endo -83.41 97.08 0.79 Allowed 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.81 2.34 . . . . 0.0 112.088 179.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.818 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.7 pp -87.13 22.73 1.99 Allowed 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 121.394 0.616 . . . . 0.0 111.382 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.62 -27.9 0.12 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.333 -0.849 . . . . 0.0 112.57 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -147.14 21.46 1.22 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -179.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 92.0 p -112.15 -11.86 13.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.739 0.304 . . . . 0.0 110.9 179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.84 -28.87 32.61 Favored Glycine 0 C--N 1.334 0.429 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.615 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 p -51.9 -31.39 28.2 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.98 0.419 . . . . 0.0 110.634 179.719 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.44 -21.38 12.76 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.98 179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.441 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 107.92 50.55 0.78 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.923 -0.656 . . . . 0.0 112.058 -179.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.714 HD22 ' SD ' ' A' ' 91' ' ' MET . 23.9 tp 80.52 -50.96 0.33 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 122.577 0.351 . . . . 0.0 111.568 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.871 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 108.66 60.4 0.54 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.045 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -173.53 154.69 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.995 0.426 . . . . 0.0 111.4 179.585 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.2 t -130.84 146.55 52.31 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.083 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.978 HG11 HD11 ' A' ' 67' ' ' LEU . 1.7 m -136.01 142.73 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.962 0.41 . . . . 0.0 111.801 -179.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.98 141.8 48.06 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.611 179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -105.39 138.63 14.34 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.703 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 0.6 OUTLIER -122.49 151.33 41.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.935 0.398 . . . . 0.0 111.126 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 86.1 mtm-85 -102.01 166.28 10.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.627 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.717 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.0 t -51.29 147.51 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.914 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.1 mmtt -77.55 -17.53 57.81 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.239 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -99.85 -31.93 11.26 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.81 0.338 . . . . 0.0 111.175 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.652 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -139.89 -169.22 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.969 -179.936 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -95.95 39.33 1.14 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.91 0.386 . . . . 0.0 110.918 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.717 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.44 108.07 18.34 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.104 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.463 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 2.0 m-20 -56.95 113.19 1.57 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.8 mt -77.35 -69.26 0.54 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.947 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -178.06 -169.67 39.26 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.576 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.923 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -111.52 138.71 38.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.924 0.392 . . . . 0.0 110.983 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -120.95 140.55 51.71 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.475 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.609 ' HA ' HG12 ' A' ' 30' ' ' VAL . 42.0 t -53.77 110.96 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.031 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.51 -38.89 21.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.997 -179.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 2.8 m -161.94 169.52 21.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.212 -179.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 9.4 mt -137.06 153.63 29.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.871 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.9 mp -104.43 103.39 15.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.07 179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -66.88 70.85 0.08 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.766 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -169.26 -31.1 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.58 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -109.53 -169.99 20.34 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.47 -0.871 . . . . 0.0 112.886 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.875 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -54.01 2.79 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.013 0.745 . . . . 0.0 113.013 -179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.41 -30.81 20.53 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.85 0.357 . . . . 0.0 111.335 -179.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.591 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.4 t -79.68 -59.84 2.58 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.571 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.473 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.8 -24.41 61.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.102 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -54.63 -50.06 69.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.862 0.363 . . . . 0.0 110.827 179.917 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.13 16.18 61.83 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.745 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.44 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 10.0 mtm180 -118.98 -12.43 9.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.713 0.292 . . . . 0.0 111.173 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.561 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.3 mm? -77.31 148.0 35.91 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.749 0.309 . . . . 0.0 110.946 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 11.1 mmp_? -133.67 124.38 26.65 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.654 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.434 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.7 t -67.38 70.39 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.348 -179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.02 -25.71 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.325 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.418 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -61.58 142.36 57.16 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.779 0.323 . . . . 0.0 110.98 -179.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.547 ' CG ' ' HB3' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -91.17 136.42 33.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.737 179.848 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.978 HD11 HG11 ' A' ' 30' ' ' VAL . 14.3 mt -80.45 134.81 36.04 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.887 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.938 HD11 ' CB ' ' A' ' 106' ' ' ALA . 24.2 mt -115.11 -31.69 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.381 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -160.29 167.27 27.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.931 0.396 . . . . 0.0 111.697 -179.67 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.553 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.0 p -152.77 113.14 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.777 179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.436 ' ND2' HG22 ' A' ' 70' ' ' VAL . 71.7 m-20 55.4 28.9 12.2 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.797 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 101.04 -19.62 51.13 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.353 -179.57 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.7 92.84 1.58 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.019 0.438 . . . . 0.0 110.703 179.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.37 113.47 2.41 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.092 -179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.555 HD23 ' CE ' ' A' ' 78' ' ' LYS . 56.1 mt -77.89 -20.28 53.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.121 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.444 HD23 ' HA ' ' A' ' 76' ' ' LEU . 12.2 mt -44.38 -73.46 0.04 OUTLIER 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.676 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -51.14 -24.44 9.32 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.742 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.555 ' CE ' HD23 ' A' ' 75' ' ' LEU . 21.7 mtmm -81.18 153.92 26.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.255 0.55 . . . . 0.0 111.177 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.463 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -92.83 -169.71 2.25 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.641 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.503 ' O ' ' HE2' ' A' ' 84' ' ' MET . 14.5 m-20 -60.07 -45.95 91.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.832 0.348 . . . . 0.0 110.633 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.96 -41.62 74.25 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.44 ' C ' ' HD2' ' A' ' 78' ' ' LYS . 32.0 mt-10 -68.47 -42.76 78.27 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 120.8 0.333 . . . . 0.0 111.207 -178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.923 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.27 -32.57 71.85 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.025 0.44 . . . . 0.0 110.063 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.503 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.0 mtm -69.33 -31.12 69.36 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.521 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -79.53 -43.59 22.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.828 -0.623 . . . . 0.0 109.668 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.3 m -59.0 -36.87 75.65 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.7 HD13 HG21 ' A' ' 30' ' ' VAL . 40.4 mt -69.13 -54.56 14.34 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -55.65 -29.29 59.02 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.297 178.111 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.19 -47.61 49.39 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.096 179.053 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.409 ' HB3' HD12 ' A' ' 101' ' ' ILE . 1.4 m -61.32 -41.31 96.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.997 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.714 ' SD ' HD22 ' A' ' 26' ' ' LEU . 15.4 mmt -77.57 -15.98 58.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.216 178.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.8 t -82.69 -52.15 7.05 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.147 -179.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.556 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -176.79 63.55 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.452 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.1 mt-10 -166.6 -46.39 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.411 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -62.93 -30.17 76.48 Favored Glycine 0 N--CA 1.443 -0.842 0 N-CA-C 110.291 -1.124 . . . . 0.0 110.291 178.184 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.818 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.5 t-20 -89.14 -117.42 0.06 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 178.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.428 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 5.9 mmpt? 62.7 3.74 1.23 Allowed 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.191 -0.318 . . . . 0.0 111.486 179.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -150.65 -39.92 0.13 Allowed 'General case' 0 CA--C 1.529 0.138 0 CA-C-O 120.796 0.331 . . . . 0.0 110.953 179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.32 13.33 1.33 Allowed Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.51 -179.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.499 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.4 OUTLIER -177.35 163.77 2.06 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.638 0.256 . . . . 0.0 111.059 -179.928 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.783 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -143.7 142.14 25.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.841 179.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -86.09 144.84 27.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.849 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.638 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.4 mt -145.35 112.34 6.01 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.161 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.453 ' CD1' HG23 ' A' ' 13' ' ' THR . 40.5 mm -91.88 142.62 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.523 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.577 HG12 ' HA ' ' A' ' 67' ' ' LEU . 27.1 m -140.54 178.1 3.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.958 -0.564 . . . . 0.0 111.744 -179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.938 ' CB ' HD11 ' A' ' 68' ' ' ILE . . . -138.84 149.2 44.65 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.868 -0.605 . . . . 0.0 110.77 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -138.15 136.27 36.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.885 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.21 110.45 23.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.924 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 110' ' ' SER . 24.2 mm -55.32 162.21 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.318 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.574 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.839 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.3 0 N-CA-C 112.445 -0.262 . . . . 0.0 112.445 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.461 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 43.9 p -156.86 40.39 0.33 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.86 0.362 . . . . 0.0 111.143 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 177.22 114.38 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.654 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -124.7 122.03 36.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.855 0.359 . . . . 0.0 111.115 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -82.46 143.01 31.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.644 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.443 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 3.6 mt -139.59 142.95 37.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.028 0.442 . . . . 0.0 111.479 -179.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.766 HG23 HD11 ' A' ' 104' ' ' ILE . 12.7 m -113.84 139.14 49.4 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.201 179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.474 ' CG ' ' HB3' ' A' ' 60' ' ' ARG . 14.0 m-85 -139.18 145.48 39.38 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.158 0.504 . . . . 0.0 112.113 -179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 11.6 mp0 -105.71 106.35 16.81 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.617 -0.72 . . . . 0.0 109.542 178.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.763 ' CG1' HD11 ' A' ' 26' ' ' LEU . 22.1 t -101.04 107.11 48.43 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.721 -178.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.768 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 2.6 Cg_endo -81.28 96.34 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.039 2.493 . . . . 0.0 113.162 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.862 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.9 pp -87.11 25.77 1.29 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-O 121.188 0.518 . . . . 0.0 110.921 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.89 -27.78 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.296 -0.865 . . . . 0.0 112.256 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -146.39 18.24 1.35 Allowed 'General case' 0 C--N 1.331 -0.208 0 N-CA-C 111.756 0.28 . . . . 0.0 111.756 -179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.415 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 90.9 p -111.67 -12.51 13.88 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.632 0.253 . . . . 0.0 111.077 179.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.52 -26.0 14.7 Favored Glycine 0 C--N 1.332 0.342 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.481 179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.4 p -55.85 -46.52 78.19 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.973 0.416 . . . . 0.0 110.548 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -91.04 -29.98 17.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.654 179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.77 56.86 0.25 Allowed Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.747 179.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.785 HD12 ' HB3' ' A' ' 18' ' ' LEU . 17.7 tp 76.55 -55.9 0.57 Allowed 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 179.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.676 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 121.57 49.33 0.27 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.589 -0.815 . . . . 0.0 111.652 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.929 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.95 159.33 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.964 0.412 . . . . 0.0 110.939 179.74 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.5 m -136.66 147.17 46.7 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.022 -0.535 . . . . 0.0 110.333 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.892 HG12 ' HA ' ' A' ' 46' ' ' VAL . 21.1 m -139.94 147.13 24.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.887 0.375 . . . . 0.0 111.491 -179.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' CD ' ' C ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -118.6 153.87 33.55 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.631 179.588 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.4 142.42 15.52 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.605 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 45' ' ' PHE . 2.1 m-80 -142.5 149.22 38.87 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.953 0.406 . . . . 0.0 111.003 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.12 166.27 10.54 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.699 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.415 ' HA ' HD11 ' A' ' 42' ' ' LEU . 5.3 t -50.38 133.34 24.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.041 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -16.89 64.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.302 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -94.83 -34.18 12.56 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.763 0.316 . . . . 0.0 111.154 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -147.8 162.67 38.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -69.73 69.72 0.3 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.784 179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.404 ' HB3' ' HB3' ' A' ' 35' ' ' SER . . . -118.23 105.63 11.97 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.098 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 15.7 m-20 -55.28 102.52 0.07 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.415 HD11 ' HA ' ' A' ' 35' ' ' SER . 13.1 mt -74.34 -35.39 63.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.969 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.561 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 140.77 -159.4 26.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.608 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.091 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -114.38 144.15 22.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.961 0.41 . . . . 0.0 110.89 179.952 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.446 ' CE2' ' HB2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.66 146.37 49.15 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.552 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.892 ' HA ' HG12 ' A' ' 30' ' ' VAL . 20.8 t -57.98 111.98 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.986 0.422 . . . . 0.0 110.809 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.401 ' HE3' ' HG2' ' A' ' 31' ' ' LYS . 0.0 OUTLIER -86.68 -37.5 17.91 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.895 -179.581 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -166.64 163.05 16.78 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.964 0.412 . . . . 0.0 111.32 -179.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.929 HG23 HG13 ' A' ' 28' ' ' VAL . 7.6 mt -125.85 151.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.77 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -102.33 99.55 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.266 179.603 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.2 OUTLIER -66.65 72.6 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.761 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -171.95 -30.71 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.45 -179.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.58 -164.12 20.79 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.79 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.768 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.22 -56.62 4.63 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 113.485 0.92 . . . . 0.0 113.485 -179.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.923 ' O ' HD21 ' A' ' 61' ' ' LEU . . . -50.87 -31.26 16.8 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.927 0.394 . . . . 0.0 111.428 -178.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 32.6 t -76.98 -58.88 3.03 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.091 0.472 . . . . 0.0 110.559 179.381 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.445 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -62.6 -24.13 67.4 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.427 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.467 ' OD2' HG22 ' A' ' 16' ' ' VAL . 37.7 t0 -58.07 -45.29 87.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.077 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 60.41 28.93 68.07 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.237 -179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.474 ' HB3' ' CG ' ' A' ' 14' ' ' PHE . 9.8 mtm180 -120.76 -57.19 1.91 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.632 0.253 . . . . 0.0 110.993 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.923 HD21 ' O ' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -48.26 170.31 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.746 0.307 . . . . 0.0 110.817 179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 46' ' ' VAL . 0.0 OUTLIER -155.85 138.48 15.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.923 0.392 . . . . 0.0 111.288 179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.576 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 11.0 t -64.5 141.25 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.116 179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.576 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.9 m-80 77.96 -6.64 1.93 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.75 -179.547 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 62' ' ' ARG . 3.7 t0 -62.74 146.18 53.02 Favored 'General case' 0 N--CA 1.462 0.138 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.224 179.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -89.74 120.95 31.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.872 0.368 . . . . 0.0 111.391 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.818 HD11 HG11 ' A' ' 30' ' ' VAL . 78.9 mt -73.11 151.09 41.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.404 179.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.742 HD13 ' O ' ' A' ' 67' ' ' LEU . 22.2 mm -141.39 -42.28 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.562 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -147.66 168.11 22.87 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.092 0.472 . . . . 0.0 111.782 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.59 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.6 p -158.14 110.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.837 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.585 ' ND2' HG22 ' A' ' 70' ' ' VAL . 48.7 m-80 55.45 47.96 19.98 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.938 0.399 . . . . 0.0 110.653 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 72.34 9.13 72.33 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.419 -179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -103.61 98.08 8.01 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.923 0.392 . . . . 0.0 110.752 179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 88.1 p -57.6 142.6 44.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.05 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.59 HD22 ' HA ' ' A' ' 83' ' ' ALA . 10.2 mt -111.67 -17.97 12.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.251 179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 8.3 mt -45.48 -61.67 1.59 Allowed 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.323 -179.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -59.23 -29.09 65.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.27 179.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 23.3 mttp -75.52 133.32 41.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.06 0.457 . . . . 0.0 111.278 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.708 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -78.72 -169.56 1.79 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.125 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.576 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.7 p30 -55.5 -54.89 38.32 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.609 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.708 HE22 ' HB3' ' A' ' 79' ' ' ALA . 3.0 pm0 -68.26 -41.12 81.55 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 1.1 mm-40 -60.54 -53.34 58.68 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-O 121.027 0.441 . . . . 0.0 110.681 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.091 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -59.29 -33.32 70.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.705 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.576 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.6 mtm -66.53 -29.71 69.86 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.418 179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -83.03 -43.76 15.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.974 179.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 1.1 m -61.97 -35.21 77.79 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.615 HD11 HD13 ' A' ' 67' ' ' LEU . 41.7 mt -69.78 -52.55 24.24 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.379 -0.828 . . . . 0.0 108.953 178.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 12.5 ptt85 -59.88 -27.89 67.08 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.493 178.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -52.12 18.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.371 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.519 ' HB3' HD12 ' A' ' 101' ' ' ILE . 69.8 m -62.0 -30.79 71.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.853 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.65 ' SD ' HD22 ' A' ' 26' ' ' LEU . 0.5 OUTLIER -88.8 -15.46 34.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.5 m -90.78 -47.71 7.47 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -179.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.569 HG23 ' O ' ' A' ' 93' ' ' THR . 9.8 t -174.81 68.57 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -178.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.518 ' CG ' ' O ' ' A' ' 93' ' ' THR . 19.8 mt-10 -170.35 -50.75 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -76.29 -31.95 53.33 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 178.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.862 ' HB2' HD21 ' A' ' 18' ' ' LEU . 2.3 t-20 -78.12 -94.12 0.03 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 178.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.407 ' HD2' ' HD2' ' A' ' 98' ' ' ARG . 0.0 OUTLIER 31.73 33.49 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 179.183 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.448 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -174.94 -33.44 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.766 0.317 . . . . 0.0 111.588 179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.448 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 122.68 18.95 3.16 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 121.091 -0.576 . . . . 0.0 112.183 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.532 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.2 OUTLIER -178.25 160.93 1.39 Allowed 'General case' 0 N--CA 1.454 -0.236 0 CA-C-O 120.645 0.259 . . . . 0.0 111.006 -179.639 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.685 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -146.18 146.03 19.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.905 179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.444 ' OE1' HG22 ' A' ' 13' ' ' THR . 8.7 mm-40 -89.5 146.05 24.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.665 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.616 HD11 ' HE1' ' A' ' 91' ' ' MET . 2.8 mt -145.78 128.47 16.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.162 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.766 HD11 HG23 ' A' ' 13' ' ' THR . 40.5 mm -106.94 142.69 19.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.648 179.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.671 HG12 ' HA ' ' A' ' 67' ' ' LEU . 20.4 m -141.14 -178.89 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.644 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -135.95 147.44 48.06 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.806 -0.633 . . . . 0.0 110.494 179.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.69 122.07 32.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.216 -179.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.423 ' HD3' ' HB ' ' A' ' 8' ' ' THR . 0.0 OUTLIER -78.38 132.78 37.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.601 179.501 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.461 ' CG1' ' HA ' ' A' ' 8' ' ' THR . 4.7 mm -90.31 164.71 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.004 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 109' ' ' ILE . 5.2 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.984 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.46 0 N-CA-C 114.18 0.432 . . . . 0.0 114.18 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.58 ' OG1' HG12 ' A' ' 109' ' ' ILE . 0.1 OUTLIER -131.22 106.26 8.2 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 117.731 0.765 . . . . 0.0 111.507 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 108' ' ' ARG . 3.1 mtt180 -84.0 136.43 34.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.285 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.413 ' OE1' HD21 ' A' ' 12' ' ' LEU . 5.4 pt-20 -118.86 137.37 53.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.731 179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -84.62 134.04 34.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.789 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.413 HD21 ' OE1' ' A' ' 10' ' ' GLU . 1.3 mt -137.14 129.87 30.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.387 -0.369 . . . . 0.0 111.266 -179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.7 ' HA ' HD13 ' A' ' 104' ' ' ILE . 23.2 m -89.82 142.75 27.4 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.315 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.595 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.2 m-85 -132.99 112.55 11.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.942 0.401 . . . . 0.0 111.858 -179.449 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -89.51 102.21 14.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.623 178.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.878 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.3 OUTLIER -100.69 112.29 64.38 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.635 -178.763 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.771 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 91.5 Cg_endo -82.5 97.36 0.88 Allowed 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 122.742 2.295 . . . . 0.0 112.777 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.856 HD21 ' HB2' ' A' ' 96' ' ' ASN . 1.8 pp -88.09 24.03 1.94 Allowed 'General case' 0 N--CA 1.462 0.134 0 CA-C-O 121.196 0.522 . . . . 0.0 110.98 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -42.14 -27.92 0.16 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.297 -0.865 . . . . 0.0 112.047 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.8 m-20 -144.24 20.32 1.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.558 -179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -112.76 -12.92 13.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.638 0.256 . . . . 0.0 111.117 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -50.74 -28.17 15.23 Favored Glycine 0 C--N 1.333 0.389 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.768 -179.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 12.5 t -53.58 -30.53 42.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.94 0.4 . . . . 0.0 110.714 179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -108.65 -19.81 13.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.96 179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 131.17 -52.71 0.82 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.043 -179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD13 ' HB3' ' A' ' 18' ' ' LEU . 16.6 tp -178.72 -34.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.678 0.275 . . . . 0.0 111.045 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.659 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 110.89 45.74 0.87 Allowed Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.249 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.867 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -172.09 165.26 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.155 0.502 . . . . 0.0 111.478 179.58 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.4 m -143.48 135.65 26.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.789 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.854 HG12 ' HA ' ' A' ' 46' ' ' VAL . 16.6 m -128.99 150.17 34.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.008 0.432 . . . . 0.0 111.753 -179.293 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HG3' ' HB2' ' A' ' 47' ' ' LYS . 0.0 OUTLIER -118.37 164.09 15.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.306 179.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -111.06 146.04 17.62 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.576 -0.821 . . . . 0.0 112.708 -179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.443 ' HB2' ' CE1' ' A' ' 45' ' ' PHE . 4.3 m-80 -131.86 175.64 9.03 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.875 0.369 . . . . 0.0 111.001 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -132.71 166.34 22.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.819 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.592 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 47.7 t -55.02 -23.38 19.36 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.096 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 71.57 6.27 5.66 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.403 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -131.03 -41.79 1.12 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.782 0.325 . . . . 0.0 110.842 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.729 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 2.3 p30 -123.81 19.37 9.38 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.184 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER 54.84 39.61 31.54 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.891 0.377 . . . . 0.0 110.984 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.729 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -92.97 112.48 24.45 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.213 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.53 101.31 0.08 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.83 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 64.5 mt -64.39 -36.02 82.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.035 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.432 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.61 -154.86 21.95 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.568 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.898 HD11 ' CB ' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 162.14 8.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 120.855 0.36 . . . . 0.0 110.982 179.943 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.489 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -148.23 139.51 23.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.449 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.854 ' HA ' HG12 ' A' ' 30' ' ' VAL . 15.0 t -55.47 104.79 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.013 0.435 . . . . 0.0 110.901 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.456 ' HB2' ' HG3' ' A' ' 31' ' ' LYS . 7.5 tppt? -79.76 -41.0 27.5 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.939 -179.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.409 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.1 OUTLIER -160.5 170.53 20.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.867 HG23 HG13 ' A' ' 28' ' ' VAL . 8.2 mt -135.89 154.92 34.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.228 -179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.558 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.8 mp -108.54 96.81 4.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.451 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.559 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.82 76.11 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.119 -179.769 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.51 -27.92 0.03 OUTLIER Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.502 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 56' ' ' SER . . . -113.11 -169.61 17.42 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.576 -0.821 . . . . 0.0 113.042 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.878 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -40.88 -57.36 1.98 Allowed 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.316 0.858 . . . . 0.0 113.316 -179.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.87 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.3 -31.19 20.68 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.874 0.369 . . . . 0.0 111.341 -178.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.8 t -75.57 -58.99 2.95 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.187 0.518 . . . . 0.0 110.255 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.458 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -60.43 -24.0 64.85 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.061 179.674 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.593 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.47 -50.13 70.68 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.032 -179.982 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 62.95 46.04 94.39 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.782 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.425 ' HB2' ' CE1' ' A' ' 14' ' ' PHE . 5.4 ptp180 -148.4 -45.94 0.15 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.756 0.312 . . . . 0.0 111.143 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.87 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -58.49 107.73 0.54 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.761 179.854 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.4 mmp_? -90.04 140.19 29.89 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.392 . . . . 0.0 110.909 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.9 t -68.37 69.87 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.337 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.96 -21.61 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.724 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.85 144.57 48.3 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.904 0.383 . . . . 0.0 111.023 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -95.31 128.31 42.05 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.913 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.835 HD13 HD11 ' A' ' 87' ' ' LEU . 59.3 mt -70.66 146.45 49.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.001 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.946 ' CD1' ' HB2' ' A' ' 106' ' ' ALA . 48.7 mt -132.33 -42.01 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.382 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.568 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -144.16 165.11 28.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.101 0.477 . . . . 0.0 111.469 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.61 ' O ' HG13 ' A' ' 70' ' ' VAL . 8.1 p -155.45 104.94 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.845 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.509 ' ND2' HG22 ' A' ' 70' ' ' VAL . 58.4 m-20 60.54 33.38 20.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.804 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.7 -16.65 60.3 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.662 -179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -81.36 102.72 10.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.899 0.38 . . . . 0.0 110.773 -179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 9.4 t -60.28 145.22 48.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 -179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.57 HD22 ' CB ' ' A' ' 83' ' ' ALA . 11.5 mt -115.78 -13.26 11.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.412 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.894 HD23 HG23 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -50.61 -53.73 28.43 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.747 0.308 . . . . 0.0 110.848 -179.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -66.58 -24.83 72.66 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.55 -0.833 . . . . 0.0 111.889 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.496 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER -72.92 142.51 47.85 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.076 0.465 . . . . 0.0 111.02 179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.94 -169.99 2.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.233 178.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.487 ' O ' ' HE2' ' A' ' 84' ' ' MET . 18.9 m-80 -60.89 -48.83 80.03 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 120.823 0.344 . . . . 0.0 110.521 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.63 -45.47 68.43 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.496 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 0.5 OUTLIER -64.85 -42.8 94.61 Favored 'General case' 0 C--N 1.332 -0.185 0 O-C-N 122.289 -0.257 . . . . 0.0 111.397 -178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 44' ' ' ILE . . . -68.7 -33.48 74.03 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.074 0.464 . . . . 0.0 109.928 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.487 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 2.7 mtm -67.41 -29.72 69.29 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.126 179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 88' ' ' ARG . 1.2 pt-20 -83.18 -36.09 24.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.107 179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.462 HG22 HG11 ' A' ' 70' ' ' VAL . 1.3 m -63.31 -36.09 82.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 178.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.835 HD11 HD13 ' A' ' 67' ' ' LEU . 76.8 mt -69.13 -55.63 10.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 85' ' ' GLU . 5.8 ptp180 -56.69 -29.39 62.33 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.428 178.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.04 -53.97 17.64 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.275 178.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.68 ' HB3' HD12 ' A' ' 101' ' ' ILE . 39.4 m -62.31 -30.25 71.02 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.376 -0.829 . . . . 0.0 109.748 178.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.717 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -84.12 -13.29 53.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.12 179.75 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 35.1 t -91.94 -48.15 6.92 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.549 HG23 ' O ' ' A' ' 93' ' ' THR . 9.2 t -176.03 63.81 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.0 mt-10 -166.28 -51.28 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.288 0.566 . . . . 0.0 109.515 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.406 ' HA2' ' ND2' ' A' ' 71' ' ' ASN . . . -65.71 -31.51 80.11 Favored Glycine 0 N--CA 1.443 -0.857 0 N-CA-C 110.253 -1.139 . . . . 0.0 110.253 178.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.856 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -85.5 -106.2 0.05 Allowed 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.663 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 23.7 mmmt 49.72 13.46 0.09 Allowed 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 179.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.663 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.3 OUTLIER -155.05 -44.29 0.08 Allowed 'General case' 0 C--O 1.232 0.181 0 CA-C-O 121.181 0.515 . . . . 0.0 110.445 -179.741 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 134.74 16.98 0.96 Allowed Glycine 0 CA--C 1.52 0.392 0 CA-C-N 115.424 -0.807 . . . . 0.0 112.168 -179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.49 ' CB ' ' HA ' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -177.42 160.59 1.66 Allowed 'General case' 0 N--CA 1.454 -0.26 0 CA-C-O 120.733 0.301 . . . . 0.0 110.898 -179.671 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.705 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -144.91 139.3 22.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 120.822 0.344 . . . . 0.0 110.86 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -87.47 143.83 27.03 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.706 -179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.493 HD23 ' HB ' ' A' ' 70' ' ' VAL . 2.6 mt -145.31 116.93 8.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.126 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.7 HD13 ' HA ' ' A' ' 13' ' ' THR . 44.8 mm -88.29 142.93 12.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.573 179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.595 HG21 ' CE2' ' A' ' 14' ' ' PHE . 29.2 m -134.63 175.79 10.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.7 -179.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.946 ' HB2' ' CD1' ' A' ' 68' ' ' ILE . . . -135.73 132.26 36.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.734 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -136.0 122.66 20.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.025 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.49 ' HA ' ' HA ' ' A' ' 9' ' ' ARG . 3.4 tpp180 -68.03 155.61 39.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.994 0.426 . . . . 0.0 111.164 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.644 HG22 ' N ' ' A' ' 110' ' ' SER . 1.2 mm -104.51 -94.32 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.385 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.644 ' N ' HG22 ' A' ' 109' ' ' ILE . 24.0 m . . . . . 0 C--N 1.333 -0.133 0 CA-C-O 120.744 0.307 . . . . 0.0 110.933 -179.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.312 0 N-CA-C 112.333 -0.307 . . . . 0.0 112.333 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.445 ' HA ' HG13 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -65.19 79.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.885 0.374 . . . . 0.0 111.154 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 177.33 120.1 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.522 179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -143.04 141.2 31.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.864 0.364 . . . . 0.0 111.044 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.555 ' HE2' HG21 ' A' ' 68' ' ' ILE . 52.1 m-85 -89.51 136.15 33.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.891 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -138.41 150.49 46.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.986 -179.867 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.451 ' HA ' HD13 ' A' ' 104' ' ' ILE . 86.9 m -101.72 133.1 46.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.311 179.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.465 ' CE1' HG21 ' A' ' 105' ' ' VAL . 3.9 m-85 -115.45 113.08 23.23 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 111.954 -179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 31.6 mp0 -97.4 100.98 12.42 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.635 178.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.912 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -107.66 116.54 57.39 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.828 -178.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.798 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 96.3 Cg_endo -84.69 97.22 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.816 2.344 . . . . 0.0 112.821 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.866 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.1 pp -88.77 24.25 2.08 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 121.034 0.445 . . . . 0.0 111.069 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -39.83 -29.86 0.07 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.884 179.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -141.33 25.97 2.01 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.114 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.4 t -113.35 -18.08 12.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.119 179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -45.93 -41.25 10.39 Favored Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.033 -0.604 . . . . 0.0 112.757 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 30.8 t -57.2 -31.18 65.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.918 0.39 . . . . 0.0 110.553 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -98.23 -25.65 14.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.999 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.07 39.93 2.56 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.26 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.693 HD22 ' SD ' ' A' ' 91' ' ' MET . 29.4 tp 80.69 -8.33 1.47 Allowed 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.822 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 65.32 61.72 5.47 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.438 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.805 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.63 153.28 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.885 0.374 . . . . 0.0 110.951 179.503 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.8 t -124.84 156.07 38.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.506 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.716 HG21 HD13 ' A' ' 87' ' ' LEU . 0.2 OUTLIER -129.3 154.9 40.78 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.501 0.667 . . . . 0.0 111.741 -179.533 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.84 138.22 48.4 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.019 -178.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -116.43 136.99 13.25 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.787 -179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -126.72 163.83 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.972 0.415 . . . . 0.0 111.135 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -117.69 166.44 12.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.638 179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.528 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 22.0 t -47.27 142.31 4.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.175 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -74.24 -9.18 58.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.258 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -108.41 -28.9 9.11 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.829 0.347 . . . . 0.0 111.062 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.561 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.1 p30 -145.18 -171.75 3.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.052 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.0 t60 -92.54 47.38 1.3 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.783 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -94.01 106.45 18.42 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.054 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.2 p30 -55.08 111.89 0.95 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.047 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.5 mt -81.33 -35.88 30.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.91 179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.477 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 145.35 -167.75 27.37 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.562 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.077 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.64 162.11 10.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.432 ' CE2' ' HG3' ' A' ' 66' ' ' GLN . 0.3 OUTLIER -143.92 145.77 32.5 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.175 179.539 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.53 ' HB ' ' O ' ' A' ' 62' ' ' ARG . 6.2 t -55.65 104.87 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.305 179.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.415 ' H ' ' HA ' ' A' ' 30' ' ' VAL . 0.0 OUTLIER -77.61 -38.11 48.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.203 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.427 ' O ' HG12 ' A' ' 28' ' ' VAL . 85.7 p -157.01 170.18 23.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.99 0.424 . . . . 0.0 111.447 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.78 HG23 HG13 ' A' ' 28' ' ' VAL . 7.5 mt -140.01 151.75 21.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.794 179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.822 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.4 mp -108.33 101.03 11.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.211 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 3.3 p30 -63.36 73.01 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.994 0.426 . . . . 0.0 110.922 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.455 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -174.47 -28.65 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.243 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.27 -171.74 22.29 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.706 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.912 ' HB1' HG12 ' A' ' 16' ' ' VAL . . . -41.11 -55.29 2.64 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.481 ' HB1' ' HG ' ' A' ' 61' ' ' LEU . . . -51.15 -31.61 20.34 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.842 0.353 . . . . 0.0 111.38 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.61 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 29.5 t -78.66 -58.62 3.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.53 179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.482 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.2 -24.07 62.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.932 179.723 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -53.31 -48.58 68.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.073 0.463 . . . . 0.0 110.396 179.764 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 74.05 5.45 70.75 Favored Glycine 0 C--N 1.33 0.229 0 C-N-CA 120.789 -0.72 . . . . 0.0 113.077 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.446 ' HG3' ' CD2' ' A' ' 14' ' ' PHE . 2.1 ptp180 -119.14 -8.67 10.13 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.744 0.272 . . . . 0.0 111.106 179.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.598 ' HB3' HD13 ' A' ' 49' ' ' ILE . 2.5 mm? -61.78 142.52 57.24 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.951 0.405 . . . . 0.0 111.036 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.53 ' O ' ' HB ' ' A' ' 46' ' ' VAL . 0.6 OUTLIER -137.47 128.01 26.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.388 179.715 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 63' ' ' VAL . 4.6 t -75.13 36.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.788 -179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.405 ' H ' ' C ' ' A' ' 62' ' ' ARG . 41.5 m-80 -162.5 17.06 0.09 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.061 179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 7.0 m-20 -94.49 138.87 31.87 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.643 0.259 . . . . 0.0 110.553 179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG3' ' CE2' ' A' ' 45' ' ' PHE . 0.3 OUTLIER -91.67 124.64 35.96 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.109 -179.74 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 HD23 HG12 ' A' ' 105' ' ' VAL . 55.6 mt -74.16 128.15 34.79 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.893 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 106' ' ' ALA . 28.0 mm -106.05 -44.9 8.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.58 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -152.67 167.73 27.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.927 0.394 . . . . 0.0 111.387 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.657 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.7 p -151.53 110.96 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.271 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.638 HD22 HG22 ' A' ' 70' ' ' VAL . 69.1 m-80 54.71 39.71 31.48 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.91 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.71 -11.47 68.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.658 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.47 92.71 8.58 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.918 0.39 . . . . 0.0 110.47 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.2 131.55 51.35 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.128 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.805 HD23 ' CE ' ' A' ' 78' ' ' LYS . 73.2 mt -95.7 -24.63 16.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.759 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.547 HD11 HG22 ' A' ' 68' ' ' ILE . 2.2 mp -45.63 -41.02 9.71 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.359 -179.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.41 43.75 2.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.258 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.805 ' CE ' HD23 ' A' ' 75' ' ' LEU . 16.4 mtmm -151.53 142.34 22.88 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.12 0.486 . . . . 0.0 111.127 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.36 -169.81 1.54 Allowed 'General case' 0 N--CA 1.448 -0.553 0 CA-C-N 115.591 -0.731 . . . . 0.0 109.796 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.474 ' HB3' ' HE3' ' A' ' 84' ' ' MET . 20.5 m-80 -59.59 -48.63 80.92 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 120.798 0.332 . . . . 0.0 110.707 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.92 -36.5 75.4 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -179.215 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.458 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 4.1 mt-10 -72.24 -42.22 65.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.829 0.347 . . . . 0.0 111.051 -179.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.077 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.86 -32.54 70.96 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.182 0.515 . . . . 0.0 109.918 179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.474 ' HE3' ' HB3' ' A' ' 80' ' ' ASN . 3.3 mtm -71.73 -30.45 65.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.572 179.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.1 pt-20 -75.63 -34.93 60.58 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.442 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.2 m -65.37 -42.34 92.85 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.037 178.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.716 HD13 HG21 ' A' ' 30' ' ' VAL . 37.7 mt -66.01 -53.69 35.58 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 108.388 -0.967 . . . . 0.0 108.388 178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.4 mtp85 -55.18 -30.17 59.34 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 115.481 -0.781 . . . . 0.0 109.11 177.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 12.7 mtt180 -71.83 -40.16 69.28 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.067 179.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.742 ' HB3' HD12 ' A' ' 101' ' ' ILE . 49.5 m -70.69 -46.19 63.6 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.7 -179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.693 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.8 mmt -68.78 -22.32 64.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.761 179.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 62.2 p -81.54 -55.42 4.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.122 -178.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.584 HG23 ' O ' ' A' ' 93' ' ' THR . 10.1 t -175.55 69.5 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.786 0.291 . . . . 0.0 111.786 -178.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.476 ' CG ' ' O ' ' A' ' 93' ' ' THR . 26.4 mt-10 -167.36 -44.65 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 179.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.451 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -82.49 -29.25 36.78 Favored Glycine 0 N--CA 1.441 -1.004 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 178.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.866 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.2 t-20 -82.16 -99.07 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 57.8 pttt 44.57 16.31 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 178.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.411 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -164.01 -34.5 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 128.54 16.18 2.1 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.478 -179.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.488 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 0.7 OUTLIER -174.94 158.44 2.53 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-O 120.606 0.241 . . . . 0.0 110.83 179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.811 HD11 HD21 ' A' ' 103' ' ' LEU . 0.1 OUTLIER -142.16 145.45 23.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.881 0.372 . . . . 0.0 111.074 -179.862 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.441 ' CG ' HG23 ' A' ' 13' ' ' THR . 26.1 tt0 -102.18 132.54 48.04 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.743 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.811 HD21 HD11 ' A' ' 101' ' ' ILE . 0.4 OUTLIER -139.37 114.43 9.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.961 0.41 . . . . 0.0 111.301 -179.872 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.451 HD13 ' HA ' ' A' ' 13' ' ' THR . 36.7 mm -74.45 143.35 13.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.102 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.72 HG12 HD23 ' A' ' 67' ' ' LEU . 28.9 m -138.13 176.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.212 0.53 . . . . 0.0 111.934 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.619 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -125.1 130.04 51.43 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.502 179.629 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.79 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -109.54 128.2 55.02 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.886 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.411 ' HB3' ' NH1' ' A' ' 108' ' ' ARG . 0.3 OUTLIER -88.71 127.31 35.59 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.857 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.724 HG22 ' H ' ' A' ' 110' ' ' SER . 1.6 mt -98.04 -177.42 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.597 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.724 ' H ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.332 -0.167 0 CA-C-O 120.832 0.349 . . . . 0.0 110.917 -179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.394 0 N-CA-C 112.536 -0.226 . . . . 0.0 112.536 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.406 ' HB ' ' HD3' ' A' ' 108' ' ' ARG . 24.5 p -155.42 36.47 0.37 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.586 0.232 . . . . 0.0 111.406 -179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.434 ' N ' HG12 ' A' ' 109' ' ' ILE . 9.2 mtt180 -169.38 122.65 0.77 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.173 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -130.19 174.1 10.13 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.69 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 7.3 m-85 -114.2 136.94 52.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.86 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.611 HD11 ' HB2' ' A' ' 107' ' ' ARG . 14.4 mt -129.65 146.37 51.44 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.028 0.442 . . . . 0.0 111.3 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.723 HG23 ' CD1' ' A' ' 104' ' ' ILE . 21.4 m -129.15 126.06 38.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.45 179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 11.8 m-85 -135.39 149.14 49.59 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.023 0.439 . . . . 0.0 111.79 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -107.86 115.11 29.55 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.033 179.256 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.769 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -105.62 103.63 44.39 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.815 -178.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.855 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.2 Cg_exo -76.04 95.27 1.02 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.819 2.346 . . . . 0.0 112.097 179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.867 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -87.08 24.3 1.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.06 0.457 . . . . 0.0 111.09 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -42.93 -27.99 0.23 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.856 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -141.67 22.33 2.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.441 -179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 37.5 p -118.87 -5.89 10.58 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.323 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -61.09 -30.67 74.25 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.507 179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.8 p -53.69 -31.47 47.98 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.972 0.415 . . . . 0.0 110.866 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.02 -21.17 14.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.0 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 106.33 49.37 0.93 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.255 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.588 HD13 ' HB3' ' A' ' 18' ' ' LEU . 6.5 tp 71.58 5.66 5.46 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 111.944 0.349 . . . . 0.0 111.944 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.851 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 55.27 65.91 3.21 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.427 -0.892 . . . . 0.0 113.034 179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.803 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.56 169.72 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-O 120.931 0.396 . . . . 0.0 111.256 179.188 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.8 m -155.91 133.83 11.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.411 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.911 HG11 HD11 ' A' ' 67' ' ' LEU . 4.7 m -125.21 147.77 29.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 121.081 0.467 . . . . 0.0 111.58 -179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.98 148.98 36.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.403 179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' N ' ' HE1' ' A' ' 84' ' ' MET . . . -110.52 138.4 14.89 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.685 -179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -126.17 156.21 40.52 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.852 0.358 . . . . 0.0 110.998 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.427 ' HD3' ' CG ' ' A' ' 39' ' ' HIS . 70.0 mtt85 -104.48 166.1 10.62 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.59 179.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.82 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 5.6 t -49.86 138.31 15.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.897 0.38 . . . . 0.0 110.972 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.03 -13.41 62.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.34 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -106.26 -41.18 5.4 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.186 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.564 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.8 p30 -128.57 -171.27 2.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.447 -0.342 . . . . 0.0 110.988 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' CG ' ' HD3' ' A' ' 34' ' ' ARG . 0.3 OUTLIER -94.25 45.43 1.13 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.827 -179.91 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.82 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.88 112.0 23.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.125 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.714 ' OD2' ' HB1' ' A' ' 79' ' ' ALA . 1.0 OUTLIER -58.06 96.0 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.866 179.918 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 32.8 mt -60.86 -75.96 0.06 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.036 -179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.522 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 179.72 -163.31 30.49 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.681 -179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.092 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.49 157.38 13.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.853 0.358 . . . . 0.0 110.988 179.999 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.447 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -141.16 138.17 33.21 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.457 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.75 ' HA ' HG12 ' A' ' 30' ' ' VAL . 21.9 t -51.89 104.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.916 0.389 . . . . 0.0 110.899 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.81 26.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.984 -179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.45 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.2 OUTLIER -161.68 168.66 22.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.093 -179.735 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.803 HG23 HG13 ' A' ' 28' ' ' VAL . 13.3 mt -140.12 155.94 24.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.014 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.851 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.0 mp -106.33 99.56 8.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.232 179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.552 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -62.93 72.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.998 0.427 . . . . 0.0 110.949 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -171.73 -29.05 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.456 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.81 -172.28 21.17 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.855 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -40.81 -54.19 2.71 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -179.558 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.16 -28.03 10.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.327 -179.321 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.552 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 28.7 t -82.97 -60.07 2.28 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.548 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.468 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.42 60.6 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.08 -179.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.579 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.5 OUTLIER -55.59 -50.21 70.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.916 0.389 . . . . 0.0 110.678 179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 63.76 15.73 58.17 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.821 179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.447 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 14.0 mtm180 -116.14 -12.34 11.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.762 0.315 . . . . 0.0 110.891 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.635 ' N ' HD22 ' A' ' 61' ' ' LEU . 2.0 mm? -84.39 148.97 26.32 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.26 131.16 38.14 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.735 179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.446 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 22.2 t -67.31 71.35 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.084 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.83 -22.91 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.368 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 1.6 m-20 -57.42 141.18 48.24 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.812 0.339 . . . . 0.0 110.92 -179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.601 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -95.34 113.16 24.81 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.189 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.911 HD11 HG11 ' A' ' 30' ' ' VAL . 17.4 mt -58.09 130.74 47.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.71 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.625 HD11 ' HB2' ' A' ' 106' ' ' ALA . 13.5 mm -116.41 -26.92 2.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.754 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.457 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -165.4 176.99 7.81 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.078 0.466 . . . . 0.0 111.634 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.594 ' O ' HG13 ' A' ' 70' ' ' VAL . 11.8 p -158.02 106.55 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.56 HD22 HG22 ' A' ' 70' ' ' VAL . 70.0 m-80 57.87 40.97 25.43 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.001 -179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.2 -12.3 66.85 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.657 -179.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.492 ' OE2' HG23 ' A' ' 86' ' ' THR . 4.5 tt0 -87.14 92.87 9.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.942 0.401 . . . . 0.0 110.5 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -54.1 150.98 7.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.172 -179.776 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.547 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.3 mt -117.28 -9.12 11.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.365 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.625 HD12 HG23 ' A' ' 68' ' ' ILE . 0.1 OUTLIER -48.69 -58.73 4.3 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.775 0.321 . . . . 0.0 111.001 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -67.59 -20.86 72.32 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.452 179.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.479 ' HD3' ' C ' ' A' ' 82' ' ' GLU . 5.5 mmtp -72.55 132.21 43.5 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-O 121.051 0.453 . . . . 0.0 111.235 179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.714 ' HB1' ' OD2' ' A' ' 41' ' ' ASP . . . -79.05 -173.87 3.79 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.506 178.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.501 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.0 p30 -57.31 -52.33 65.78 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.855 0.359 . . . . 0.0 110.814 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -36.37 75.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.193 -179.613 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.479 ' C ' ' HD3' ' A' ' 78' ' ' LYS . 4.1 mm-40 -69.3 -44.26 72.13 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.71 0.29 . . . . 0.0 111.25 -179.295 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.092 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -68.73 -33.4 73.86 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.1 0.476 . . . . 0.0 109.979 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.501 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.0 mtm -69.8 -31.0 68.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.161 179.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.411 ' O ' ' N ' ' A' ' 89' ' ' ARG . 0.5 OUTLIER -81.65 -42.25 20.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.698 179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.492 HG23 ' OE2' ' A' ' 73' ' ' GLU . 1.3 m -62.98 -37.08 85.71 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.643 HD11 HD13 ' A' ' 67' ' ' LEU . 15.1 mt -69.16 -55.55 10.32 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 30.4 mtt-85 -54.73 -30.3 55.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.372 177.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.411 ' N ' ' O ' ' A' ' 85' ' ' GLU . 11.9 mtp180 -70.79 -53.26 16.07 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.608 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.564 ' HA ' ' H ' ' A' ' 95' ' ' GLY . 49.4 m -61.96 -30.19 70.75 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.439 -0.8 . . . . 0.0 109.836 179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.613 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -82.0 -18.4 43.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.798 179.565 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 30.1 t -98.34 -51.92 3.82 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -179.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.586 HG23 ' O ' ' A' ' 93' ' ' THR . 9.9 t -172.15 72.83 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.37 0.507 . . . . 0.0 112.37 -178.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.498 ' CG ' ' O ' ' A' ' 93' ' ' THR . 18.9 mt-10 -169.03 -44.61 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.441 0.639 . . . . 0.0 109.749 179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.564 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -96.87 -24.32 13.45 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.867 ' HB2' HD21 ' A' ' 18' ' ' LEU . 11.5 t30 -96.13 -83.69 0.37 Allowed 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.089 -0.555 . . . . 0.0 110.088 179.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.586 ' C ' ' HG3' ' A' ' 98' ' ' ARG . 20.3 pttt 45.29 15.37 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 112.095 0.406 . . . . 0.0 112.095 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.586 ' HG3' ' C ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -153.31 -40.02 0.1 Allowed 'General case' 0 N--CA 1.463 0.195 0 CA-C-O 120.928 0.394 . . . . 0.0 110.791 179.81 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . 138.18 15.55 0.68 Allowed Glycine 0 CA--C 1.523 0.586 0 CA-C-N 115.822 -0.627 . . . . 0.0 112.495 -179.161 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.485 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 6.8 ptm -164.92 148.71 8.77 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-O 120.709 0.29 . . . . 0.0 110.82 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.492 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -140.41 149.51 21.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.82 0.343 . . . . 0.0 111.206 -179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 24.1 tt0 -102.57 119.84 39.52 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.316 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.441 HD21 HD11 ' A' ' 101' ' ' ILE . 4.2 mt -117.42 135.62 53.76 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.034 0.445 . . . . 0.0 111.539 -179.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.723 ' CD1' HG23 ' A' ' 13' ' ' THR . 38.7 mm -104.59 142.52 17.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.237 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.728 HG12 ' HA ' ' A' ' 67' ' ' LEU . 3.1 m -141.21 174.88 6.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.873 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.625 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -118.13 130.77 56.31 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.531 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.611 ' HB2' HD11 ' A' ' 12' ' ' LEU . 0.0 OUTLIER -115.27 141.78 47.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.303 -179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.406 ' HD3' ' HB ' ' A' ' 8' ' ' THR . 0.3 OUTLIER -84.81 144.83 28.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.673 179.671 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG22 ' N ' ' A' ' 110' ' ' SER . 12.0 mm -83.7 159.78 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.305 -179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.336 0 N-CA-C 112.258 -0.337 . . . . 0.0 112.258 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 12.5 p -154.02 174.92 14.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.87 0.367 . . . . 0.0 110.755 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 3.0 mtt85 62.95 110.55 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.04 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -131.15 121.81 25.54 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.985 179.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -78.05 132.08 37.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.673 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 14' ' ' PHE . 1.2 mt -136.56 129.19 30.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.089 0.471 . . . . 0.0 111.379 -179.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.646 HG23 HD11 ' A' ' 104' ' ' ILE . 17.0 m -97.36 135.92 38.57 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.207 179.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 16.1 m-85 -135.36 130.32 34.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.016 0.436 . . . . 0.0 112.059 -179.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -98.9 104.35 16.39 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.576 178.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.844 HG22 ' OD2' ' A' ' 58' ' ' ASP . 19.5 t -99.44 110.06 57.12 Favored Pre-proline 0 C--N 1.327 -0.402 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.802 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 92.0 Cg_endo -83.63 96.15 0.77 Allowed 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.977 2.451 . . . . 0.0 112.893 179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.974 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -86.53 24.79 1.34 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.102 0.477 . . . . 0.0 110.83 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.57 -27.26 0.09 Allowed 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.42 -0.809 . . . . 0.0 112.052 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -143.89 20.36 1.8 Allowed 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 77.7 p -115.61 -11.48 11.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.645 0.259 . . . . 0.0 111.26 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -54.04 -26.4 34.6 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.558 179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 p -55.95 -39.6 71.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.891 0.377 . . . . 0.0 110.673 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -96.34 -28.68 14.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.796 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.412 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 115.91 49.32 0.47 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.543 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.774 HD11 ' CG1' ' A' ' 16' ' ' VAL . 20.2 tp 77.29 -1.1 2.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.876 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 62.22 55.23 29.01 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.032 -1.08 . . . . 0.0 111.965 -179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.847 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -168.76 160.14 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 111.073 179.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -135.91 129.9 32.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.62 179.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG11 HD12 ' A' ' 67' ' ' LEU . 2.1 t -112.48 151.67 14.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.949 0.404 . . . . 0.0 111.05 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.498 ' C ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -133.29 138.17 46.31 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.941 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.68 144.32 15.85 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.479 -179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -123.25 162.94 21.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.883 0.373 . . . . 0.0 110.921 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.02 145.28 49.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.807 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.452 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -58.89 133.32 55.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.748 179.935 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 5.1 mptt -85.93 6.87 26.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.463 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -105.26 -30.26 9.78 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.711 0.291 . . . . 0.0 111.136 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -152.99 23.32 0.57 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.434 -179.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 3.3 m80 51.66 37.25 19.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.784 0.326 . . . . 0.0 111.14 179.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.452 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -86.49 121.84 29.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.146 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -57.03 108.25 0.49 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.0 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 9.1 mt -75.69 -35.33 60.36 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.928 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.611 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 135.0 -160.3 24.27 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.582 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 0.997 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -121.41 162.12 20.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 120.929 0.395 . . . . 0.0 110.81 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.439 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -151.24 147.9 27.56 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.642 -179.956 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.405 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 46.2 t -53.02 104.77 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.913 0.387 . . . . 0.0 110.686 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.88 -35.01 33.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.207 -179.333 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 0.3 OUTLIER -163.01 170.09 18.56 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.985 -179.762 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.704 HG23 HG13 ' A' ' 28' ' ' VAL . 17.7 mt -139.03 157.03 28.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.128 0.489 . . . . 0.0 111.188 -179.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.876 HD13 ' C ' ' A' ' 27' ' ' GLY . 1.3 mp -111.61 105.67 19.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.872 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.483 ' HA ' ' CB ' ' A' ' 56' ' ' SER . 0.5 OUTLIER -68.75 66.92 0.13 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.023 0.439 . . . . 0.0 110.716 -179.693 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -162.94 -29.57 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.765 -179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.93 -166.94 17.92 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.502 -0.856 . . . . 0.0 112.968 -179.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.802 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -41.9 -54.16 3.54 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.223 0.823 . . . . 0.0 113.223 -179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.865 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.07 -30.52 16.1 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.706 0.289 . . . . 0.0 111.561 -178.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 51' ' ' ASN . 32.4 p -78.64 -58.21 3.36 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.342 0.592 . . . . 0.0 110.461 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.491 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.35 -24.31 66.37 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.684 -179.627 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.844 ' OD2' HG22 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -59.65 -50.43 73.91 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.79 0.328 . . . . 0.0 111.008 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.83 42.45 97.03 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.395 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 0.0 OUTLIER -140.55 -55.67 0.52 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.065 0.46 . . . . 0.0 110.764 -179.82 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.865 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -49.41 90.97 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.865 179.598 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 60' ' ' ARG . 0.2 OUTLIER -81.26 127.85 33.16 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.161 -179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.574 ' O ' ' HB2' ' A' ' 64' ' ' ASN . 13.2 t -50.71 144.31 2.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.359 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.574 ' HB2' ' O ' ' A' ' 63' ' ' VAL . 3.0 m-80 77.96 -10.84 1.29 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.706 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -59.22 139.64 56.75 Favored 'General case' 0 N--CA 1.461 0.084 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -84.52 131.78 34.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.824 0.345 . . . . 0.0 111.237 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.84 HD23 HG12 ' A' ' 105' ' ' VAL . 77.5 mt -84.14 139.34 32.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.477 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.948 HD11 ' HB2' ' A' ' 106' ' ' ALA . 24.6 mt -128.24 -42.55 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.635 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.647 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -143.42 166.7 24.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.06 0.457 . . . . 0.0 111.581 -179.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.912 HG22 ' ND2' ' A' ' 71' ' ' ASN . 12.2 p -158.02 104.78 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.906 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.912 ' ND2' HG22 ' A' ' 70' ' ' VAL . 7.0 m-80 57.95 35.98 25.79 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.64 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.7 -19.8 51.94 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.299 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -71.77 99.41 2.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.993 0.425 . . . . 0.0 110.37 179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 77.5 p -70.88 100.41 1.93 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.708 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.553 HD22 ' CB ' ' A' ' 83' ' ' ALA . 12.9 mt -63.04 -15.71 57.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.145 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.86 100.46 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.114 0 CA-C-O 120.892 0.377 . . . . 0.0 110.719 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 124.72 -43.35 1.4 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.655 -179.451 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 15.2 mttp -61.33 118.43 6.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.92 0.391 . . . . 0.0 110.581 179.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.622 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -56.67 -173.92 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.429 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.464 ' O ' ' HE3' ' A' ' 84' ' ' MET . 2.5 p30 -57.59 -54.48 46.43 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.918 -179.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.622 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.5 pm0 -69.27 -35.53 76.16 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.519 -179.719 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -61.99 -53.43 55.66 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-O 121.305 0.574 . . . . 0.0 110.374 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 0.997 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.35 -33.66 75.15 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.307 179.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.464 ' HE3' ' O ' ' A' ' 80' ' ' ASN . 2.8 mtm -65.95 -28.47 68.94 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.067 178.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.575 ' HG3' ' N ' ' A' ' 86' ' ' THR . 0.0 OUTLIER -80.7 -38.12 29.47 Favored 'General case' 0 N--CA 1.454 -0.236 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.675 179.615 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.575 ' N ' ' HG3' ' A' ' 85' ' ' GLU . 1.4 m -65.59 -38.61 90.0 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.581 HD11 ' CD1' ' A' ' 67' ' ' LEU . 86.3 mt -69.17 -55.17 11.42 Favored 'General case' 0 N--CA 1.452 -0.362 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.198 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.1 mtt-85 -53.52 -31.49 46.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.168 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -70.24 -46.65 64.01 Favored 'General case' 0 N--CA 1.454 -0.262 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.982 178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.835 ' HB3' HD12 ' A' ' 101' ' ' ILE . 21.2 m -61.46 -42.29 98.54 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.957 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.763 ' SD ' HD22 ' A' ' 26' ' ' LEU . 14.0 mmt -69.98 -22.78 63.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.007 178.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.451 ' O ' ' HB ' ' A' ' 93' ' ' THR . 2.9 m -84.4 -55.01 4.38 Favored 'General case' 0 N--CA 1.455 -0.2 0 CA-C-N 116.227 -0.442 . . . . 0.0 112.09 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.627 HG23 ' O ' ' A' ' 93' ' ' THR . 8.5 t 177.75 76.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 111.977 0.362 . . . . 0.0 111.977 -178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.496 ' CG ' ' O ' ' A' ' 93' ' ' THR . 14.2 mt-10 -167.84 -41.08 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.45 0.643 . . . . 0.0 109.755 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 71' ' ' ASN . . . -98.98 -27.74 8.13 Favored Glycine 0 N--CA 1.442 -0.962 0 N-CA-C 110.135 -1.186 . . . . 0.0 110.135 178.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.974 ' HB2' HD21 ' A' ' 18' ' ' LEU . 14.6 t30 -89.76 -82.8 0.26 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 115.137 -0.532 . . . . 0.0 109.734 178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 0.1 OUTLIER 39.32 30.26 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.522 179.381 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.487 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.2 OUTLIER -172.64 -31.13 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.821 -179.772 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.467 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.68 19.02 2.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.193 -179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.554 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 7.4 ptm -169.57 152.22 4.63 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.752 0.31 . . . . 0.0 111.272 -179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.835 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.92 143.77 21.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.358 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -93.21 141.16 28.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.225 179.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.719 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.1 mt -140.3 124.0 17.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.895 0.379 . . . . 0.0 111.623 -179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.647 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 39.6 mm -95.92 142.53 13.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.299 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.84 HG12 HD23 ' A' ' 67' ' ' LEU . 28.8 m -139.05 176.17 6.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.125 0.488 . . . . 0.0 111.96 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.948 ' HB2' HD11 ' A' ' 68' ' ' ILE . . . -134.64 131.47 37.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.514 -0.767 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.91 128.0 54.02 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.244 -179.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.51 128.5 34.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.756 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.494 HG22 ' N ' ' A' ' 110' ' ' SER . 7.4 mt -97.99 159.54 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.4 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.494 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.023 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.4 0 N-CA-C 112.308 -0.317 . . . . 0.0 112.308 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.408 ' HA ' ' HB ' ' A' ' 109' ' ' ILE . 11.1 p -153.07 54.23 0.76 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.877 0.37 . . . . 0.0 110.86 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -179.84 102.68 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.822 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -113.21 124.8 53.38 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.918 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -87.82 141.99 28.16 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 2.8 mt -139.05 144.89 39.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.16 -179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.712 HG23 HD11 ' A' ' 104' ' ' ILE . 13.8 m -110.08 139.52 45.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.455 179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 60' ' ' ARG . 26.0 m-85 -139.98 142.97 36.29 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.059 0.457 . . . . 0.0 111.739 -179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.444 ' HB3' ' HE2' ' A' ' 100' ' ' MET . 1.0 OUTLIER -111.27 109.92 20.17 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.855 179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.725 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -102.46 106.25 48.07 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.704 -179.066 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.806 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.91 94.21 0.95 Allowed 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.898 2.399 . . . . 0.0 112.542 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.762 ' O ' HD12 ' A' ' 18' ' ' LEU . 2.3 pp -86.55 24.49 1.41 Allowed 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.108 0.48 . . . . 0.0 111.156 179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -38.96 -29.16 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.564 -0.743 . . . . 0.0 112.103 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -145.33 20.84 1.55 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.742 -179.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.425 ' OG ' ' HA ' ' A' ' 18' ' ' LEU . 80.4 p -118.63 -4.11 10.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.64 -0.255 . . . . 0.0 111.303 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.418 ' CA ' HD13 ' A' ' 18' ' ' LEU . . . -62.63 -27.44 69.81 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.466 179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 p -54.18 -29.15 44.76 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.878 0.371 . . . . 0.0 110.856 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -103.13 -16.43 15.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.278 179.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.421 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 104.34 47.78 1.19 Allowed Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.065 -179.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB ' ' A' ' 16' ' ' VAL . 21.5 tp 73.02 4.5 4.97 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.877 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 58.22 63.14 5.52 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.923 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.764 ' N ' HD13 ' A' ' 50' ' ' ILE . 0.0 OUTLIER -174.77 163.24 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.204 0 CA-C-O 121.023 0.44 . . . . 0.0 111.501 179.018 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.1 m -146.51 137.27 24.08 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.172 179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.953 HG11 HD11 ' A' ' 67' ' ' LEU . 20.6 m -130.06 145.03 36.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.157 0.503 . . . . 0.0 112.028 -179.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.477 ' O ' HG22 ' A' ' 44' ' ' ILE . 0.0 OUTLIER -114.01 155.28 26.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.07 179.337 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -117.17 147.05 18.88 Favored Glycine 0 N--CA 1.453 -0.198 0 C-N-CA 120.39 -0.909 . . . . 0.0 112.993 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -124.41 -172.49 2.57 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.914 0.388 . . . . 0.0 110.949 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -140.93 166.09 25.75 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.738 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.73 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 1.0 OUTLIER -56.32 135.22 53.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.946 180.0 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.63 -16.19 64.03 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.211 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tt0 -97.54 -28.12 14.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.64 0.257 . . . . 0.0 111.161 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.8 OUTLIER -152.94 162.91 40.73 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.885 0.374 . . . . 0.0 111.09 -179.788 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -70.7 65.59 0.32 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.789 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.73 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -115.53 104.79 12.08 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.023 179.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.91 111.43 0.75 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.033 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.1 mt -78.3 -34.33 48.83 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.487 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 147.33 -165.3 28.66 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.55 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.045 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -112.29 157.82 12.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.792 0.329 . . . . 0.0 110.994 179.984 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.474 ' N ' ' CD1' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -138.27 140.26 39.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.378 179.848 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.84 ' HA ' HG12 ' A' ' 30' ' ' VAL . 41.0 t -52.89 104.86 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-O 120.955 0.407 . . . . 0.0 110.758 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -81.39 -36.86 29.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.102 -179.45 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . 0.49 ' O ' HG12 ' A' ' 28' ' ' VAL . 1.3 t -161.3 174.66 13.24 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.056 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.709 HG23 HG13 ' A' ' 28' ' ' VAL . 27.8 mt -145.01 158.12 13.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.096 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.877 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.1 mp -106.77 96.18 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.164 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.535 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -61.19 73.74 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.05 0.452 . . . . 0.0 111.028 -179.773 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -175.32 -28.29 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.176 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -107.21 -168.41 22.12 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.596 -0.812 . . . . 0.0 112.681 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.806 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.73 -54.64 7.57 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.906 0.706 . . . . 0.0 112.906 -179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.891 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.08 -30.29 15.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.889 0.376 . . . . 0.0 111.268 -179.019 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.2 t -77.81 -60.1 2.51 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.226 0.536 . . . . 0.0 110.51 179.353 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.477 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.82 -24.34 64.08 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.493 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.596 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.4 OUTLIER -57.97 -50.28 73.92 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.801 0.334 . . . . 0.0 111.14 -179.758 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 65.06 41.75 97.01 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.484 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.418 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.36 -55.85 0.64 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.19 0.519 . . . . 0.0 110.619 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.891 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.1 OUTLIER -53.48 90.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.028 179.827 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 62' ' ' ARG . 3.3 mmp_? -77.95 140.08 39.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.806 0.336 . . . . 0.0 110.843 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.448 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 16.5 t -67.78 72.37 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.153 -179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.97 -24.3 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.323 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' A' ' 45' ' ' PHE . 78.1 m-20 -57.67 138.36 55.49 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.768 0.318 . . . . 0.0 111.078 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.458 ' HG2' ' CD2' ' A' ' 45' ' ' PHE . 0.1 OUTLIER -89.77 113.82 25.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.04 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.953 HD11 HG11 ' A' ' 30' ' ' VAL . 70.3 mt -60.32 132.42 53.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.826 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 22.8 mm -118.62 -35.6 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.402 -179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.672 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -149.2 169.33 20.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.892 0.377 . . . . 0.0 111.462 -179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.631 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.9 p -158.04 113.25 0.16 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.016 -179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.631 ' ND2' HG22 ' A' ' 70' ' ' VAL . 39.3 m-20 56.48 36.56 27.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.784 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.75 -13.88 64.6 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.568 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -82.78 123.52 29.41 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.803 0.335 . . . . 0.0 110.791 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 56.9 p -79.76 129.89 34.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.99 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 83' ' ' ALA . 13.8 mt -96.62 -14.66 22.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.295 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -46.36 -54.82 8.31 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.758 0.313 . . . . 0.0 111.335 -179.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.48 -26.19 74.76 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.528 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 7.3 mttp -77.88 125.84 29.95 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.076 0.465 . . . . 0.0 111.308 -179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.747 ' HB3' ' NE2' ' A' ' 81' ' ' GLN . . . -69.7 -170.83 0.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.28 179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.498 ' O ' ' HE2' ' A' ' 84' ' ' MET . 26.2 m-20 -56.41 -56.32 22.62 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.249 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.747 ' NE2' ' HB3' ' A' ' 79' ' ' ALA . 2.0 pp0? -67.6 -33.82 75.77 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.672 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -66.92 -53.23 33.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.206 0.527 . . . . 0.0 110.665 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.045 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.49 -33.24 74.47 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.493 -0.776 . . . . 0.0 109.954 179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.498 ' HE2' ' O ' ' A' ' 80' ' ' ASN . 3.6 mtm -68.47 -30.53 69.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.264 179.332 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -80.26 -41.1 25.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.755 179.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.417 HG22 HG11 ' A' ' 70' ' ' VAL . 1.2 m -62.12 -36.13 80.83 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.634 HD13 HG21 ' A' ' 30' ' ' VAL . 40.3 mt -69.29 -55.33 10.81 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.213 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.6 ptt180 -55.03 -29.77 58.13 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 178.033 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.4 mtt85 -70.51 -43.07 70.41 Favored 'General case' 0 N--CA 1.454 -0.264 0 CA-C-N 115.246 -0.888 . . . . 0.0 109.815 178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.8 m -67.15 -44.49 79.64 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.413 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.551 ' SD ' HD13 ' A' ' 101' ' ' ILE . 4.0 mmt -72.3 -17.81 61.84 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.672 179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 3.6 m -86.69 -54.07 4.59 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.846 -179.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 93' ' ' THR . 9.4 t -175.82 69.72 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.581 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.491 ' CG ' ' O ' ' A' ' 93' ' ' THR . 12.3 mt-10 -168.29 -43.75 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.426 ' H ' ' HA ' ' A' ' 90' ' ' SER . . . -84.29 -29.81 29.58 Favored Glycine 0 N--CA 1.442 -0.932 0 N-CA-C 110.365 -1.094 . . . . 0.0 110.365 178.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.756 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.4 t-20 -81.78 -97.84 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 178.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.404 ' HE2' ' O ' ' A' ' 94' ' ' GLU . 56.2 pttt 44.04 16.84 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 112.777 0.658 . . . . 0.0 112.777 178.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -166.39 -34.24 0.03 OUTLIER 'General case' 0 N--CA 1.455 -0.22 0 CA-C-O 120.842 0.353 . . . . 0.0 111.474 -179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.436 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 125.91 17.25 2.56 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.479 179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.517 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 11.1 ptm -172.67 154.97 3.16 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-O 120.635 0.255 . . . . 0.0 111.251 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -145.0 144.1 21.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.228 -179.917 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.455 ' O ' HD12 ' A' ' 103' ' ' LEU . 6.1 mt-30 -84.95 148.62 26.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.386 179.645 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.637 HD11 HD11 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -147.58 118.17 7.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.82 0.343 . . . . 0.0 111.293 -179.784 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.712 HD11 HG23 ' A' ' 13' ' ' THR . 40.1 mm -96.17 142.77 13.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.435 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.589 HG12 HD23 ' A' ' 67' ' ' LEU . 30.6 m -141.12 166.34 18.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.533 -179.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -124.65 147.41 48.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.672 179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -133.72 129.74 37.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.949 0.404 . . . . 0.0 111.186 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.29 121.62 25.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.667 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.408 ' HB ' ' HA ' ' A' ' 8' ' ' THR . 26.9 mm -59.27 -81.59 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.185 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.301 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.186 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.288 0 N-CA-C 112.489 -0.244 . . . . 0.0 112.489 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.401 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 21.5 p -153.81 47.34 0.64 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.867 0.365 . . . . 0.0 111.007 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 9.7 mtm-85 -177.09 113.4 0.09 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.89 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.478 ' CD ' HD21 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -139.22 141.74 37.88 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.852 0.358 . . . . 0.0 111.055 179.982 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.573 ' HE2' HG21 ' A' ' 68' ' ' ILE . 10.5 m-85 -83.18 149.21 26.98 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.611 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.478 HD21 ' CD ' ' A' ' 10' ' ' GLU . 1.2 mt -136.94 119.97 16.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.977 0.418 . . . . 0.0 111.43 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.576 ' HA ' HD13 ' A' ' 104' ' ' ILE . 47.9 m -88.49 136.74 32.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.017 179.207 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.532 ' CE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -126.61 138.07 53.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.184 0.516 . . . . 0.0 112.118 -179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.423 ' HB3' ' CE ' ' A' ' 100' ' ' MET . 27.2 mp0 -110.52 102.82 11.39 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.354 -0.839 . . . . 0.0 109.42 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.815 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -106.35 109.62 63.27 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.783 -178.615 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.83 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 86.1 Cg_endo -81.84 98.05 0.95 Allowed 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.862 2.375 . . . . 0.0 113.007 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.804 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.2 pp -88.46 23.44 2.22 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 120.977 0.417 . . . . 0.0 110.881 179.28 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.401 HD22 ' N ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -36.4 -32.17 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.432 -0.804 . . . . 0.0 112.052 179.539 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.18 26.36 1.21 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.871 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.2 m -110.3 -16.47 13.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.929 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -51.24 -30.66 25.25 Favored Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.644 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.2 t -53.95 -36.0 62.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.128 0.489 . . . . 0.0 110.639 179.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -102.89 -25.4 13.5 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.831 179.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 109.74 50.82 0.67 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.97 -0.633 . . . . 0.0 112.372 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.642 HD22 ' SD ' ' A' ' 91' ' ' MET . 20.0 tp 78.81 -53.5 0.46 Allowed 'General case' 0 N--CA 1.464 0.233 0 N-CA-C 111.824 0.305 . . . . 0.0 111.824 179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.669 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 116.37 53.71 0.35 Allowed Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.43 -0.891 . . . . 0.0 112.257 -179.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.89 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -168.27 166.35 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 121.061 0.458 . . . . 0.0 111.466 179.303 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 t -147.52 138.84 23.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.12 179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.766 HG12 ' HA ' ' A' ' 46' ' ' VAL . 6.3 m -130.4 157.25 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-O 120.976 0.417 . . . . 0.0 111.728 -179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 140.82 48.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.823 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.434 ' HA2' ' O ' ' A' ' 43' ' ' GLY . . . -95.98 130.79 10.4 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.164 179.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.734 ' ND2' HD12 ' A' ' 42' ' ' LEU . 0.7 OUTLIER -105.34 139.24 40.29 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 120.92 0.391 . . . . 0.0 110.661 -179.631 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.66 140.34 35.07 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.968 179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -56.69 136.54 54.97 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.914 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.59 5.44 31.68 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.474 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -103.65 -32.66 9.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.546 0.212 . . . . 0.0 111.206 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -149.19 20.83 0.97 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.518 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 7.4 m80 51.44 48.33 23.15 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.007 0.432 . . . . 0.0 111.072 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -101.99 115.52 30.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.125 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -53.81 105.34 0.13 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.156 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.734 HD12 ' ND2' ' A' ' 33' ' ' ASN . 19.4 mt -66.27 -65.5 0.67 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.198 0.523 . . . . 0.0 110.918 179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.434 ' O ' ' HA2' ' A' ' 32' ' ' GLY . . . 175.18 -177.93 47.01 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.048 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.126 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -100.89 140.11 20.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 121.005 0.431 . . . . 0.0 111.03 179.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.468 ' CE2' ' HB3' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -124.17 144.02 50.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.397 -179.989 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.766 ' HA ' HG12 ' A' ' 30' ' ' VAL . 19.0 t -55.09 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 121.01 0.433 . . . . 0.0 110.74 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 16.4 tppt? -77.49 -42.04 37.2 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.964 -179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.45 173.88 14.25 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.89 HG23 HG13 ' A' ' 28' ' ' VAL . 10.0 mt -138.2 154.95 28.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.209 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.692 HD13 ' N ' ' A' ' 28' ' ' VAL . 3.9 mp -107.19 103.94 16.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.312 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.573 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.6 OUTLIER -66.07 73.42 0.07 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.83 179.996 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.4 -28.74 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.983 -179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -111.57 -167.52 18.37 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.416 -0.897 . . . . 0.0 112.909 -179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.83 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -45.1 -53.87 7.44 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.846 0.684 . . . . 0.0 112.846 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.861 ' HB1' ' CD1' ' A' ' 61' ' ' LEU . . . -51.37 -31.08 20.99 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.784 0.326 . . . . 0.0 111.322 -179.04 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.573 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 27.2 t -76.24 -60.51 2.3 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.179 0.514 . . . . 0.0 110.427 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.48 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -58.54 -24.47 60.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.212 179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.642 ' OD2' HG13 ' A' ' 16' ' ' VAL . 1.0 OUTLIER -59.4 -50.38 74.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.996 -179.904 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 61.66 24.12 63.85 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.007 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.429 ' HG3' ' CG ' ' A' ' 14' ' ' PHE . 9.5 ptp180 -128.41 2.73 5.66 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.749 0.275 . . . . 0.0 111.546 179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.861 ' CD1' ' HB1' ' A' ' 55' ' ' ALA . 0.2 OUTLIER -105.39 97.79 7.58 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.74 0.305 . . . . 0.0 110.827 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.01 141.43 38.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.865 0.364 . . . . 0.0 110.828 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.436 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 21.6 t -73.19 71.05 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.281 -179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.23 -20.24 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.81 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.07 147.71 23.67 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-O 120.761 0.315 . . . . 0.0 111.171 -179.46 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.432 ' HG2' ' CD1' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -94.7 129.66 41.5 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.886 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.738 HD11 HG11 ' A' ' 30' ' ' VAL . 34.1 mt -77.6 143.79 38.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.882 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HG21 ' HE2' ' A' ' 11' ' ' PHE . 23.7 mm -131.78 -42.51 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.327 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.621 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -145.78 164.12 32.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.877 0.37 . . . . 0.0 111.309 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.71 HG22 ' ND2' ' A' ' 71' ' ' ASN . 8.3 p -157.47 116.44 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.257 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.71 ' ND2' HG22 ' A' ' 70' ' ' VAL . 27.4 m-20 55.39 37.24 28.6 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.919 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 91.77 -16.94 58.13 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.51 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.02 138.83 44.33 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.752 0.31 . . . . 0.0 110.401 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 35.5 p -101.68 98.19 8.51 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.057 0.456 . . . . 0.0 111.229 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.845 HD22 ' HB1' ' A' ' 83' ' ' ALA . 28.0 mt -59.68 -20.74 58.24 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.963 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 68.8 mt -51.3 130.04 26.01 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.817 0.341 . . . . 0.0 111.035 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . 96.63 -26.98 19.57 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.368 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.779 ' CE ' HD23 ' A' ' 75' ' ' LEU . 17.8 mtmm -79.52 134.24 36.5 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.181 0.515 . . . . 0.0 111.083 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.648 ' HB3' HE22 ' A' ' 81' ' ' GLN . . . -70.78 -169.26 0.33 Allowed 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.849 179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 84' ' ' MET . 2.2 m120 -57.91 -55.24 37.44 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.941 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.648 HE22 ' HB3' ' A' ' 79' ' ' ALA . 2.9 pm0 -69.17 -33.78 73.92 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.438 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 1.1 mm-40 -66.27 -47.29 74.18 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.267 0.556 . . . . 0.0 110.028 179.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.126 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -69.4 -33.04 72.41 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.854 179.043 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.446 ' HB2' ' O ' ' A' ' 80' ' ' ASN . 3.2 mtm -68.1 -26.49 65.84 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.262 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.7 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 6.2 mm-40 -77.05 -41.42 42.55 Favored 'General case' 0 CA--C 1.509 -0.614 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.731 179.261 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.429 ' HB ' ' HE3' ' A' ' 78' ' ' LYS . 1.1 m -60.04 -42.22 93.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.941 -0.572 . . . . 0.0 109.653 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.674 HD13 HG21 ' A' ' 30' ' ' VAL . 5.6 mt -68.21 -55.01 13.77 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.424 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.1 mtt180 -55.61 -30.11 60.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.552 0.691 . . . . 0.0 109.473 177.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.7 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -72.41 -43.61 63.64 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.712 179.143 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.837 ' HB3' HD12 ' A' ' 101' ' ' ILE . 38.2 m -64.82 -45.34 86.6 Favored 'General case' 0 N--CA 1.451 -0.397 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.186 179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.642 ' SD ' HD22 ' A' ' 26' ' ' LEU . 9.7 mmt -70.6 -19.81 62.82 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.852 -0.613 . . . . 0.0 110.196 178.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 16.7 t -82.61 -55.28 4.55 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.947 -0.57 . . . . 0.0 112.031 -179.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.643 HG23 ' O ' ' A' ' 93' ' ' THR . 10.0 t -176.86 86.46 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.015 0.436 . . . . 0.0 112.059 -179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.557 ' HG3' ' HA ' ' A' ' 90' ' ' SER . 0.0 OUTLIER 167.02 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 178.852 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -79.96 -35.79 26.78 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 177.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.804 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.3 t-20 -78.8 -100.69 0.02 OUTLIER 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.44 ' HD2' ' N ' ' A' ' 97' ' ' LYS . 0.4 OUTLIER 46.95 20.16 0.11 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 178.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.423 ' HG2' ' N ' ' A' ' 99' ' ' GLY . 0.0 OUTLIER -168.88 -32.72 0.02 OUTLIER 'General case' 0 C--O 1.233 0.184 0 CA-C-O 120.89 0.376 . . . . 0.0 111.472 -179.915 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.423 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 124.74 19.66 2.46 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 121.114 -0.565 . . . . 0.0 111.844 -179.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.539 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 2.6 ppp? -179.65 165.18 1.31 Allowed 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.708 0.29 . . . . 0.0 111.149 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.837 HD12 ' HB3' ' A' ' 90' ' ' SER . 0.1 OUTLIER -146.52 136.96 17.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.743 179.632 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -82.79 142.54 31.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.467 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.622 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mt -142.21 110.91 6.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.88 0.371 . . . . 0.0 111.441 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.621 ' HB ' ' HB3' ' A' ' 69' ' ' ALA . 41.1 mm -88.49 142.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.431 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.532 HG21 ' CE2' ' A' ' 14' ' ' PHE . 26.8 m -141.05 179.74 2.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.757 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -131.19 139.36 49.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.56 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 27.3 ttm180 -143.75 149.7 37.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.04 -179.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.404 ' N ' ' HG2' ' A' ' 107' ' ' ARG . 0.2 OUTLIER -90.92 151.05 21.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.839 179.834 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.467 HG22 ' N ' ' A' ' 110' ' ' SER . 8.8 mm -85.35 160.69 3.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.982 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.467 ' N ' HG22 ' A' ' 109' ' ' ILE . 16.8 p . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.94 -179.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.256 0 N-CA-C 112.535 -0.226 . . . . 0.0 112.535 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . 0.412 ' HA ' ' CG1' ' A' ' 109' ' ' ILE . 39.2 p -59.23 166.5 2.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.053 0.454 . . . . 0.0 110.973 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' H ' ' HA ' ' A' ' 108' ' ' ARG . 13.4 mtt180 62.78 136.75 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.418 179.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 16.7 pt-20 -163.31 131.39 3.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.685 -0.688 . . . . 0.0 111.042 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -81.35 143.98 31.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.51 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 1.5 mt -139.17 141.07 38.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.984 0.421 . . . . 0.0 111.203 -179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.577 ' HA ' HD13 ' A' ' 104' ' ' ILE . 19.2 m -106.64 135.2 48.57 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.288 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.436 ' HE2' HG21 ' A' ' 105' ' ' VAL . 21.0 m-85 -135.31 130.96 35.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.086 0.47 . . . . 0.0 111.796 -179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -102.95 109.07 20.49 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.967 179.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.751 HG12 ' CB ' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -100.35 107.14 46.47 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.474 -179.094 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.838 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 72.9 Cg_endo -75.81 92.67 1.03 Allowed 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 122.62 2.213 . . . . 0.0 112.644 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.815 HD21 ' HB2' ' A' ' 96' ' ' ASN . 2.0 pp -82.99 24.52 0.76 Allowed 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 121.095 0.474 . . . . 0.0 111.139 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -43.63 -26.95 0.26 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.986 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -141.63 15.44 2.16 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.699 -179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 55.2 p -109.9 -7.83 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.731 0.3 . . . . 0.0 111.075 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -56.1 -31.15 58.67 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.493 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.51 -40.97 63.03 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.942 0.401 . . . . 0.0 110.447 179.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -97.63 -15.67 20.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.803 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 125.22 -50.54 0.86 Allowed Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.91 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' O ' HD12 ' A' ' 26' ' ' LEU . 6.0 tp 178.84 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.599 0.238 . . . . 0.0 111.103 179.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 55' ' ' ALA . . . 107.17 48.91 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.496 -0.859 . . . . 0.0 112.095 -179.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.858 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -171.6 162.1 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 121.082 0.468 . . . . 0.0 111.544 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.2 132.13 27.71 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.02 179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 1.029 HG11 HD11 ' A' ' 67' ' ' LEU . 5.6 m -121.61 151.13 24.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.126 0.489 . . . . 0.0 111.889 -179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.62 141.84 49.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.463 179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -105.29 137.01 13.49 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.814 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.98 175.93 5.67 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.849 0.357 . . . . 0.0 111.086 179.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 25.8 mtt180 -133.12 157.53 45.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.725 179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -60.32 143.26 53.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.752 179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.63 9.24 21.94 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.279 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 mt-10 -117.96 -32.55 4.74 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.563 -0.29 . . . . 0.0 111.244 -179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.798 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 0.9 OUTLIER -139.65 13.09 2.52 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 116.573 -0.285 . . . . 0.0 111.672 -179.656 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 4.1 m170 53.34 38.61 28.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.745 0.307 . . . . 0.0 111.31 179.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.798 ' HB2' ' OD1' ' A' ' 38' ' ' ASN . . . -91.82 119.81 31.96 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.9 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -52.34 108.32 0.28 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.86 0.362 . . . . 0.0 111.185 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.7 mt -73.84 -33.88 64.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.488 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 144.97 -163.29 28.06 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.646 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.082 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -116.02 151.82 17.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.785 0.326 . . . . 0.0 110.908 179.995 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . 0.455 ' CD1' ' N ' ' A' ' 45' ' ' PHE . 0.0 OUTLIER -134.3 142.23 47.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.332 179.864 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.576 ' HA ' HG12 ' A' ' 30' ' ' VAL . 35.7 t -51.88 104.56 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.043 0.449 . . . . 0.0 110.698 179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -83.02 -35.92 25.41 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.919 -179.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.56 161.26 26.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.014 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.858 HG23 HG13 ' A' ' 28' ' ' VAL . 8.1 mt -131.5 153.84 39.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.058 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.603 HD13 ' N ' ' A' ' 28' ' ' VAL . 4.5 mp -107.79 104.11 16.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.333 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.7 OUTLIER -65.34 74.65 0.06 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.8 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -172.65 -28.28 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.853 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -110.64 -169.98 19.47 Favored Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.876 -179.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.838 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -44.68 -51.02 9.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.873 ' HB1' HD11 ' A' ' 61' ' ' LEU . . . -51.7 -37.94 52.94 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.952 0.406 . . . . 0.0 111.088 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.569 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 30.6 t -69.34 -59.37 3.04 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.728 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.485 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -61.91 -24.01 66.69 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.249 -179.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.555 ' OD2' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.81 -50.75 69.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.842 0.353 . . . . 0.0 111.126 -179.698 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.54 39.81 97.12 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.361 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.435 ' HB3' ' CE1' ' A' ' 14' ' ' PHE . 0.3 OUTLIER -138.1 -53.69 0.63 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.166 0.508 . . . . 0.0 110.751 -179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.873 HD11 ' HB1' ' A' ' 55' ' ' ALA . 0.0 OUTLIER -54.84 89.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.981 179.908 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.402 ' NH1' ' HA ' ' A' ' 62' ' ' ARG . 1.2 mmp_? -77.77 140.73 39.48 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.609 179.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.466 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 12.1 t -66.75 72.19 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.16 -179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 169.47 -24.58 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.649 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -60.21 134.97 57.56 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.736 0.303 . . . . 0.0 111.058 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.484 ' NE2' HD13 ' A' ' 68' ' ' ILE . 0.0 OUTLIER -89.52 119.49 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.171 -179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 1.029 HD11 HG11 ' A' ' 30' ' ' VAL . 11.6 mt -63.32 128.09 34.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.723 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 HD13 ' NE2' ' A' ' 66' ' ' GLN . 22.7 mm -114.44 -30.59 2.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.536 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.563 ' HB3' ' HB ' ' A' ' 104' ' ' ILE . . . -157.18 168.72 26.61 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.021 0.438 . . . . 0.0 111.461 -179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.72 HG23 ' HG ' ' A' ' 103' ' ' LEU . 9.6 p -157.12 108.71 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.606 ' ND2' HG22 ' A' ' 70' ' ' VAL . 51.6 m-80 58.07 31.18 20.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.918 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.59 -17.1 59.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.643 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.62 102.55 10.73 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.769 0.318 . . . . 0.0 110.916 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 10.8 t -59.77 140.26 56.67 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.864 -179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.677 HD22 ' HA ' ' A' ' 83' ' ' ALA . 9.7 mt -107.25 -21.27 13.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -47.16 -48.6 23.4 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.214 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -74.1 -27.8 65.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.384 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 3.0 mttp -76.2 128.1 34.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.086 0.469 . . . . 0.0 111.116 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -67.6 -169.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.404 179.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.548 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 3.2 p30 -58.84 -52.58 65.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.1 -37.97 78.68 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.537 -179.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 85' ' ' GLU . 8.1 mt-10 -63.89 -51.96 62.15 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-O 121.233 0.539 . . . . 0.0 111.147 -179.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.082 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -63.07 -33.39 75.34 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.075 -179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.548 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.8 mtm -72.5 -30.95 64.96 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.347 179.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 82' ' ' GLU . 1.6 pt-20 -78.4 -38.07 42.48 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.443 179.22 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.436 HG22 HG11 ' A' ' 70' ' ' VAL . 1.1 m -64.85 -36.36 84.1 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.33 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.972 HD11 HD13 ' A' ' 67' ' ' LEU . 27.8 mt -67.44 -55.26 14.38 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 82.0 mtt180 -55.03 -31.88 61.42 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.216 177.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 6.6 mtt180 -67.68 -52.54 36.72 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.485 178.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.602 ' HB3' HD12 ' A' ' 101' ' ' ILE . 27.6 m -63.15 -30.4 71.56 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.018 179.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.773 ' HE1' HD22 ' A' ' 87' ' ' LEU . 0.0 OUTLIER -80.23 -17.45 52.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.078 179.644 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.5 t -93.25 -50.88 5.27 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.599 HG23 ' O ' ' A' ' 93' ' ' THR . 9.0 t -175.45 70.93 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.481 ' CG ' ' O ' ' A' ' 93' ' ' THR . 11.2 mt-10 -167.81 -45.43 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.338 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.447 ' O ' ' O ' ' A' ' 100' ' ' MET . . . -89.13 -30.53 14.01 Favored Glycine 0 N--CA 1.443 -0.88 0 N-CA-C 110.016 -1.233 . . . . 0.0 110.016 177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.815 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.5 t-20 -76.83 -91.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 178.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 96' ' ' ASN . 13.2 pttt 42.05 17.62 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.987 0.736 . . . . 0.0 112.987 179.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.459 ' N ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -170.12 -34.49 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.739 0.304 . . . . 0.0 111.552 -179.89 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.437 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 128.82 13.55 2.46 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.481 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.507 ' HA ' ' HA ' ' A' ' 17' ' ' PRO . 9.6 ptm -163.6 151.95 13.53 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.567 0.222 . . . . 0.0 111.008 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.698 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -142.59 149.12 19.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.823 179.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -98.22 143.83 28.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.878 -179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.72 ' HG ' HG23 ' A' ' 70' ' ' VAL . 1.5 mp -144.53 122.93 12.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.187 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.577 HD13 ' HA ' ' A' ' 13' ' ' THR . 40.4 mm -92.52 142.78 12.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.579 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 67' ' ' LEU . 17.0 m -141.26 156.42 21.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.808 -179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -119.2 131.54 55.85 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.236 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG2' ' N ' ' A' ' 108' ' ' ARG . 6.6 ttm180 -140.69 143.47 35.09 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.904 0.383 . . . . 0.0 111.239 -179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . 0.448 ' HA ' ' H ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -78.02 152.99 32.75 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.908 179.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 110' ' ' SER . 26.2 mm -79.76 157.86 4.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.844 0.354 . . . . 0.0 111.073 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.478 ' N ' HG22 ' A' ' 109' ' ' ILE . 42.7 p . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.315 0 N-CA-C 112.657 -0.177 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' THR . . . . . . . . . . . . . 10.8 p 54.74 38.39 30.02 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.779 0.323 . . . . 0.0 111.027 -179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.597 ' HE ' ' HB1' ' A' ' 106' ' ' ALA . 0.0 OUTLIER -168.64 135.43 1.91 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.831 179.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -140.97 134.78 30.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.077 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 18.9 m-85 -96.13 146.73 24.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.679 179.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.404 ' CD1' ' HD2' ' A' ' 107' ' ' ARG . 2.0 mt -142.48 150.23 40.25 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.169 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.441 HG23 ' CD1' ' A' ' 104' ' ' ILE . 15.1 m -118.0 136.07 53.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.405 179.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . 0.45 ' CD1' ' HB3' ' A' ' 60' ' ' ARG . 17.3 m-85 -135.73 138.08 42.36 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.107 0.48 . . . . 0.0 111.861 -179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -101.57 110.32 22.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.798 179.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.759 HG12 ' HB1' ' A' ' 54' ' ' ALA . 0.2 OUTLIER -104.2 104.87 46.49 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.548 -0.297 . . . . 0.0 111.636 -179.05 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.871 ' O ' ' HB2' ' A' ' 54' ' ' ALA . 3.8 Cg_exo -74.76 96.33 1.0 Allowed 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.882 2.388 . . . . 0.0 112.515 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.782 HD23 ' CG2' ' A' ' 101' ' ' ILE . 2.3 pp -87.25 23.49 1.83 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 121.15 0.5 . . . . 0.0 111.189 179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -41.06 -28.47 0.09 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.656 -0.702 . . . . 0.0 111.755 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.2 t0 -139.98 25.51 2.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.111 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.7 t -116.49 -16.37 10.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.261 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -47.61 -43.37 21.48 Favored Glycine 0 C--N 1.333 0.363 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.834 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.7 t -55.67 -27.99 53.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.931 0.395 . . . . 0.0 110.726 179.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -100.76 -23.79 14.53 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.092 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' A' ' 26' ' ' LEU . . . 103.41 38.41 2.83 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.184 -179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD11 ' HB ' ' A' ' 16' ' ' VAL . 41.0 tp 81.22 -12.09 1.04 Allowed 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 122.866 0.466 . . . . 0.0 112.033 179.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.85 ' C ' HD13 ' A' ' 50' ' ' ILE . . . 71.61 63.56 3.01 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.302 -0.952 . . . . 0.0 112.669 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . 0.836 HG13 HG23 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -176.3 153.81 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-O 120.932 0.396 . . . . 0.0 111.117 179.118 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.0 m -132.07 146.21 51.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.355 179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.987 HG11 HD11 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -126.29 159.25 35.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 121.119 0.485 . . . . 0.0 111.716 -179.72 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.17 131.03 41.84 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.12 -179.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -106.51 131.04 10.45 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.779 -179.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -109.22 -179.0 3.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.018 0.437 . . . . 0.0 111.191 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.438 ' HD3' ' CD2' ' A' ' 39' ' ' HIS . 9.7 mtt-85 -130.41 166.18 21.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.28 179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.642 ' HB2' ' HB3' ' A' ' 40' ' ' ALA . 19.7 t -51.44 136.02 26.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.86 0.362 . . . . 0.0 110.855 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.4 mptt -70.18 -11.9 61.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.179 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -108.06 -36.09 6.42 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.617 ' OD1' ' HB2' ' A' ' 40' ' ' ALA . 1.3 p30 -135.62 -167.87 2.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.987 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.438 ' CD2' ' HD3' ' A' ' 34' ' ' ARG . 0.2 OUTLIER -95.53 38.44 1.15 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.848 0.356 . . . . 0.0 110.924 -179.971 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.642 ' HB3' ' HB2' ' A' ' 35' ' ' SER . . . -90.5 110.55 21.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.041 179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -53.22 132.42 38.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.117 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 10.7 mt -100.22 -40.01 7.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.848 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.503 ' C ' HD13 ' A' ' 44' ' ' ILE . . . 148.17 -172.81 28.36 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.682 -0.771 . . . . 0.0 112.572 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ILE . . . . . 1.123 HD11 ' HB3' ' A' ' 83' ' ' ALA . 0.0 OUTLIER -110.29 155.37 11.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.761 0.315 . . . . 0.0 110.907 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.44 139.72 42.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.475 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 63' ' ' VAL . 24.3 t -51.91 104.92 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-O 120.971 0.415 . . . . 0.0 110.734 179.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 -37.29 27.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.996 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 29.1 t -160.21 165.65 31.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.089 0.471 . . . . 0.0 111.569 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.836 HG23 HG13 ' A' ' 28' ' ' VAL . 6.9 mt -137.09 151.54 27.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.58 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.85 HD13 ' C ' ' A' ' 27' ' ' GLY . 2.2 mp -103.49 100.02 9.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.465 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . 0.597 ' HA ' ' HB2' ' A' ' 56' ' ' SER . 0.4 OUTLIER -63.95 72.48 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.03 0.443 . . . . 0.0 110.923 -179.95 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 50' ' ' ILE . . . -173.15 -28.92 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.375 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . -108.39 -169.77 21.23 Favored Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.543 -0.836 . . . . 0.0 112.613 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.871 ' HB2' ' O ' ' A' ' 17' ' ' PRO . . . -42.9 -53.02 4.89 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 27' ' ' GLY . . . -51.18 -29.68 14.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.862 0.363 . . . . 0.0 111.421 -179.112 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.597 ' HB2' ' HA ' ' A' ' 51' ' ' ASN . 35.6 t -81.98 -58.94 2.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.741 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.489 ' CG ' ' HA ' ' A' ' 54' ' ' ALA . 0.0 OUTLIER -59.1 -24.45 62.96 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.111 -179.9 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.528 ' CG ' HG13 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -55.85 -50.46 70.52 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.763 179.981 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 64.97 15.19 60.02 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.811 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.45 ' HB3' ' CD1' ' A' ' 14' ' ' PHE . 2.8 mtm180 -114.8 -20.85 10.44 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.874 0.368 . . . . 0.0 110.977 179.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.486 ' N ' HD22 ' A' ' 61' ' ' LEU . 1.8 mm? -70.94 162.4 29.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.976 -179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -150.31 126.05 10.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.683 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.445 ' HA ' ' HB ' ' A' ' 46' ' ' VAL . 11.6 t -66.12 73.03 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.232 -179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 2.2 p30 168.01 -24.56 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.233 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -57.45 138.79 54.64 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.799 0.333 . . . . 0.0 111.06 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -90.0 115.87 27.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.902 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.987 HD11 HG11 ' A' ' 30' ' ' VAL . 96.2 mt -58.83 131.41 50.88 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.78 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.533 HG23 ' HG ' ' A' ' 76' ' ' LEU . 24.6 mm -119.37 -35.84 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.46 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.428 ' HB3' ' CG1' ' A' ' 104' ' ' ILE . . . -153.06 167.45 29.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.968 0.413 . . . . 0.0 111.51 -179.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.658 HG23 ' HG ' ' A' ' 103' ' ' LEU . 11.5 p -157.62 106.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.916 179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASN . . . . . 0.622 ' ND2' HG22 ' A' ' 70' ' ' VAL . 30.3 m-80 58.17 36.11 25.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.809 -179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.31 -16.13 60.55 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.532 -179.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLU . . . . . 0.437 ' HG2' HG23 ' A' ' 86' ' ' THR . 0.6 OUTLIER -79.42 99.11 7.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.832 0.349 . . . . 0.0 110.801 179.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.0 t -60.51 136.14 57.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.882 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.621 HD22 ' HA ' ' A' ' 83' ' ' ALA . 12.4 mt -106.79 -19.48 13.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.533 ' HG ' HG23 ' A' ' 68' ' ' ILE . 8.6 mt -46.55 -52.77 12.72 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-O 120.793 0.33 . . . . 0.0 111.23 -179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -70.3 -27.68 72.44 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.287 179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 6.5 mttp -76.1 133.0 40.39 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.084 0.468 . . . . 0.0 111.203 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -74.05 -169.75 0.81 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.197 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASN . . . . . 0.414 ' HB2' ' HE3' ' A' ' 84' ' ' MET . 7.6 p30 -59.65 -48.26 82.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.703 0.287 . . . . 0.0 110.966 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.17 -43.09 74.94 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.604 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -60.52 -53.04 62.31 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.068 0.461 . . . . 0.0 111.175 -179.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ALA . . . . . 1.123 ' HB3' HD11 ' A' ' 44' ' ' ILE . . . -62.09 -33.28 74.13 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.932 -0.577 . . . . 0.0 109.898 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' MET . . . . . 0.414 ' HE3' ' HB2' ' A' ' 80' ' ' ASN . 3.3 mtm -66.59 -29.89 70.05 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.169 178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -82.97 -41.76 18.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.78 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.437 HG23 ' HG2' ' A' ' 73' ' ' GLU . 1.9 m -62.34 -37.42 85.59 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.826 HD13 HG21 ' A' ' 30' ' ' VAL . 12.2 mt -69.01 -54.7 13.79 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 mtp180 -54.38 -30.95 53.69 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.193 177.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 -69.72 -44.91 69.37 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.178 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.714 ' HB3' HD12 ' A' ' 101' ' ' ILE . 24.0 m -66.7 -43.11 85.23 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.723 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' MET . . . . . 0.555 ' SD ' HD22 ' A' ' 26' ' ' LEU . 13.1 mmt -75.19 -15.53 60.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.832 179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.1 t -86.66 -51.28 6.22 Favored 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.55 HG23 ' O ' ' A' ' 93' ' ' THR . 8.8 t -176.3 64.8 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.753 0.311 . . . . 0.0 111.797 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.443 ' CG ' ' O ' ' A' ' 93' ' ' THR . 13.2 mt-10 -165.65 -49.26 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.338 -0.616 . . . . 0.0 109.338 179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLY . . . . . 0.438 ' CA ' ' HB ' ' A' ' 101' ' ' ILE . . . -68.58 -32.69 75.13 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 178.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.774 ' HB2' HD21 ' A' ' 18' ' ' LEU . 3.2 t-20 -81.1 -102.72 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.358 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.8 mmmt 44.78 21.2 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.333 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.429 ' CD ' ' O ' ' A' ' 96' ' ' ASN . 0.0 OUTLIER -168.5 -33.53 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.249 0 CA-C-O 120.736 0.303 . . . . 0.0 111.465 179.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 98' ' ' ARG . . . 123.2 17.6 3.27 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.324 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' MET . . . . . 0.552 ' HE2' ' N ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -177.52 158.71 1.42 Allowed 'General case' 0 N--CA 1.452 -0.355 0 CA-C-O 120.664 0.269 . . . . 0.0 111.213 -179.653 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.782 ' CG2' HD23 ' A' ' 18' ' ' LEU . 0.1 OUTLIER -145.43 140.87 22.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.801 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -96.09 145.62 25.33 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.961 -179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.774 HD11 HG12 ' A' ' 101' ' ' ILE . 3.4 mp -146.06 138.05 25.14 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.095 179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.441 ' CD1' HG23 ' A' ' 13' ' ' THR . 39.6 mm -102.08 142.85 15.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.67 179.631 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.59 167.8 20.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.31 -179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.597 ' HB1' ' HE ' ' A' ' 9' ' ' ARG . . . -134.59 141.51 46.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.918 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.404 ' HD2' ' CD1' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -133.08 148.97 52.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.86 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.97 146.95 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.793 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.425 HG22 ' N ' ' A' ' 110' ' ' SER . 10.7 mm -94.64 159.31 2.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.166 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.425 ' N ' HG22 ' A' ' 109' ' ' ILE . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -180.0 . . . . . . . . 2 2 . 1 stop_ save_